| | OMB APPROVAL |
| | OMB Number: | 3235-0570 |
| | Expires: | June 30, 2021 |
| UNITED STATES | Estimated average burden hours per response. . . . . . . . . . . . . . .20.6 |
| SECURITIES AND EXCHANGE COMMISSION | |
| Washington, D.C. 20549 | |
FORM N-CSR
CERTIFIED SHAREHOLDER REPORT OF REGISTERED
MANAGEMENT INVESTMENT COMPANIES
Investment Company Act file number | 811-07986 |
|
The Alger Institutional Funds |
(Exact name of registrant as specified in charter) |
|
360 Park Avenue South New York, New York | | 10010 |
(Address of principal executive offices) | | (Zip code) |
|
Mr. Hal Liebes Fred Alger Management, Inc. 360 Park Avenue South New York, New York 10010 |
(Name and address of agent for service) |
|
Registrant’s telephone number, including area code: | 212-806-8800 | |
|
Date of fiscal year end: | October 31 | |
|
Date of reporting period: | April 30, 2019 | |
| | | | | | | | |
Form N-CSR is to be used by management investment companies to file reports with the Commission, not later than 10 days after the transmission to Stockholders of any report to be transmitted to Stockholders under Rule 30e-1 under the Investment Company Act of 1940 (17 CFR 270.30e1). The Commission may use the information provided on Form N-CSR in its regulatory, disclosure review, inspection, and policymaking roles.
A registrant is required to disclose the information specified by Form N-CSR, and the Commission will make this information public. A registrant is not required to respond to the collection of information contained in Form N-CSR unless the Form displays a currently valid Office of Management and Budget (“OMB”) control number. Please direct comments concerning the accuracy of the information collection burden estimate and any suggestions for reducing the burden to the Secretary, Securities and Exchange Commission, 450 Fifth Street, NW, Washington, DC 20549-0609. The OMB has reviewed this collection of information under the clearance requirements of 44 U.S.C. § 3507.
ITEM 1. REPORT(S) TO STOCKHOLDERS.
![](https://capedge.com/proxy/N-CSRS/0001104659-19-038912/g72444bi01i001.jpg)
Table of Contents
The Alger Institutional Funds | |
| |
Shareholders’ Letter | 1 |
| |
Fund Highlights | 11 |
| |
Portfolio Summary | 19 |
| |
Schedules of Investments | 20 |
| |
Statements of Assets and Liabilities | 37 |
| |
Statements of Operations | 41 |
| |
Statements of Changes in Net Assets | 43 |
| |
Financial Highlights | 47 |
| |
Notes to Financial Statements | 62 |
| |
Additional Information | 85 |
Optional Internet Availability of Alger Shareholder Reports
Beginning on January 1, 2021, as permitted by regulations adopted by the Securities and Exchange Commission, paper copies of The Alger Funds’ shareholder reports like this one will no longer be sent by mail, unless you specifically request paper copies of the reports from the Fund or from your financial intermediary. Instead, the reports will be made available on a website, and you will be notified by mail each time a report is posted and provided with a website link to access the report.
If you already elected to receive shareholder reports electronically, you will not be affected by this change and you need not take any action. You may elect to receive shareholder reports and other communications from the Fund electronically by contacting your financial intermediary or, if you are a direct investor, by signing up for paperless delivery at www.icsdelivery.com/alger.
You may elect to receive all future reports in paper free of charge. If you invest directly with the Fund you can inform the Fund that you wish to continue receiving paper copies of your shareholder reports by calling 1-866-345-5954 or visiting fundreports.com. If you invest through a financial intermediary, you can contact your financial intermediary to elect to continue receiving paper copies of your shareholder reports. Your election to receive reports in paper will apply to all funds held within the Alger Fund Complex or with your financial intermediary.
Shareholders’ Letter (Unaudited) | | April 30, 2019 |
Dear Shareholders,
Equities Rally as Economic Recovery Marches toward 10th Birthday
During the six-month reporting period ended April 30, 2019, the economic recovery marched toward a potential mid-year milestone—its 10th birthday. Despite encouraging economic data, market pundits predictably and frequently opined that the duration of the economic recovery could point to an economic slowdown or recession leading to a bear market. Notwithstanding this sentiment, the S&P 500 Index returned 9.76% during the reporting period while, in our view, economic data continued to suggest that a recession was unlikely in the near future. During the reporting period, our investment team navigated considerable market volatility by continuing to focus on what we have done for over 50 years—fundamental stock research. We also spent time reaffirming our broad investment themes, including innovation that is surging through all economic sectors. Our continuing research resulted in us staying the course while maintaining a positive outlook for equities.
Volatility Returns
The S&P 500 Index hit a peak on October 3, 2018 and then fell 19.25% to a December 24, 2018 low of 2351.1. It then rallied 26.13% from the December 24 low until the close of markets on April 30, 2019. Emerging markets led during the reporting period with the MSCI Emerging Markets Index returning 13.89% compared to the 9.15% gain of the MSCI World Index of developed markets. From a broader perspective, international markets returned 9.39% as measured by the MSCI ACWI ex USA Index. Wise investors did not react to the sharp, yet short-term, selloff, but instead stayed focused on the long-term potential of their investments.
Staying the Course
Pessimists frequently focused on the aging of the economic recovery, but we believe that cumulative growth is a more important factor to assess. While the current recovery has been longer than typical, it has generated real cumulative growth of approximately 20% compared to growth of typically more than 35% associated with expansions occurring after 1960, according to data from the U.S. Bureau of Economic Analysis. In addition, the Conference Board Leading Economic Index, which we believe is a good indicator of future economic activity, has remained positive year over year and was up 3% as of the end of April. Since the late 1960s, recessions haven’t occurred until the index declined 3.4% on average year over year.
Market pundits also pounced upon the fourth quarter market decline as an example that the bull market was dying, but we viewed it as an opportunity to buy high-quality companies and we believed that equities could snap back. Since 1987 equity returns have averaged 19% after P/E ratios declined by double-digit amounts, according to data from FactSet Research Systems. We reasoned that with the S&P 500 Index P/E dropping 21% in the fourth quarter, the market was ready to rally. We believe the attractive P/E ratios resulting from the selloff and optimism regarding trade negotiations between the U.S. and China resulted in the strong market gains during the first four months of 2019.
1
Pundits also focused on declining earnings estimates later in the reporting period. By the end of the six-month reporting period ended April 30, 2019, 46% of S&P 500 companies had reported first quarter results. Based on reported results and estimates for companies that hadn’t reported, first quarter earnings were expected to decline 2.3% year over year, which would be the first year-over-year decline since the second quarter of 2016, according to FactSet Research Systems. For calendar year 2019, earnings are forecast to grow only 3% to 4% compared to 20% last year, according to FactSet Research Systems.
However, during the past 35 years, the Russell 1000 Growth Index generated a median return of 15.8% compared to 14.1% for the Russell 1000 Value Index during periods when earnings growth weakened. We believe this outperformance resulted from the less cyclical nature of growth equities and the tendency for value stocks to have more operational and financial leverage. Going forward, earnings growth is expected to strengthen and reach 8.1% in the final quarter of this year, according to FactSet Research Systems data as of the end of the six-month reporting period ended April 30, 2019.
Moderating economic growth was another concern among pundits. In March the Federal Reserve (the Fed) lowered its prior estimate for 2019 U.S. gross domestic product (GDP) growth from 2.3% to 2.1% while GDP grew 3.1% in 2018. Based on our observations of innovation that is surging through virtually all industries, we continued to believe that the economy is healthy. This belief was confirmed when first quarter 2019 GDP grew 3.2%, the strongest first quarter since 2015. In addition, with the exception of four years associated with recessions, the S&P 500 Index has generated positive gains during periods of moderating GDP growth occurring during the past 35 years.(1) We believe there is no reason to expect a recession this year and we believe that a recession is unlikely in 2020.
Going Forward
We remain optimistic due to the positive Conference Board Leading Economic Index, favorable monetary policy, potential earnings growth and most importantly, innovation that is occurring throughout the economy and supporting economic growth. Regarding monetary policy, the real fed funds rate(2) is under 1%, which we believe is encouraging. Over the past half century, every U.S. recession was preceded by a materially positive real fed funds rate of 2% or higher. For much of 2018, many market pundits thought the Fed would raise interest rates three to four times in 2019. We, on the other hand, argued and correctly predicted that this was highly unlikely and moreover that, regardless of Fed actions, interest rates would remain very low by historical standards and moderate by recent ones. We were correct. The Fed in fact has paused its rate increases since its December 2018 meeting. Oddly, the same pundits have flipped 180 degrees and suggest that the Fed might actually cut rates more than once this year. We think they are again incorrect. Our view is that we are on pause for 2019, and while there might be one more Fed rate action in the next 18 months, the direction is unclear.
We believe that when considering current interest rates and corporate earnings, equities remain very attractive. The “earnings yield” or the inverse of price-to-equity ratios for the S&P 500 Index has historically been just modestly above 10-year Treasury yields. Since the global financial crisis, however, the spread has widened and was approximately 340 basis points as of April 30, 2019, which we believe makes equities attractive relative to bonds.
2
We are also optimistic that earnings growth will improve when considering that certain idiosyncratic factors, such as weak semiconductor and energy sector profits, have been limiting the growth of corporate profits. As the semiconductor cycle improves and higher oil prices flow through oil and gas company financial statements, we believe overall earnings growth should improve by the end of the year. According to FactSet Research Systems consensus expectations, earnings growth could reach 8.1% for the fourth quarter of this year.
We are also optimistic because innovation is strong. The digital revolution, including the Internet of Things, cloud computing, artificial intelligence, driver assistance technology and 5G wireless communication, is helping leading corporations grow their earnings by creating new products and services that are disrupting legacy business models. In closing we intend to continue to focus on conducting in-depth fundamental research to find companies that are positioned to potentially grow their earnings by capturing market share or creating new niches with innovative products and services.
Portfolio Matters
Alger Capital Appreciation Institutional Fund
The Alger Capital Appreciation Institutional Fund returned 12.99% for the fiscal six-month period ended April 30, 2019, compared to the 12.09% return of the Russell 1000 Growth Index.
Contributors to Performance
During the reporting period, the largest portfolio sector weightings were Information Technology and Health Care. The largest sector overweight was Health Care and the largest underweight was Consumer Staples. The Consumer Discretionary and Information Technology sectors provided the greatest contributions to relative performance.
Among individual positions, Microsoft Corp.; Amazon.com, Inc.; Visa, Inc., Cl. A; Adobe. Inc.; and Facebook, Inc., Cl. A. were the top contributors to performance. Shares of Amazon.com performed strongly in response to the company continuing to take market share from brick and mortar retailers. Strong growth of the company’s web hosting and digital advertising services also supported the performance of Amazon.com shares.
Detractors from Performance
Consumer Staples and Industrials were among the sectors that detracted from results. Among individual positions, Apple, Inc.; UnitedHealth Group, Inc.; Conagra Brands, Inc.; NVIDIA Corp.; and Cigna Corp. were the top detractors from performance. Apple is a leading technology provider in telecommunications, computing and services. Apple’s iOS operating system is the company’s unique intellectual property and competitive strength. This software drives extremely tight engagement with consumers and enterprises. Such engagement fosters growing purchases of high margin services such as music and apps, along with increasing use of Apple Pay. The shares underperformed earlier in the reporting period as investors considered a slowing consumer demand environment for smartphones, which is driven by some skepticism around the utility of phones sold at increasingly high price points.
3
Alger Focus Equity Fund
The Alger Focus Equity Fund returned 13.35% for the fiscal six-month period ended April 30, 2019, compared to the 12.09% return of the Russell 1000 Growth Index.
Contributors to Performance
During the reporting period, the largest sector weightings were Information Technology and Consumer Discretionary. The largest sector overweight was Health Care and the largest underweight was Consumer Staples. The Health Care and Information Technology sectors provided the greatest contributions to relative performance.
Regarding individual positions, Amazon.com, Inc.; Microsoft Corp.; Altaba, Inc.; Visa, Inc., Cl. A; and Adobe, Inc. were the top contributors to performance. Microsoft created the world’s leading desktop operating system and it is transitioning its products to the cloud, which we believe is improving the company’s potential for increasing its profits. In addition, Microsoft’s enterprise cloud product, Azure, is rapidly growing and capturing market share. The company generates very strong free cash flow that it is returning to shareholders through dividends and share repurchases. Its shares performed strongly in response to investors’ reactions to the company’s positive lifecycle change in moving products to the cloud.
Detractors from Performance
The Consumer Staples and Industrials sectors were among the sectors that detracted from results. Regarding individual positions, Apple, Inc.; Vail Resorts, Inc.; UnitedHealth Group, Inc.; NVIDIA Corp.; and Cigna Corp. were among the top detractors from results. Shares of Apple underperformed in response to developments identified in the Alger Capital Appreciation Institutional Fund discussion.
Alger Mid Cap Growth Institutional Fund
The Alger Mid Cap Growth Institutional Fund returned 11.29% for the fiscal six-month period ended April 30, 2019, compared to the 16.55% return of the Russell Midcap Growth Index.
Contributors to Performance
During the reporting period, the largest sector weightings were Information Technology and Health Care. The largest sector overweight was Health Care and the largest underweight was Information Technology. The Industrials and Real Estate sectors provided the largest contributions to relative performance.
Among individual positions, Avalara, Inc.; ServiceNow, Inc.; Tandem Diabetes Care, Inc.; Advanced Micro Devices, Inc.; and Veeva Systems, Inc., Cl. A were among the top contributors to performance. Tandem Diabetes Care provides the t:slim X2 Insulin Delivery System for treating diabetes. It is the smallest durable insulin pump available and it is the only pump on the market with software that can be updated remotely. The company also sells insulin reservoir cartridges and infusion sets for use with its pumps. Tandem stock outperformed after the company announced stronger-than-expected fourth quarter 2018 financial results. The company’s new t:slim X2 insulin pump with a Basal-IQ algorithm and integration with a no-calibration continuous glucose monitoring (CGM) sensor has helped Tandem gain significant U.S. market share. Tandem sales have also benefited from the company expanding internationally and a competitor exiting the insulin pump market in late 2017.
4
Detractors from Performance
The Consumer Discretionary and Information Technology sectors were among the sectors that detracted from results. Among individual positions, Take-Two Interactive Software, Inc.; Conagra Brands, Inc.; Vail Resorts, Inc.; GrubHub, Inc.; and Yelp, Inc. were among the top detractors from performance. Take-Two Interactive owns the Rockstar Games and 2K videogame studios and distributes titles such as Grand Theft Auto, Red Dead Redemption, NBA 2K and Borderlands. Shares of Take-Two Interactive underperformed in response to the company’s lower-than-expected revenue and profitability guidance for the fiscal fourth quarter ending March 31, 2019.
Alger Small Cap Growth Institutional Fund
The Alger Small Cap Growth Institutional Fund returned 11.74% for the fiscal six-month period ended April 30, 2019, compared to the 8.27% return of the Russell 2000 Growth Index.
Contributors to Performance
During the reporting period, the largest sector weightings were Health Care and Information Technology. The largest sector overweight was Health Care and the largest underweight was Industrials. The Information Technology and Energy sectors provided the largest contributions to relative performance.
Among individual positions, Veeva Systems, Inc., Cl. A; Avalara, Inc.; Etsy, Inc.; Paycom Software, Inc.; and Shopify, Inc., Cl. A were among the top contributors to performance. Veeva Systems is a leading provider of cloud-based solutions for the global life sciences industry. Veeva’s key solutions are its Commercial Cloud products, offering multi-channel customer relationship management software, and Veeva Vault, offering regulated content management for pharmaceutical and biotechnology companies. Shares of Veeva performed strongly after the company reported better-than-expected fiscal fourth quarter 2019 results and raised its fiscal year 2020 guidance. Veeva’s key growth driver has been the strong adoption of Veeva Vault, increased its revenue 49% in fiscal year 2019 and represents 47% of Veeva’s total revenue. Veeva also demonstrated strong operating margin expansion during the year and we believe it has potential to continue its strong growth in fiscal year 2020, in part due to its very robust pipeline of new products.
Detractors from Performance
The Industrials and Communication Services sectors were among the sectors that detracted from results. Among individual positions, Inogen, Inc.; Take-Two Interactive Software, Inc.; ABIOMED, Inc.; Sun Hydraulics Corp.; and HealthEquity, Inc. were among the top detractors from performance. Shares of Take-Two Interactive underperformed in response to developments identified in the Alger Mid Cap Growth Institutional Fund discussion.
5
I thank you for putting your trust in Alger.
Sincerely,
![](https://capedge.com/proxy/N-CSRS/0001104659-19-038912/g72444bi01i002.gif)
Daniel C. Chung, CFA
Chief Investment Officer
Fred Alger Management, Inc.
(1) Source: FactSet Research Systems and Alger. Periods of material slowing of GDP are defined as negative change in the annual real GDP growth rate of 50 basis points or more.
(2) Fed funds are overnight loans banks use to meet reserve requirement at the end of each day. The real rate of the fed funds is the interest rate charged for these overnight loans established by the Federal Reserve minus the year-over-year change in the PCE Price Index (personal consumption expenditure) ex food and energy.
This report and the financial statements contained herein are submitted for the general information of shareholders of the funds. This report is not authorized for distribution to prospective investors in a fund unless preceded or accompanied by an effective prospectus for the fund. Fund returns represent the fiscal six-month period return of Class I shares.
The performance data quoted represents past performance, which is not an indication or guarantee of future results.
Investors cannot invest directly in an index. Index performance does not reflect the deduction for fees, expenses or taxes.
Standardized performance results can be found on the following pages. The investment return and principal value of an investment in a fund will fluctuate so that an investor’s shares, when redeemed, may be worth more or less than their original cost. Current performance may be lower or higher than the performance quoted. For performance data current to the most recent month-end, visit us at www.alger.com, or call us at (800) 992-3863.
The views and opinions of the funds’ management in this report are as of the date of the Shareholders’ Letter and are subject to change at any time subsequent to this date. There is no guarantee that any of the assumptions that formed the basis for the opinions stated herein are accurate or that they will materialize. Moreover, the information forming the basis for such assumptions is from sources believed to be reliable; however, there is no guarantee that such information is accurate. Any securities mentioned, whether owned in a fund or otherwise, are considered in the context of the construction of an overall portfolio of securities and therefore reference to them should not be construed as a recommendation or offer to purchase or sell any such security. Inclusion of such securities in a fund and transactions in such securities, if any, may be for a variety of reasons, including, without limitation, in response to cash flows, inclusion in a benchmark, and risk control. The reference to a specific security should also be understood in such context and not viewed as a statement that the security is a significant holding in a fund. Please refer to the Schedules of Investments for each fund that is included in this report for a complete list of fund holdings as of April 30, 2019. Securities mentioned in the Shareholders’ Letter, if not found in the Schedule of Investments, may have been held by the funds during the fiscal six-month period April 30, 2019.
6
Risk Disclosures
Alger Capital Appreciation Institutional Fund
Investing in the stock market involves risks, and may not be suitable for all investors. Growth stocks tend to be more volatile than other stocks as their prices tend to be higher in relation to their companies’ earnings and may be more sensitive to market, political, and economic developments. A significant portion of assets will be invested in technology and healthcare companies, which may be significantly affected by competition, innovation, regulation, and product obsolescence, and may be more volatile than the securities of other companies.
Alger Focus Equity Fund
Investing in the stock market involves risks, and may not be suitable for all investors. Growth stocks tend to be more volatile than other stocks as their prices tend to be higher in relation to their companies’ earnings and may be more sensitive to market, political, and economic developments. A significant portion of assets will be invested in technology companies, which may be significantly affected by competition, innovation, regulation, and product obsolescence, and may be more volatile than the securities of other companies. Assets may be focused in a small number of holdings, making them susceptible to risks associated with a single economic, political or regulatory event than a more diversified portfolio. Active trading may increase transaction costs, brokerage commissions, and taxes, which can lower the return on investment.
Alger Mid Cap Growth Institutional Fund
Investing in the stock market involves risks, and may not be suitable for all investors. Growth stocks tend to be more volatile than other stocks as their prices tend to be higher in relation to their companies’ earnings and may be more sensitive to market, political, and economic developments. A significant portion of assets will be invested in technology and healthcare companies, which may be significantly affected by competition, innovation, regulation, and product obsolescence, and may be more volatile than the securities of other companies. Investing in companies of medium capitalizations involves the risk that such issuers may have limited product lines or financial resources, lack management depth, or have limited liquidity.
Alger Small Cap Growth Institutional Fund
Investing in the stock market involves risks, and may not be suitable for all investors. Growth stocks tend to be more volatile than other stocks as their prices tend to be higher in relation to their companies’ earnings and may be more sensitive to market, political, and economic developments. A significant portion of assets will be invested in technology and healthcare companies, which may be significantly affected by competition, innovation, regulation, and product obsolescence, and may be more volatile than the securities of other companies. Investing in companies of small capitalizations involves the risk that such issuers may have limited product lines or financial resources, lack management depth, or have limited liquidity.
For a more detailed discussion of the risks associated with a fund, please see the Prospectus.
7
Before investing, carefully consider a fund’s investment objective, risks, charges, and expenses.
For aprospectus or a summaryprospectus containing this and other information about The Alger Institutional Funds call us at (800) 992-3863 or visit us at www.alger.com. Read it carefully before investing.
Fred Alger & Company, Incorporated, Distributor. Member NYSE Euronext, SIPC. NOT FDIC INSURED. NOT BANK GUARANTEED. MAY LOSE VALUE. Definitions:
· The S&P 500 Index: An index of large company stocks considered to be representative of the U.S. stock market.
· The Russell 1000 Growth Index measures the performance of the large-cap growth segment of the U.S. equity universe. It includes those Russell 1000 companies with higher growth earning potential as defined by Russell’s lead-ing style methodology. The Russell 1000 Growth Index is constructed to provide a comprehensive and unbiased barometer for the large-cap growth segment.
· The Russell 1000 Value Index measures the performance of those Russell 1000 companies with lower price/book ratios and lower forecasted growth values.
· The MSCI ACWI ex USA Index (gross) captures large and mid cap represen-tation across 23 of 24 Developed Markets (DM) countries (excluding the US) and 23 Emerging Markets (EM) countries. The index covers approximately 85% of the global equity opportunity set outside the US.
· The MSCI World Index is a broad global equity benchmark that represents large and mid-cap equity performance of 23 developed market countries.
· The Conference Board Leading Economic Index is based on a variety of economic data and is part of the Conference Board’s analytic system that seeks to signal peaks and troughs in the business cycle.
· The Morgan Stanley Capital International (MSCI) Emerging Markets Index (gross) is a free float-adjusted market capitalization index that is designed to measure equity market performance in the global emerging markets.
· The Russell Midcap Growth Index measures the performance of the mid-cap growth segment of the U.S. equity universe. It includes those Russell Midcap Index companies with higher growth earning potential as defined by Russell’s leading style methodology. The Russell Midcap Growth Index is constructed to provide a comprehensive and unbiased barometer of the mid-cap growth market. Russell 2500 Growth Index: An unmanaged index designed to measure the performance of the 2,500 smallest companies in the Russell 3000 Index with higher price-to-book ratios and higher forecasted growth values.
· The Russell 2000 Growth Index measures the performance of the small-
8
cap growth segment of the U.S. equity universe. It includes those Russell 2000 companies with higher growth earning potential as defined by Russell’s leading style methodology. The Russell 2000 Growth Index is constructed to provide a comprehensive and unbiased barometer for the small-cap growth segment.
· FactSet Research Systems provides data and research for investment managers, hedge funds, investment bankers and other financial professionals.
9
FUND PERFORMANCE AS OF 3/31/19 (Unaudited)
AVERAGE ANNUAL TOTAL RETURNS
| | 1 YEAR | | 5 YEARS | | 10 YEARS | | SINCE INCEPTION | |
Alger Capital Appreciation Institutional Class I (Inception 11/8/93) | | 11.37 | % | 12.46 | % | 17.27 | % | 12.13 | % |
Alger Capital Appreciation Institutional Class R (Inception 1/27/03)* | | 10.86 | % | 11.94 | % | 16.70 | % | 11.57 | % |
Alger Capital Appreciation Institutional Class Y (Inception 2/28/17) | | 11.80 | % | n/a | | n/a | | 16.90 | % |
Alger Capital Appreciation Institutional Class Z.2 (Inception 10/14/16) | | 11.71 | % | n/a | | n/a | | 18.23 | % |
Alger Focus Equity Class A (Inception 12/31/12) | | 6.54 | % | 12.75 | % | n/a | | 15.64 | % |
Alger Focus Equity Class C (Inception 12/31/12) | | 10.60 | % | 13.11 | % | n/a | | 15.76 | % |
Alger Focus Equity Class I (Inception 11/8/93) | | 12.50 | % | 14.05 | % | 16.39 | % | 9.28 | % |
Alger Focus Equity Class Y (Inception 2/28/17) | | 12.85 | % | n/a | | n/a | | 19.50 | % |
Alger Focus Equity Class Z (Inception 12/31/12) | | 12.84 | % | 14.36 | % | n/a | | 17.05 | % |
Alger Mid Cap Growth Institutional Class I (Inception 11/8/93) | | 9.21 | % | 9.04 | % | 15.23 | % | 11.73 | % |
Alger Mid Cap Growth Institutional Class R (Inception 1/27/03)* | | 8.71 | % | 8.48 | % | 14.63 | % | 11.17 | % |
Alger Mid Cap Growth Institutional Class Z.2 (Inception 10/14/16) | | 9.55 | % | n/a | | n/a | | 17.70 | % |
Alger Small Cap Growth Institutional Class I (Inception 11/8/93) | | 15.31 | % | 9.59 | % | 15.59 | % | 9.69 | % |
Alger Small Cap Growth Institutional Class R (Inception 1/27/03)* | | 14.78 | % | 9.06 | % | 15.04 | % | 9.16 | % |
Alger Small Cap Growth Institutional Class Z.2 (Inception 8/1/16) | | 15.72 | % | n/a | | n/a | | 20.20 | % |
The performance data quoted represents past performance, which is not an indication or a guarantee of future results. The Fund’s average annual total returns include changes in share price and reinvestment of dividends and capital gains.
On October 15, 2018, Alger Capital Appreciation Focus Fund changed its name to Alger Focus Equity Fund.
* Since inception performance is calculated from 11/8/93. Performance figures prior to 1/27/03, inception of Class R shares, are those of the Fund’s Class I Shares. The performance figures prior to 1/27/03 have been reduced to reflect the higher operating expenses of Class R shares.
10
ALGER CAPITAL APPRECIATION INSTITUTIONAL FUND
Fund Highlights Through April 30, 2019 (Unaudited)
HYPOTHETICAL $10,000 INVESTMENT IN CLASS I SHARES
— 10 years ended 4/30/19
![GRAPHIC](https://capedge.com/proxy/N-CSRS/0001104659-19-038912/g72444bi03i001.gif)
The chart above illustrates the change in value of a hypothetical $10,000 investment made in the Alger Capital Appreciation Institutional Fund Class I shares and the Russell 1000 Growth Index (an unmanaged index of common stocks) for the ten years ended April 30, 2019. Figures for the Alger Capital Appreciation Institutional Fund Class I shares and the Russell 1000 Growth Index include reinvestment of dividends. Figures for the Alger Capital Appreciation Institutional Fund Class I shares also include reinvestment of capital gains. Performance for the Alger Capital Appreciation Institutional Fund Class R, Class Y and Class Z-2 shares may vary from the results shown above due to differences in expenses the class bears. Investors cannot invest directly in any index. Index performance does not reflect deduction for fees, expenses, or taxes.
11
ALGER CAPITAL APPRECIATION INSTITUTIONAL FUND
Fund Highlights Through April 30, 2019 (Unaudited) (Continued)
PERFORMANCE COMPARISON AS OF 4/30/19
AVERAGE ANNUAL TOTAL RETURNS
| | 1 YEAR | | 5 YEARS | | 10 YEARS | | Since 11/8/1993 | |
Class I (Inception 11/8/93) | | 15.30 | % | 13.80 | % | 16.77 | % | 12.30 | % |
Class R (Inception 1/27/03)* | | 14.82 | % | 13.27 | % | 16.20 | % | 11.74 | % |
Russell 1000 Growth Index | | 17.43 | % | 14.50 | % | 16.96 | % | 9.65 | % |
| | 1 YEAR | | 5 YEARS | | 10 YEARS | | Since 2/28/2017 | |
Class Y (Inception 2/28/17) | | 15.80 | % | n/a | | n/a | | 18.91 | % |
Russell 1000 Growth Index | | 17.43 | % | n/a | | n/a | | 18.53 | % |
| | 1 YEAR | | 5 YEARS | | 10 YEARS | | Since 10/14/2016 | |
Class Z-2 (Inception 10/14/16) | | 15.67 | % | n/a | | n/a | | 19.90 | % |
Russell 1000 Growth Index | | 17.43 | % | n/a | | n/a | | 20.36 | % |
The performance data quoted represents past performance, which is not an indication or a guarantee of future results. The Fund’s average annual total returns include changes in share price and reinvestment of dividends and capital gains. The chart and table above do not reflect the deduction of taxes that a shareholder would have paid on Fund distributions or on the redemption of Fund shares. Investment return and principal will fluctuate and the Fund’s shares, when redeemed, may be worth more or less than their original cost. Current performance may be higher or lower than the performance quoted. For updated performance, visit us at www.alger.com or call us at (800) 992-3863.
* Performance figures prior to 1/27/03, inception of Class R shares, are those of the Fund’s Class I Shares. The performance
figures prior to 1/27/03 have been reduced to reflect the higher operating expenses of Class R shares.
12
ALGER FOCUS EQUITY FUND
Fund Highlights Through April 30, 2019 (Unaudited)
HYPOTHETICAL $10,000 INVESTMENT IN CLASS I SHARES
— 10 years ended 4/30/19
![GRAPHIC](https://capedge.com/proxy/N-CSRS/0001104659-19-038912/g72444bi03i002.gif)
The chart above illustrates the change in value of a hypothetical $10,000 investment made in the Alger Focus Equity Fund Class I shares and the Russell 1000 Growth Index (an unmanaged index of common stocks) for the ten years ended April 30, 2019. On October 15, 2018, Alger Capital Appreciation Focus Fund changed its name to Alger Focus Equity Fund. Beginning December 31, 2012, Alger Focus Equity Fund changed its investment strategy to invest in a smaller number of issuers. Figures for Alger Focus Equity Fund Class I shares and the Russell 1000 Growth Index include reinvestment of dividends. Figures for the Alger Focus Equity Fund Class I shares also include reinvestment of capital gains. Performance for Alger Focus Equity Fund Class A, Class C, Class Y and Class Z shares may vary from the results shown above due to differences in expenses the class bears. Investors cannot invest directly in any index. Index performance does not reflect deduction for fees, expenses, or taxes.
13
ALGER FOCUS EQUITY FUND
Fund Highlights Through April 30, 2019 (Unaudited) (Continued)
PERFORMANCE COMPARISON AS OF 04/30/19
AVERAGE ANNUAL TOTAL RETURNS
| | 1 YEAR | | 5 YEARS | | 10 YEARS | | Since 11/8/1993 | |
Class I (Inception 11/8/93) | | 16.17 | % | 15.45 | % | 16.04 | % | 9.47 | % |
Russell 1000 Growth Index | | 17.43 | % | 14.50 | % | 16.96 | % | 9.65 | % |
| | | | | | | | Since | |
| | 1 YEAR | | 5 YEARS | | 10 YEARS | | 12/31/2012 | |
Class A (Inception 12/31/12) | | 10.03 | % | 14.14 | % | n/a | | 16.39 | % |
Class C (Inception 12/31/12) | | 14.27 | % | 14.52 | % | n/a | | 16.50 | % |
Class Z (Inception 12/31/12) | | 16.52 | % | 15.78 | % | n/a | | 17.79 | % |
Russell 1000 Growth Index | | 17.43 | % | 14.50 | % | n/a | | 16.70 | % |
| | | | | | | | Since | |
| | 1 YEAR | | 5 YEARS | | 10 YEARS | | 2/28/2017 | |
Class Y (Inception 2/28/17) | | 16.56 | % | n/a | | n/a | | 21.65 | % |
Russell 1000 Growth Index | | 17.43 | % | n/a | | n/a | | 18.53 | % |
The performance data quoted represents past performance, which is not an indication or a guarantee of future results. The Fund’s average annual total returns include changes in share price and reinvestment of dividends and capital gains. Class A returns reflect the maximum initial sales charge and Class C returns reflect the applicable contingent deferred sales charge. The chart and table above do not reflect the deduction of taxes that a shareholder would have paid on Fund distributions or on the redemption of Fund shares. Investment return and principal will fluctuate and the Fund’s shares, when redeemed, may be worth more or less than their original cost. Current performance may be higher or lower than the performance quoted. For updated performance, visit us at www.alger.com or call us at (800) 992-3863.
14
ALGER MID CAP GROWTH INSTITUTIONAL FUND
Fund Highlights Through April 30, 2019 (Unaudited)
HYPOTHETICAL $10,000 INVESTMENT IN CLASS I SHARES
— 10 years ended 4/30/19
![GRAPHIC](https://capedge.com/proxy/N-CSRS/0001104659-19-038912/g72444bi05i001.gif)
The chart above illustrates the change in value of a hypothetical $10,000 investment made in the Alger Mid Cap Growth Institutional Fund Class I shares and the Russell Midcap Growth Index (an unmanaged index of common stocks) for the ten years ended April 30, 2019. Figures for Alger Mid Cap Growth Institutional Fund Class I shares and the Russell Midcap Growth Index include reinvestment of dividends. Figures for the Alger Mid Cap Growth Institutional Fund Class I shares also include reinvestment of capital gains. Performance for the Alger Mid Cap Growth Institutional Fund Class R and Class Z-2 shares may vary from the results shown above due to differences in expenses the class bears. Investors cannot invest directly in any index. Index performance does not reflect deduction for fees, expenses, or taxes.
15
ALGER MID CAP GROWTH INSTITUTIONAL FUND
Fund Highlights Through April 30, 2019 (Unaudited) (Continued)
PERFORMANCE COMPARISON AS OF 4/30/19
AVERAGE ANNUAL TOTAL RETURNS
| | 1 YEAR | | 5 YEARS | | 10 YEARS | | Since 11/8/1993 | |
Class I (Inception 11/8/93) | | 13.43 | % | 10.27 | % | 14.31 | % | 11.84 | % |
Class R (Inception 1/27/03)* | | 12.90 | % | 9.70 | % | 13.71 | % | 11.28 | % |
Russell Midcap Growth Index | | 17.64 | % | 12.20 | % | 16.56 | % | 10.00 | % |
| | | | | | | | Since | |
| | 1 YEAR | | 5 YEARS | | 10 YEARS | | 10/14/2016 | |
Class Z-2 (Inception 10/14/16) | | 13.76 | % | n/a | | n/a | | 18.62 | % |
Russell Midcap Growth Index | | 17.64 | % | n/a | | n/a | | 18.68 | % |
The performance data quoted represents past performance, which is not an indication or a guarantee of future results. The Fund’s average annual total returns include changes in share price and reinvestment of dividends and capital gains. The chart and table above do not reflect the deduction of taxes that a shareholder would have paid on Fund distributions or on the redemption of Fund shares. Investment return and principal will fluctuate and the Fund’s shares, when redeemed, may be worth more or less than their original cost. Current performance may be higher or lower than the performance quoted. For updated performance, visit us at www.alger.com or call us at (800) 992-3863.
* Performance figures prior to 1/27/03, inception of Class R shares, are those of the Fund’s Class I Shares. The performance
figures prior to 1/27/03 have been reduced to reflect the higher operating expenses of Class R shares.
16
ALGER SMALL CAP GROWTH INSTITUTIONAL FUND
Fund Highlights Through April 30, 2019 (Unaudited)
HYPOTHETICAL $10,000 INVESTMENT IN CLASS I SHARES
— 10 years ended 4/30/19
![GRAPHIC](https://capedge.com/proxy/N-CSRS/0001104659-19-038912/g72444bi05i002.gif)
The chart above illustrates the change in value of a hypothetical $10,000 investment made in the Alger Small Cap Growth Institutional Fund Class I shares and the Russell 2000 Growth Index (an unmanaged index of common stocks) for the ten years ended April 30, 2019. Figures for the Alger Small Cap Growth Institutional Fund Class I shares and the Russell 2000 Growth Index include reinvestment of dividends. Figures for the Alger Small Cap Growth Institutional Fund Class I shares also include reinvestment of capital gains. Performance for the Alger Small Cap Growth Institutional Fund Class R and Class Z-2 shares may vary from the results shown above due to differences in expenses the class bears. Investors cannot invest directly in any index. Index performance does not reflect deduction for fees, expenses, or taxes.
17
ALGER SMALL CAP GROWTH INSTITUTIONAL FUND
Fund Highlights Through April 30, 2019 (Unaudited) (Continued)
PERFORMANCE COMPARISON AS OF 4/30/19
AVERAGE ANNUAL TOTAL RETURNS
| | 1 YEAR | | 5 YEARS | | 10 YEARS | | Since 11/8/1993 | |
Class I (Inception 11/8/93) | | 18.47 | % | 12.10 | % | 14.88 | % | 9.84 | % |
Class R (Inception 1/27/03)* | | 17.96 | % | 11.56 | % | 14.33 | % | 9.31 | % |
Russell 2000 Growth Index | | 6.91 | % | 10.22 | % | 15.24 | % | 7.65 | % |
| | | | | | | | Since | |
| | 1 YEAR | | 5 YEARS | | 10 YEARS | | 8/1/2016 | |
Class Z-2 (Inception 8/1/16) | | 18.90 | % | n/a | | n/a | | 21.40 | % |
Russell 2000 Growth Index | | 6.91 | % | n/a | | n/a | | 13.52 | % |
The performance data quoted represents past performance, which is not an indication or a guarantee of future results. The Fund’s average annual total returns include changes in share price and reinvestment of dividends and capital gains. The chart and table above do not reflect the deduction of taxes that a shareholder would have paid on Fund distributions or on the redemption of Fund shares. Investment return and principal will fluctuate and the Fund’s shares, when redeemed, may be worth more or less than their original cost. Current performance may be higher or lower than the performance quoted. For updated performance, visit us at www.alger.com or call us at (800) 992-3863.
* Performance figures prior to 1/27/03, inception of Class R shares, are those of the Fund’s Class I Shares. The performance figures prior to 1/27/03 have been reduced to reflect the higher operating expenses of Class R shares.
18
PORTFOLIO SUMMARY†
April 30, 2019 (Unaudited)
SECTORS | | Alger Capital Appreciation Institutional Fund | | Alger Focus Equity Fund | | Alger Mid Cap Growth Institutional Fund | | Alger Small Cap Growth Institutional Fund | |
Communication Services | | 12.7 | % | 10.6 | % | 6.3 | % | 3.4 | % |
Consumer Discretionary | | 19.3 | | 20.3 | | 18.8 | | 11.9 | |
Consumer Staples | | 0.0 | | 0.0 | | 1.9 | | 1.4 | |
Energy | | 0.3 | | 0.0 | | 0.3 | | 1.8 | |
Financials | | 5.5 | | 6.7 | | 5.2 | | 1.5 | |
Health Care | | 14.8 | | 12.5 | | 17.7 | | 41.6 | |
Industrials | | 7.6 | | 7.9 | | 17.2 | | 2.7 | |
Information Technology | | 36.3 | | 37.8 | | 26.0 | | 31.9 | |
Materials | | 3.0 | | 2.8 | | 1.3 | | 1.7 | |
Real Estate | | 0.5 | | 0.0 | | 5.4 | | 0.0 | |
Short-Term Investments and Net Other Assets (Liabilities) | | 0.0 | | 1.4 | | (0.1 | ) | 2.1 | |
| | 100.0 | % | 100.0 | % | 100.0 | % | 100.0 | % |
† Based on net assets for each Fund.
19
THE ALGER INSTITUTIONAL FUNDS |
ALGER CAPITAL APPRECIATION INSTITUTIONAL FUND
Schedule of Investments April 30, 2019 (Unaudited)
COMMON STOCKS—99.3% | | SHARES | | VALUE | |
AEROSPACE & DEFENSE—2.3% | | | | | |
L3 Technologies, Inc. | | 33,576 | | $ | 7,339,042 | |
The Boeing Co. | | 140,282 | | 52,983,109 | |
United Technologies Corp. | | 156,616 | | 22,335,008 | |
| | | | 82,657,159 | |
AGRICULTURAL & FARM MACHINERY—0.5% | | | | | |
Deere & Co. | | 114,193 | | 18,913,787 | |
| | | | | |
APPAREL ACCESSORIES & LUXURY GOODS—0.3% | | | | | |
Lululemon Athletica, Inc.* | | 56,146 | | 9,901,347 | |
| | | | | |
APPLICATION SOFTWARE—8.4% | | | | | |
Adobe, Inc.* | | 505,586 | | 146,240,750 | |
Palantir Technologies, Inc., Cl. A*,@,(a) | | 239,030 | | 1,374,423 | |
salesforce.com, Inc.* | | 784,752 | | 129,758,743 | |
Workday, Inc., Cl. A* | | 118,781 | | 24,424,937 | |
| | | | 301,798,853 | |
AUTO PARTS & EQUIPMENT—0.6% | | | | | |
Aptiv PLC. | | 244,232 | | 20,930,682 | |
| | | | | |
BIOTECHNOLOGY—1.7% | | | | | |
Sarepta Therapeutics, Inc.* | | 160,980 | | 18,825,001 | |
Vertex Pharmaceuticals, Inc.* | | 241,660 | | 40,835,707 | |
| | | | 59,660,708 | |
CABLE & SATELLITE—0.4% | | | | | |
Charter Communications, Inc., Cl. A* | | 40,097 | | 14,883,605 | |
| | | | | |
CASINOS & GAMING—0.4% | | | | | |
Las Vegas Sands Corp. | | 226,753 | | 15,203,789 | |
| | | | | |
CONSTRUCTION MATERIALS—0.8% | | | | | |
Vulcan Materials Co. | | 238,363 | | 30,059,958 | |
| | | | | |
DATA PROCESSING & OUTSOURCED SERVICES—8.0% | | | | | |
Fidelity National Information Services, Inc. | | 200,033 | | 23,189,826 | |
PayPal Holdings, Inc.* | | 582,217 | | 65,656,611 | |
Square, Inc., Cl. A* | | 238,664 | | 17,379,512 | |
Visa, Inc., Cl. A | | 1,100,942 | | 181,027,893 | |
| | | | 287,253,842 | |
DIVERSIFIED BANKS—1.3% | | | | | |
Citigroup, Inc. | | 476,456 | | 33,685,439 | |
JPMorgan Chase & Co. | | 125,395 | | 14,552,090 | |
| | | | 48,237,529 | |
DIVERSIFIED SUPPORT SERVICES—1.2% | | | | | |
Cintas Corp. | | 192,592 | | 41,819,427 | |
| | | | | |
FINANCIAL EXCHANGES & DATA—2.3% | | | | | |
Intercontinental Exchange, Inc. | | 665,156 | | 54,110,441 | |
S&P Global, Inc. | | 123,625 | | 27,279,092 | |
| | | | 81,389,533 | |
GENERAL MERCHANDISE STORES—1.2% | | | | | |
Dollar Tree, Inc.* | | 389,044 | | 43,292,816 | |
| | | | | | |
20
THE ALGER INSTITUTIONAL FUNDS |
ALGER CAPITAL APPRECIATION INSTITUTIONAL FUND
Schedule of Investments April 30, 2019 (Unaudited) (Continued)
COMMON STOCKS—99.3% (CONT.) | | SHARES | | VALUE | |
HEALTH CARE EQUIPMENT—7.7% | | | | | |
Abbott Laboratories | | 876,932 | | $ | 69,768,710 | |
Boston Scientific Corp.* | | 1,888,066 | | 70,085,010 | |
Danaher Corp. | | 655,790 | | 86,852,828 | |
Edwards Lifesciences Corp.* | | 41,904 | | 7,378,037 | |
Intuitive Surgical, Inc.* | | 68,396 | | 34,925,049 | |
Medtronic PLC. | | 53,479 | | 4,749,470 | |
| | | | 273,759,104 | |
HEALTH CARE SERVICES—0.3% | | | | | |
Cigna Corp. | | 70,453 | | 11,190,755 | |
| | | | | |
HOME IMPROVEMENT RETAIL—1.6% | | | | | |
The Home Depot, Inc. | | 273,300 | | 55,671,210 | |
| | | | | |
HOTELS RESORTS & CRUISE LINES—1.3% | | | | | |
Royal Caribbean Cruises Ltd. | | 374,777 | | 45,325,530 | |
| | | | | |
INDUSTRIAL CONGLOMERATES—2.3% | | | | | |
Honeywell International, Inc. | | 477,199 | | 82,856,062 | |
| | | | | |
INDUSTRIAL GASES—1.2% | | | | | |
Air Products & Chemicals, Inc. | | 203,731 | | 41,925,802 | |
| | | | | |
INTERACTIVE MEDIA & SERVICES—9.6% | | | | | |
Alphabet, Inc., Cl. C* | | 167,968 | | 199,626,609 | |
Facebook, Inc., Cl. A* | | 624,158 | | 120,712,157 | |
Tencent Holdings Ltd. | | 426,604 | | 21,026,180 | |
| | | | 341,364,946 | |
INTERNET & DIRECT MARKETING RETAIL—13.2% | | | | | |
Alibaba Group Holding Ltd.#,* | | 156,048 | | 28,957,827 | |
Altaba, Inc.* | | 1,297,328 | | 97,805,558 | |
Amazon.com, Inc.* | | 175,228 | | 337,580,247 | |
MercadoLibre, Inc.* | | 17,246 | | 8,349,478 | |
| | | | 472,693,110 | |
INVESTMENT BANKING & BROKERAGE—0.6% | | | | | |
Morgan Stanley | | 449,607 | | 21,693,538 | |
| | | | | |
IT CONSULTING & OTHER SERVICES—0.2% | | | | | |
Cognizant Technology Solutions Corp., Cl. A | | 80,990 | | 5,909,030 | |
| | | | | |
LEISURE FACILITIES—0.7% | | | | | |
Vail Resorts, Inc. | | 104,676 | | 23,955,103 | |
| | | | | |
LIFE SCIENCES TOOLS & SERVICES—2.3% | | | | | |
Illumina, Inc.* | | 97,541 | | 30,432,792 | |
Thermo Fisher Scientific, Inc. | | 188,325 | | 52,250,771 | |
| | | | 82,683,563 | |
MANAGED HEALTH CARE—2.3% | | | | | |
UnitedHealth Group, Inc. | | 346,310 | | 80,714,472 | |
| | | | | |
MOVIES & ENTERTAINMENT—2.4% | | | | | |
Netflix, Inc.* | | 106,712 | | 39,541,065 | |
The Walt Disney Co. | | 347,054 | | 47,535,986 | |
| | | | 87,077,051 | |
| | | | | | |
21
THE ALGER INSTITUTIONAL FUNDS |
ALGER CAPITAL APPRECIATION INSTITUTIONAL FUND
Schedule of Investments April 30, 2019 (Unaudited) (Continued)
COMMON STOCKS—99.3% (CONT.) | | SHARES | | VALUE | |
OIL & GAS EXPLORATION & PRODUCTION—0.3% | | | | | |
Pioneer Natural Resources Co. | | 60,562 | | $ | 10,081,151 | |
| | | | | |
PHARMACEUTICALS—0.5% | | | | | |
Allergan PLC. | | 64,895 | | 9,539,565 | |
GW Pharmaceuticals PLC.#,* | | 59,578 | | 10,087,151 | |
| | | | 19,626,716 | |
PROPERTY & CASUALTY INSURANCE—1.3% | | | | | |
The Progressive Corp. | | 580,317 | | 45,351,774 | |
| | | | | |
RAILROADS—1.3% | | | | | |
Union Pacific Corp. | | 262,883 | | 46,540,806 | |
| | | | | |
SEMICONDUCTOR EQUIPMENT—1.6% | | | | | |
Applied Materials, Inc. | | 82,517 | | 3,636,524 | |
Lam Research Corp. | | 251,469 | | 52,162,215 | |
| | | | 55,798,739 | |
SEMICONDUCTORS—4.4% | | | | | |
Broadcom, Inc. | | 156,306 | | 49,767,830 | |
Micron Technology, Inc.* | | 199,153 | | 8,376,375 | |
NXP Semiconductors NV | | 313,125 | | 33,072,263 | |
QUALCOMM, Inc. | | 517,501 | | 44,572,361 | |
Taiwan Semiconductor Manufacturing Co., Ltd.# | | 522,480 | | 22,895,074 | |
| | | | 158,683,903 | |
SPECIALTY CHEMICALS—1.0% | | | | | |
The Sherwin-Williams Co. | | 76,087 | | 34,606,650 | |
| | | | | |
SYSTEMS SOFTWARE—10.5% | | | | | |
Microsoft Corp. | | 2,647,247 | | 345,730,458 | |
Palo Alto Networks, Inc.* | | 29,465 | | 7,331,776 | |
ServiceNow, Inc.* | | 73,701 | | 20,010,559 | |
| | | | 373,072,793 | |
TECHNOLOGY HARDWARE STORAGE & PERIPHERALS—3.0% | | | | | |
Apple, Inc. | | 534,981 | | 107,354,637 | |
| | | | | |
WIRELESS TELECOMMUNICATION SERVICES—0.3% | | | | | |
T-Mobile US, Inc.* | | 172,457 | | 12,587,636 | |
| | | | | |
TOTAL COMMON STOCKS (Cost $2,324,727,965) | | | | 3,546,527,116 | |
| | | | | | |
PREFERRED STOCKS—0.2% | | SHARES | | VALUE | |
APPLICATION SOFTWARE—0.2% | | | | | |
Palantir Technologies, Inc., Cl. B*,@,(a) | | 974,841 | | 5,605,336 | |
Palantir Technologies, Inc., Cl. D*,@,(a) | | 127,007 | | 730,290 | |
| | | | 6,335,626 | |
PHARMACEUTICALS—0.0% | | | | | |
Intarcia Therapeutics, Inc., Series DD*,@,(a) | | 111,655 | | 1,037,275 | |
TOTAL PREFERRED STOCKS (Cost $10,892,407) | | | | 7,372,901 | |
22
THE ALGER INSTITUTIONAL FUNDS |
ALGER CAPITAL APPRECIATION INSTITUTIONAL FUND
Schedule of Investments April 30, 2019 (Unaudited) (Continued)
REAL ESTATE INVESTMENT TRUST—0.5% | | SHARES | | VALUE | |
SPECIALIZED—0.5% | | | | | |
Crown Castle International Corp. | | 128,383 | | $ | 16,148,014 | |
(Cost $13,878,660) | | | | 16,148,014 | |
Total Investments (Cost $2,349,499,032) | | 100.0 | % | $ | 3,570,048,031 | |
Unaffiliated Securities (Cost $2,349,499,032) | | | | 3,570,048,031 | |
Liabilities in Excess of Other Assets | | 0.0 | % | (1,635,441 | ) |
NET ASSETS | | 100.0 | % | $ | 3,568,412,590 | |
# American Depositary Receipts.
(a) Security is valued in good faith at fair value determined using significant unobservable inputs pursuant to procedures established by the Board.
* Non-income producing security.
@ Restricted security - Investment in security not registered under the Securities Act of 1933. The investment may be sold only to qualified buyers.
| | | | | | % of net assets | | | | % of net assets | |
| | Acquisition | | Acquisition | | (Acquisition | | Market | | as of | |
Security | | Date(s) | | Cost | | Date) | | Value | | 4/30/2019 | |
Intarcia Therapeutics, Inc., Series DD | | 03/27/14 | | $ | 3,616,505 | | 0.14 | % | $ | 1,037,275 | | 0.03 | % |
Palantir Technologies, Inc., Cl. A | | 10/07/14 | | 1,555,368 | | 0.05 | % | 1,374,423 | | 0.04 | % |
Palantir Technologies, Inc., Cl. B | | 10/07/14 | | 6,437,297 | | 0.22 | % | 5,605,336 | | 0.16 | % |
Palantir Technologies, Inc., Cl. D | | 10/14/14 | | 838,605 | | 0.03 | % | 730,290 | | 0.02 | % |
Total | | | | | | | | $ | 8,747,324 | | 0.25 | % |
| | | | | | | | | | | | | |
See Notes to Financial Statements.
23
THE ALGER INSTITUTIONAL FUNDS | ALGER FOCUS EQUITY FUND
Schedule of Investments April 30, 2019 (Unaudited)
COMMON STOCKS—98.6% | | SHARES | | VALUE | |
AEROSPACE & DEFENSE—1.4% | | | | | |
The Boeing Co. | | 19,061 | | $ | 7,199,149 | |
| | | | | |
APPLICATION SOFTWARE—8.8% | | | | | |
Adobe, Inc.* | | 81,009 | | 23,431,853 | |
Avalara, Inc.* | | 51,090 | | 3,007,668 | |
salesforce.com, Inc.* | | 112,083 | | 18,532,924 | |
| | | | 44,972,445 | |
AUTO PARTS & EQUIPMENT—0.8% | | | | | |
Aptiv PLC. | | 44,551 | | 3,818,021 | |
| | | | | |
BIOTECHNOLOGY—1.2% | | | | | |
Alnylam Pharmaceuticals, Inc.* | | 13,742 | | 1,227,710 | |
Sarepta Therapeutics, Inc.* | | 13,811 | | 1,615,058 | |
Vertex Pharmaceuticals, Inc.* | | 18,922 | | 3,197,440 | |
| | | | 6,040,208 | |
CONSTRUCTION MACHINERY & HEAVY TRUCKS—0.4% | | | | | |
Caterpillar, Inc. | | 16,211 | | 2,260,138 | |
| | | | | |
CONSTRUCTION MATERIALS—0.9% | | | | | |
Vulcan Materials Co. | | 35,930 | | 4,531,132 | |
| | | | | |
DATA PROCESSING & OUTSOURCED SERVICES—8.7% | | | | | |
PayPal Holdings, Inc.* | | 82,423 | | 9,294,842 | |
Visa, Inc., Cl. A | | 155,357 | | 25,545,351 | |
Worldpay, Inc., Cl. A* | | 78,612 | | 9,214,113 | |
| | | | 44,054,306 | |
DIVERSIFIED BANKS—2.0% | | | | | |
Citigroup, Inc. | | 144,453 | | 10,212,827 | |
| | | | | |
DIVERSIFIED SUPPORT SERVICES—2.8% | | | | | |
Cintas Corp. | | 66,430 | | 14,424,610 | |
| | | | | |
FINANCIAL EXCHANGES & DATA—1.3% | | | | | |
S&P Global, Inc. | | 29,994 | | 6,618,476 | |
| | | | | |
GENERAL MERCHANDISE STORES—1.4% | | | | | |
Dollar Tree, Inc.* | | 64,217 | | 7,146,068 | |
| | | | | |
HEALTH CARE EQUIPMENT—6.5% | | | | | |
Abbott Laboratories | | 150,601 | | 11,981,816 | |
Boston Scientific Corp.* | | 184,702 | | 6,856,138 | |
Danaher Corp. | | 98,082 | | 12,989,980 | |
DexCom, Inc.* | | 8,196 | | 992,290 | |
| | | | 32,820,224 | |
HOME IMPROVEMENT RETAIL—1.5% | | | | | |
The Home Depot, Inc. | | 37,481 | | 7,634,880 | |
| | | | | |
HOTELS RESORTS & CRUISE LINES—1.2% | | | | | |
Royal Caribbean Cruises Ltd. | | 50,654 | | 6,126,095 | |
| | | | | |
INDUSTRIAL CONGLOMERATES—2.1% | | | | | |
Honeywell International, Inc. | | 62,764 | | 10,897,713 | |
| | | | | |
INDUSTRIAL GASES—1.0% | | | | | |
Air Products & Chemicals, Inc. | | 25,076 | | 5,160,390 | |
| | | | | | |
24
THE ALGER INSTITUTIONAL FUNDS | ALGER FOCUS EQUITY FUND
Schedule of Investments April 30, 2019 (Unaudited) (Continued)
COMMON STOCKS—98.6% (CONT.) | | SHARES | | VALUE | |
INTERACTIVE MEDIA & SERVICES—7.9% | | | | | |
Alphabet, Inc., Cl. C* | | 18,543 | | $ | 22,037,985 | |
Facebook, Inc., Cl. A* | | 92,988 | | 17,983,879 | |
| | | | 40,021,864 | |
INTERNET & DIRECT MARKETING RETAIL—13.2% | | | | | |
Altaba, Inc.* | | 278,145 | | 20,969,352 | |
Amazon.com, Inc.* | | 24,119 | | 46,465,736 | |
| | | | 67,435,088 | |
INVESTMENT BANKING & BROKERAGE—1.3% | | | | | |
Morgan Stanley | | 135,318 | | 6,529,093 | |
| | | | | |
LEISURE FACILITIES—1.2% | | | | | |
Vail Resorts, Inc. | | 25,778 | | 5,899,295 | |
| | | | | |
LIFE SCIENCES TOOLS & SERVICES—2.1% | | | | | |
Illumina, Inc.* | | 9,578 | | 2,988,336 | |
Thermo Fisher Scientific, Inc. | | 26,951 | | 7,477,555 | |
| | | | 10,465,891 | |
MANAGED HEALTH CARE—2.1% | | | | | |
UnitedHealth Group, Inc. | | 44,804 | | 10,442,468 | |
| | | | | |
MOVIES & ENTERTAINMENT—2.7% | | | | | |
Live Nation Entertainment, Inc.* | | 26,768 | | 1,749,021 | |
Madison Square Garden Co., Cl. A* | | 10,453 | | 3,265,935 | |
Netflix, Inc.* | | 24,078 | | 8,921,862 | |
| | | | 13,936,818 | |
PHARMACEUTICALS—0.6% | | | | | |
GW Pharmaceuticals PLC.#,* | | 17,014 | | 2,880,640 | |
| | | | | |
PROPERTY & CASUALTY INSURANCE—2.1% | | | | | |
The Progressive Corp. | | 135,370 | | 10,579,165 | |
| | | | | |
RAILROADS—1.2% | | | | | |
Union Pacific Corp. | | 34,789 | | 6,159,045 | |
| | | | | |
RESTAURANTS—1.0% | | | | | |
McDonald’s Corp. | | 25,867 | | 5,110,543 | |
| | | | | |
SEMICONDUCTOR EQUIPMENT—2.2% | | | | | |
Applied Materials, Inc. | | 100,810 | | 4,442,697 | |
Lam Research Corp. | | 33,649 | | 6,979,812 | |
| | | | 11,422,509 | |
SEMICONDUCTORS—6.0% | | | | | |
Broadcom, Inc. | | 28,599 | | 9,105,922 | |
NXP Semiconductors NV | | 48,488 | | 5,121,303 | |
QUALCOMM, Inc. | | 157,406 | | 13,557,379 | |
Taiwan Semiconductor Manufacturing Co., Ltd.# | | 61,060 | | 2,675,649 | |
| | | | 30,460,253 | |
SPECIALTY CHEMICALS—0.9% | | | | | |
The Sherwin-Williams Co. | | 10,194 | | 4,636,537 | |
| | | | | |
SYSTEMS SOFTWARE—9.6% | | | | | |
Microsoft Corp. | | 375,538 | | 49,045,263 | |
| | | | | | |
25
THE ALGER INSTITUTIONAL FUNDS | ALGER FOCUS EQUITY FUND
Schedule of Investments April 30, 2019 (Unaudited) (Continued)
COMMON STOCKS—98.6% (CONT.) | | SHARES | | VALUE | |
TECHNOLOGY HARDWARE STORAGE & PERIPHERALS—2.5% | | | | | |
Apple, Inc. | | 62,225 | | $ | 12,486,691 | |
TOTAL COMMON STOCKS (Cost $420,351,788) | | | | 501,427,845 | |
| | | | | | |
PREFERRED STOCKS—0.0% | | SHARES | | VALUE | |
BIOTECHNOLOGY—0.0% | | | | | |
Prosetta Biosciences, Inc., Series D*,@,(a),(b) | | 76,825 | | 154,418 | |
(Cost $345,713) | | | | 154,418 | |
Total Investments (Cost $420,697,501) | | 98.6 | % | $ | 501,582,263 | |
Affiliated Securities (Cost $345,713) | | | | 154,418 | |
Unaffiliated Securities (Cost $420,351,788) | | | | 501,427,845 | |
Other Assets in Excess of Liabilities | | 1.4 | % | 7,024,034 | |
NET ASSETS | | 100.0 | % | $ | 508,606,297 | |
# American Depositary Receipts.
(a) Deemed an affiliate of the Fund in accordance with Section 2(a)(3) of the Investment Company Act of 1940. See Note 11 - Affiliated Securities.
(b) Security is valued in good faith at fair value determined using significant unobservable inputs pursuant to procedures established by the Board.
* Non-income producing security.
@ Restricted security - Investment in security not registered under the Securities Act of 1933. The investment may be sold only to qualified buyers.
| | | | | | % of net assets | | | | % of net assets | |
| | Acquisition | | Acquisition | | (Acquisition | | Market | | as of | |
Security | | Date(s) | | Cost | | Date) | | Value | | 4/30/2019 | |
Prosetta Biosciences, Inc., Series D | | 02/06/15 | | $ | 345,713 | | 0.80 | % | $ | 154,418 | | 0.03 | % |
Total | | | | | | | | $ | 154,418 | | 0.03 | % |
| | | | | | | | | | | | | |
See Notes to Financial Statements.
26
THE ALGER INSTITUTIONAL FUNDS | ALGER MID CAP GROWTH INSTITUTIONAL FUND
Schedule of Investments April 30, 2019 (Unaudited)
COMMON STOCKS—92.9% | | SHARES | | VALUE | |
AEROSPACE & DEFENSE—3.3% | | | | | |
Arconic, Inc. | | 26,241 | | $ | 563,657 | |
HEICO Corp. | | 18,902 | | 1,994,728 | |
L3 Technologies, Inc. | | 4,832 | | 1,056,179 | |
| | | | 3,614,564 | |
AIR FREIGHT & LOGISTICS—0.5% | | | | | |
XPO Logistics, Inc.* | | 8,155 | | 555,192 | |
| | | | | |
APPAREL ACCESSORIES & LUXURY GOODS—3.7% | | | | | |
Levi Strauss & Co., Cl. A* | | 22,525 | | 504,785 | |
Lululemon Athletica, Inc.* | | 9,441 | | 1,664,920 | |
Tapestry, Inc. | | 32,135 | | 1,036,996 | |
VF Corp. | | 8,643 | | 815,986 | |
| | | | 4,022,687 | |
APPAREL RETAIL—2.3% | | | | | |
Burlington Stores, Inc.* | | 8,315 | | 1,404,487 | |
Ross Stores, Inc. | | 10,794 | | 1,054,142 | |
| | | | 2,458,629 | |
APPLICATION SOFTWARE—9.5% | | | | | |
ANSYS, Inc.* | | 6,931 | | 1,357,090 | |
Aspen Technology, Inc.* | | 7,564 | | 922,127 | |
Avalara, Inc.* | | 21,966 | | 1,293,138 | |
Cadence Design Systems, Inc.* | | 14,634 | | 1,015,307 | |
Fair Isaac Corp.* | | 2,851 | | 797,567 | |
MicroStrategy, Inc., Cl. A* | | 5,497 | | 822,901 | |
Palantir Technologies, Inc., Cl. A*,@,(a) | | 12,426 | | 71,450 | |
PTC, Inc.* | | 13,789 | | 1,247,491 | |
RealPage, Inc.* | | 8,551 | | 557,611 | |
SS&C Technologies Holdings, Inc. | | 16,471 | | 1,114,428 | |
Workday, Inc., Cl. A* | | 5,545 | | 1,140,218 | |
| | | | 10,339,328 | |
ASSET MANAGEMENT & CUSTODY BANKS—0.5% | | | | | |
WisdomTree Investments, Inc. | | 68,015 | | 489,708 | |
| | | | | |
AUTO PARTS & EQUIPMENT—0.9% | | | | | |
Aptiv PLC. | | 11,874 | | 1,017,602 | |
| | | | | |
AUTOMOTIVE RETAIL—1.2% | | | | | |
O’Reilly Automotive, Inc.* | | 3,377 | | 1,278,431 | |
| | | | | |
BIOTECHNOLOGY—3.6% | | | | | |
Alexion Pharmaceuticals, Inc.* | | 3,399 | | 462,706 | |
Alnylam Pharmaceuticals, Inc.* | | 6,152 | | 549,620 | |
Array BioPharma, Inc.* | | 18,326 | | 414,351 | |
Bluebird Bio, Inc.* | | 2,605 | | 369,467 | |
Incyte Corp.* | | 8,852 | | 679,834 | |
Neurocrine Biosciences, Inc.* | | 6,640 | | 479,674 | |
Sarepta Therapeutics, Inc.* | | 8,079 | | 944,758 | |
| | | | 3,900,410 | |
BUILDING PRODUCTS—1.4% | | | | | |
AO Smith Corp. | | 29,573 | | 1,554,653 | |
| | | | | | |
27
THE ALGER INSTITUTIONAL FUNDS | ALGER MID CAP GROWTH INSTITUTIONAL FUND
Schedule of Investments April 30, 2019 (Unaudited) (Continued)
COMMON STOCKS—92.9% (CONT.) | | SHARES | | VALUE | |
CASINOS & GAMING—0.5% | | | | | |
Wynn Resorts Ltd. | | 3,784 | | $ | 546,599 | |
| | | | | |
CONSTRUCTION MATERIALS—0.5% | | | | | |
Vulcan Materials Co. | | 4,438 | | 559,676 | |
| | | | | |
CONSUMER ELECTRONICS—0.5% | | | | | |
Garmin Ltd. | | 6,221 | | 533,389 | |
| | | | | |
DATA PROCESSING & OUTSOURCED SERVICES—4.2% | | | | | |
Fiserv, Inc.* | | 19,186 | | 1,673,787 | |
Square, Inc., Cl. A* | | 22,400 | | 1,631,168 | |
Worldpay, Inc., Cl. A* | | 10,866 | | 1,273,604 | |
| | | | 4,578,559 | |
DEPARTMENT STORES—0.9% | | | | | |
Kohl’s Corp. | | 14,471 | | 1,028,888 | |
| | | | | |
DIVERSIFIED SUPPORT SERVICES—2.2% | | | | | |
Cintas Corp. | | 8,682 | | 1,885,209 | |
UniFirst Corp. | | 3,490 | | 551,874 | |
| | | | 2,437,083 | |
ELECTRICAL COMPONENTS & EQUIPMENT—1.8% | | | | | |
AMETEK, Inc. | | 22,395 | | 1,974,567 | |
| | | | | |
ELECTRONIC EQUIPMENT & INSTRUMENTS—2.4% | | | | | |
FLIR Systems, Inc. | | 24,752 | | 1,310,371 | |
Trimble, Inc.* | | 31,954 | | 1,304,362 | |
| | | | 2,614,733 | |
ENVIRONMENTAL & FACILITIES SERVICES—1.0% | | | | | |
Waste Connections, Inc. | | 12,077 | | 1,120,383 | |
| | | | | |
FINANCIAL EXCHANGES & DATA—0.8% | | | | | |
MarketAxess Holdings, Inc. | | 3,012 | | 838,330 | |
| | | | | |
GENERAL MERCHANDISE STORES—1.4% | | | | | |
Dollar Tree, Inc.* | | 13,191 | | 1,467,894 | |
| | | | | |
HEALTH CARE EQUIPMENT—4.9% | | | | | |
ABIOMED, Inc.* | | 3,140 | | 871,067 | |
DexCom, Inc.* | | 12,353 | | 1,495,578 | |
Edwards Lifesciences Corp.* | | 3,378 | | 594,764 | |
IDEXX Laboratories, Inc.* | | 3,394 | | 787,408 | |
Insulet Corp.* | | 3,833 | | 330,596 | |
Masimo Corp.* | | 4,038 | | 525,546 | |
Tandem Diabetes Care, Inc.* | | 11,629 | | 714,137 | |
| | | | 5,319,096 | |
HEALTH CARE SERVICES—0.6% | | | | | |
Guardant Health, Inc.* | | 9,921 | | 649,925 | |
| | | | | |
HEALTH CARE SUPPLIES—1.1% | | | | | |
Align Technology, Inc.* | | 1,031 | | 334,745 | |
DENTSPLY SIRONA, Inc. | | 10,663 | | 545,199 | |
STAAR Surgical Co.* | | 11,248 | | 365,335 | |
| | | | 1,245,279 | |
| | | | | | |
28
THE ALGER INSTITUTIONAL FUNDS | ALGER MID CAP GROWTH INSTITUTIONAL FUND
Schedule of Investments April 30, 2019 (Unaudited) (Continued)
COMMON STOCKS—92.9% (CONT.) | | SHARES | | VALUE | |
HEALTH CARE TECHNOLOGY—1.5% | | | | | |
Teladoc Health, Inc.* | | 7,301 | | $ | 415,281 | |
Veeva Systems, Inc., Cl. A* | | 8,269 | | 1,156,585 | |
| | | | 1,571,866 | |
HOMEBUILDING—0.5% | | | | | |
NVR, Inc.* | | 163 | | 513,854 | |
| | | | | |
HOUSEHOLD PRODUCTS—1.0% | | | | | |
Church & Dwight Co., Inc. | | 14,580 | | 1,092,771 | |
| | | | | |
HUMAN RESOURCE & EMPLOYMENT SERVICES—0.8% | | | | | |
WageWorks, Inc.* | | 17,296 | | 843,872 | |
| | | | | |
HYPERMARKETS & SUPER CENTERS—0.9% | | | | | |
BJ’s Wholesale Club Holdings, Inc.* | | 35,689 | | 1,011,783 | |
| | | | | |
INDUSTRIAL CONGLOMERATES—1.2% | | | | | |
Roper Technologies, Inc. | | 3,501 | | 1,259,310 | |
| | | | | |
INDUSTRIAL MACHINERY—1.0% | | | | | |
Fortive Corp. | | 12,958 | | 1,118,794 | |
| | | | | |
INTERACTIVE HOME ENTERTAINMENT—0.8% | | | | | |
Take-Two Interactive Software, Inc.* | | 8,665 | | 839,032 | |
| | | | | |
INTERACTIVE MEDIA & SERVICES—2.2% | | | | | |
Pinterest, Inc., Cl. A* | | 77,801 | | 2,410,275 | |
| | | | | |
INTERNET & DIRECT MARKETING RETAIL—4.0% | | | | | |
Etsy, Inc.* | | 15,830 | | 1,069,158 | |
Farfetch Ltd., Cl. A* | | 17,217 | | 426,637 | |
GrubHub, Inc.* | | 23,683 | | 1,581,788 | |
MercadoLibre, Inc.* | | 1,608 | | 778,497 | |
Waitr Holdings, Inc.* | | 45,808 | | 447,086 | |
| | | | 4,303,166 | |
INTERNET SERVICES & INFRASTRUCTURE—1.9% | | | | | |
Okta, Inc., Cl. A* | | 6,229 | | 648,003 | |
Shopify, Inc., Cl. A* | | 1,228 | | 299,055 | |
VeriSign, Inc.* | | 5,450 | | 1,076,102 | |
| | | | 2,023,160 | |
INVESTMENT BANKING & BROKERAGE—0.8% | | | | | |
Virtu Financial, Inc., Cl. A | | 35,611 | | 875,318 | |
| | | | | |
IT CONSULTING & OTHER SERVICES—0.5% | | | | | |
Endava PLC.#,* | | 17,747 | | 586,893 | |
| | | | | |
LEISURE FACILITIES—1.1% | | | | | |
Planet Fitness, Inc., Cl. A* | | 15,914 | | 1,204,690 | |
| | | | | |
LIFE SCIENCES TOOLS & SERVICES—1.9% | | | | | |
Bio-Techne Corp. | | 5,185 | | 1,060,799 | |
NanoString Technologies, Inc.* | | 36,733 | | 953,956 | |
| | | | 2,014,755 | |
MOVIES & ENTERTAINMENT—3.3% | | | | | |
AMC Entertainment Holdings, Inc., Cl. A | | 55,266 | | 837,833 | |
Live Nation Entertainment, Inc.* | | 33,879 | | 2,213,654 | |
| | | | | | |
29
THE ALGER INSTITUTIONAL FUNDS | ALGER MID CAP GROWTH INSTITUTIONAL FUND
Schedule of Investments April 30, 2019 (Unaudited) (Continued)
COMMON STOCKS—92.9% (CONT.) | | SHARES | | VALUE | |
MOVIES & ENTERTAINMENT—3.3% (CONT.) | | | | | |
The Madison Square Garden Co., Cl. A* | | 1,662 | | $ | 519,275 | |
| | | | 3,570,762 | |
OIL & GAS EXPLORATION & PRODUCTION—0.3% | | | | | |
Diamondback Energy, Inc. | | 3,401 | | 361,832 | |
| | | | | |
PHARMACEUTICALS—2.6% | | | | | |
Canopy Growth Corp.* | | 20,663 | | 1,043,895 | |
GW Pharmaceuticals PLC.#,* | | 10,456 | | 1,770,305 | |
| | | | 2,814,200 | |
PROPERTY & CASUALTY INSURANCE—1.3% | | | | | |
The Progressive Corp. | | 18,296 | | 1,429,832 | |
| | | | | |
REAL ESTATE SERVICES—0.5% | | | | | |
Redfin Corp.* | | 24,025 | | 496,837 | |
| | | | | |
REGIONAL BANKS—0.5% | | | | | |
SVB Financial Group* | | 2,077 | | 522,822 | |
| | | | | |
RESEARCH & CONSULTING SERVICES—2.7% | | | | | |
CoStar Group, Inc.* | | 1,655 | | 821,294 | |
IHS Markit Ltd.* | | 17,878 | | 1,023,694 | |
Verisk Analytics, Inc., Cl. A | | 7,745 | | 1,093,129 | |
| | | | 2,938,117 | |
RESTAURANTS—1.8% | | | | | |
Shake Shack, Inc., Cl. A* | | 9,086 | | 556,972 | |
Wingstop, Inc. | | 17,839 | | 1,342,742 | |
| | | | 1,899,714 | |
SEMICONDUCTOR EQUIPMENT—2.0% | | | | | |
KLA-Tencor Corp. | | 8,636 | | 1,100,917 | |
Lam Research Corp. | | 5,272 | | 1,093,571 | |
| | | | 2,194,488 | |
SEMICONDUCTORS—3.0% | | | | | |
Advanced Micro Devices, Inc.* | | 39,422 | | 1,089,230 | |
Microchip Technology, Inc. | | 5,613 | | 560,683 | |
Monolithic Power Systems, Inc. | | 3,396 | | 528,791 | |
Xilinx, Inc. | | 8,940 | | 1,074,052 | |
| | | | 3,252,756 | |
SPECIALTY CHEMICALS—0.8% | | | | | |
WR Grace & Co. | | 11,101 | | 839,014 | |
| | | | | |
SYSTEMS SOFTWARE—2.2% | | | | | |
ServiceNow, Inc.* | | 8,659 | | 2,351,005 | |
| | | | | |
THRIFTS & MORTGAGE FINANCE—0.8% | | | | | |
LendingTree, Inc.* | | 2,151 | | 827,748 | |
| | | | | |
TRADING COMPANIES & DISTRIBUTORS—0.8% | | | | | |
Fastenal Co. | | 11,766 | | 830,091 | |
| | | | | |
TRUCKING—0.5% | | | | | |
Old Dominion Freight Line, Inc. | | 3,923 | | 585,625 | |
TOTAL COMMON STOCKS (Cost $85,734,884) | | | | 100,729,987 | |
| | | | | | |
30
THE ALGER INSTITUTIONAL FUNDS | ALGER MID CAP GROWTH INSTITUTIONAL FUND
Schedule of Investments April 30, 2019 (Unaudited) (Continued)
PREFERRED STOCKS—0.7% | | SHARES | | VALUE | |
APPLICATION SOFTWARE—0.3% | | | | | |
Palantir Technologies, Inc., Cl. B*,@,(a) | | 50,675 | | $ | 291,381 | |
BIOTECHNOLOGY—0.3% | | | | | |
Prosetta Biosciences, Inc., Series D*,@,(a),(b) | | 166,009 | | 333,678 | |
PHARMACEUTICALS—0.1% | | | | | |
Intarcia Therapeutics, Inc., Series DD*,@,(a) | | 7,588 | | 70,493 | |
TOTAL PREFERRED STOCKS (Cost $1,327,444) | | | | 695,552 | |
| | | | | | |
RIGHTS—1.1% | | SHARES | | VALUE | |
BIOTECHNOLOGY—1.1% | | | | | |
Tolero CDR*,@,(a),(c) | | 422,928 | | 1,201,115 | |
(Cost $226,186) | | | | 1,201,115 | |
MASTER LIMITED PARTNERSHIP—0.5% | | SHARES | | VALUE | |
ASSET MANAGEMENT & CUSTODY BANKS—0.5% | | | | | |
The Carlyle Group LP. | | 25,609 | | 536,509 | |
(Cost $526,361) | | | | 536,509 | |
REAL ESTATE INVESTMENT TRUST—4.9% | | SHARES | | VALUE | |
HEALTH CARE—1.0% | | | | | |
Welltower, Inc. | | 14,515 | | 1,081,803 | |
| | | | | |
INDUSTRIAL—1.4% | | | | | |
Americold Realty Trust | | 17,341 | | 555,085 | |
Rexford Industrial Realty, Inc. | | 26,290 | | 996,128 | |
| | | | 1,551,213 | |
RESIDENTIAL—0.5% | | | | | |
Equity LifeStyle Properties, Inc. | | 4,693 | | 547,673 | |
| | | | | |
SPECIALIZED—2.0% | | | | | |
Crown Castle International Corp. | | 17,014 | | 2,140,021 | |
TOTAL REAL ESTATE INVESTMENT TRUST (Cost $4,771,671) | | | | 5,320,710 | |
SPECIAL PURPOSE VEHICLE—0.0% | | SHARES | | VALUE | |
CONSUMER FINANCE—0.0% | | | | | |
JS Kred SPV I, LLC*,@,(a) | | 240,362 | | — | |
(Cost $240,362) | | | | — | |
PURCHASED OPTIONS—0.0% | | | | | | | | | |
SECURITY NAME/ | | | | | | | | | |
EXPIRATION DATE/ | | NOTIONAL | | | | NUMBER OF | | | |
STRIKE PRICE | | AMOUNTS | | COUNTERPARTY | | CONTRACTS | | VALUE | |
PUT OPTIONS—0.0% | | | | | | | | | |
GrubHub, Inc., 5/17/19, 67.5* | | $ | 1,068,640 | | BNP Paribas | | 160 | | $ | 50,240 | |
(Cost $86,766) | | | | | | | | 50,240 | |
| | | | | | | | | | | |
31
THE ALGER INSTITUTIONAL FUNDS | ALGER MID CAP GROWTH INSTITUTIONAL FUND
Schedule of Investments April 30, 2019 (Unaudited) (Continued)
| | | | VALUE | |
Total Investments (Cost $92,913,674) | | 100.1 | % | $ | 108,534,113 | |
Affiliated Securities (Cost $747,040) | | | | 333,678 | |
Unaffiliated Securities (Cost $92,166,634) | | | | 108,200,435 | |
Liabilities in Excess of Other Assets | | (0.1 | )% | (137,262 | ) |
NET ASSETS | | 100.0 | % | $ | 108,396,851 | |
# American Depositary Receipts.
(a) Security is valued in good faith at fair value determined using significant unobservable inputs pursuant to procedures established by the Board.
(b) Deemed an affiliate of the Fund in accordance with Section 2(a)(3) of the Investment Company Act of 1940. See Note 11 - Affiliated Securities.
(c) Contingent Deferred Rights.
* Non-income producing security.
@ Restricted security - Investment in security not registered under the Securities Act of 1933. The investment may be sold only to qualified buyers.
| | | | | | % of net assets | | | | % of net assets | |
| | Acquisition | | Acquisition | | (Acquisition | | Market | | as of | |
Security | | Date(s) | | Cost | | Date) | | Value | | 4/30/2019 | |
Intarcia Therapeutics, Inc., Series DD | | 03/27/14 | | $ | 245,775 | | 0.14 | % | $ | 70,493 | | 0.06 | % |
JS Kred SPV I, LLC | | 06/26/15 | | 240,362 | | 0.15 | % | 0 | | 0.00 | % |
Palantir Technologies, Inc., Cl. A | | 10/07/14 | | 80,856 | | 0.05 | % | 71,450 | | 0.07 | % |
Palantir Technologies, Inc., Cl. B | | 10/07/14 | | 334,629 | | 0.22 | % | 291,381 | | 0.27 | % |
Prosetta Biosciences, Inc., Series D | | 02/06/15 | | 747,040 | | 0.50 | % | 333,678 | | 0.31 | % |
Toler o CDR | | 02/06/17 | | 226,186 | | 0.23 | % | 1,201,115 | | 1.11 | % |
Total | | | | | | | | $ | 1,968,117 | | 1.82 | % |
| | | | | | | | | | | | | |
See Notes to Financial Statements.
32
THE ALGER INSTITUTIONAL FUNDS | ALGER SMALL CAP GROWTH INSTITUTIONAL FUND
Schedule of Investments April 30, 2019 (Unaudited)
COMMON STOCKS—96.8% | | SHARES | | VALUE | |
AEROSPACE & DEFENSE—1.8% | | | | | |
Hexcel Corp. | | 12,956 | | $ | 916,119 | |
Mercury Systems, Inc.* | | 37,184 | | 2,715,176 | |
| | | | 3,631,295 | |
APPAREL ACCESSORIES & LUXURY GOODS—0.9% | | | | | |
Canada Goose Holdings, Inc.* | | 33,605 | | 1,794,171 | |
| | | | | |
APPAREL RETAIL—1.5% | | | | | |
Burlington Stores, Inc.* | | 17,686 | | 2,987,342 | |
| | | | | |
APPLICATION SOFTWARE—22.6% | | | | | |
ACI Worldwide, Inc.* | | 115,662 | | 4,108,314 | |
Avalara, Inc.* | | 77,696 | | 4,573,964 | |
Blackbaud, Inc. | | 47,691 | | 3,781,419 | |
Blackline, Inc.* | | 21,058 | | 1,075,643 | |
Coupa Software, Inc.* | | 19,786 | | 2,044,487 | |
Everbridge, Inc.* | | 31,931 | | 2,359,382 | |
Guidewire Software, Inc.* | | 30,490 | | 3,247,185 | |
HubSpot, Inc.* | | 23,617 | | 4,357,100 | |
Manhattan Associates, Inc.* | | 35,791 | | 2,414,103 | |
MicroStrategy, Inc., Cl. A* | | 12,640 | | 1,892,208 | |
Paycom Software, Inc.* | | 20,728 | | 4,198,042 | |
Q2 Holdings, Inc.* | | 40,416 | | 3,048,175 | |
Smartsheet, Inc., Cl. A* | | 32,187 | | 1,362,476 | |
SPS Commerce, Inc.* | | 16,768 | | 1,739,512 | |
Tyler Technologies, Inc.* | | 19,381 | | 4,494,648 | |
| | | | 44,696,658 | |
ASSET MANAGEMENT & CUSTODY BANKS—1.1% | | | | | |
WisdomTree Investments, Inc. | | 313,501 | | 2,257,207 | |
| | | | | |
BIOTECHNOLOGY—5.8% | | | | | |
Bluebird Bio, Inc.* | | 7,766 | | 1,101,452 | |
CareDx, Inc.* | | 118,771 | | 3,231,759 | |
Exact Sciences Corp.* | | 16,793 | | 1,657,301 | |
Heron Therapeutics, Inc.* | | 18,857 | | 408,820 | |
Portola Pharmaceuticals, Inc.* | | 27,052 | | 954,936 | |
Repligen Corp.* | | 18,372 | | 1,237,905 | |
Sarepta Therapeutics, Inc.* | | 24,971 | | 2,920,109 | |
| | | | 11,512,282 | |
ELECTRONIC COMPONENTS—0.8% | | | | | |
Dolby Laboratories, Inc., Cl. A | | 23,607 | | 1,527,137 | |
| | | | | |
ELECTRONIC EQUIPMENT & INSTRUMENTS—3.2% | | | | | |
Cognex Corp. | | 62,815 | | 3,167,760 | |
FLIR Systems, Inc. | | 58,597 | | 3,102,125 | |
| | | | 6,269,885 | |
GENERAL MERCHANDISE STORES—0.6% | | | | | |
Ollie’s Bargain Outlet Holdings, Inc.* | | 12,093 | | 1,156,574 | |
| | | | | |
HEALTH CARE EQUIPMENT—12.0% | | | | | |
ABIOMED, Inc.* | | 21,715 | | 6,023,958 | |
Axogen, Inc.* | | 33,401 | | 784,255 | |
| | | | | | |
33
THE ALGER INSTITUTIONAL FUNDS | ALGER SMALL CAP GROWTH INSTITUTIONAL FUND
Schedule of Investments April 30, 2019 (Unaudited) (Continued)
COMMON STOCKS—96.8% (CONT.) | | SHARES | | VALUE | |
HEALTH CARE EQUIPMENT—12.0% (CONT.) | | | | | |
Cantel Medical Corp. | | 56,086 | | $ | 3,866,569 | |
CryoPort, Inc.* | | 60,961 | | 857,721 | |
DexCom, Inc.* | | 19,699 | | 2,384,958 | |
Inogen, Inc.* | | 23,089 | | 2,015,670 | |
Insulet Corp.* | | 51,139 | | 4,410,739 | |
Tandem Diabetes Care, Inc.* | | 54,747 | | 3,362,013 | |
| | | | 23,705,883 | |
HEALTH CARE SUPPLIES—6.4% | | | | | |
Neogen Corp.* | | 78,619 | | 4,769,029 | |
OraSure Technologies, Inc.* | | 92,301 | | 873,167 | |
Quidel Corp.* | | 110,410 | | 7,059,615 | |
| | | | 12,701,811 | |
HEALTH CARE TECHNOLOGY—8.9% | | | | | |
Medidata Solutions, Inc.* | | 59,985 | | 5,419,045 | |
Veeva Systems, Inc., Cl. A* | | 63,152 | | 8,833,070 | |
Vocera Communications, Inc.* | | 107,896 | | 3,436,488 | |
| | | | 17,688,603 | |
HUMAN RESOURCE & EMPLOYMENT SERVICES—0.9% | | | | | |
WageWorks, Inc.* | | 38,033 | | 1,855,630 | |
| | | | | |
HYPERMARKETS & SUPER CENTERS—1.1% | | | | | |
BJ’s Wholesale Club Holdings, Inc.* | | 73,846 | | 2,093,534 | |
| | | | | |
INSURANCE BROKERS—0.4% | | | | | |
eHealth, Inc.* | | 12,046 | | 731,674 | |
| | | | | |
INTERACTIVE HOME ENTERTAINMENT—2.1% | | | | | |
Take-Two Interactive Software, Inc.* | | 43,602 | | 4,221,982 | |
| | | | | |
INTERACTIVE MEDIA & SERVICES—0.4% | | | | | |
Pinterest, Inc., Cl. A* | | 27,682 | | 857,588 | |
| | | | | |
INTERNET & DIRECT MARKETING RETAIL—3.8% | | | | | |
Etsy, Inc.* | | 78,225 | | 5,283,316 | |
GrubHub, Inc.* | | 20,510 | | 1,369,863 | |
Waitr Holdings, Inc.* | | 78,021 | | 761,485 | |
| | | | 7,414,664 | |
INTERNET SERVICES & INFRASTRUCTURE—1.8% | | | | | |
Shopify, Inc., Cl. A* | | 14,347 | | 3,493,925 | |
| | | | | |
IT CONSULTING & OTHER SERVICES—0.8% | | | | | |
InterXion Holding NV* | | 21,462 | | 1,484,956 | |
| | | | | |
LEISURE FACILITIES—2.0% | | | | | |
Planet Fitness, Inc., Cl. A* | | 51,853 | | 3,925,272 | |
| | | | | |
LIFE SCIENCES TOOLS & SERVICES—5.5% | | | | | |
Bio-Techne Corp. | | 32,736 | | 6,697,458 | |
NanoString Technologies, Inc.* | | 78,519 | | 2,039,138 | |
PRA Health Sciences, Inc.* | | 22,411 | | 2,169,833 | |
| | | | 10,906,429 | |
MANAGED HEALTH CARE—1.0% | | | | | |
HealthEquity, Inc.* | | 29,847 | | 2,022,134 | |
| | | | | | |
34
THE ALGER INSTITUTIONAL FUNDS | ALGER SMALL CAP GROWTH INSTITUTIONAL FUND
Schedule of Investments April 30, 2019 (Unaudited) (Continued)
COMMON STOCKS—96.8% (CONT.) | | SHARES | | VALUE | |
MOVIES & ENTERTAINMENT—0.9% | | | | | |
Live Nation Entertainment, Inc.* | | 26,941 | | $ | 1,760,325 | |
| | | | | |
OIL & GAS EQUIPMENT & SERVICES—1.1% | | | | | |
DMC Global, Inc. | | 31,148 | | 2,158,556 | |
| | | | | |
OIL & GAS EXPLORATION & PRODUCTION—0.7% | | | | | |
Magnolia Oil & Gas Corp.* | | 106,011 | | 1,397,225 | |
| | | | | |
PERSONAL PRODUCTS—0.3% | | | | | |
elf Beauty, Inc.* | | 52,999 | | 677,857 | |
| | | | | |
PHARMACEUTICALS—0.9% | | | | | |
Aerie Pharmaceuticals, Inc.* | | 21,392 | | 816,105 | |
GW Pharmaceuticals PLC.#,* | | 5,556 | | 940,686 | |
| | | | 1,756,791 | |
RESTAURANTS—2.0% | | | | | |
Shake Shack, Inc., Cl. A* | | 41,046 | | 2,516,120 | |
Wingstop, Inc. | | 18,544 | | 1,395,807 | |
| | | | 3,911,927 | |
SEMICONDUCTORS—0.6% | | | | | |
Universal Display Corp. | | 7,618 | | 1,215,833 | |
| | | | | |
SPECIALTY CHEMICALS—1.7% | | | | | |
Balchem Corp. | | 33,007 | | 3,350,541 | |
| | | | | |
SPECIALTY STORES—1.1% | | | | | |
Five Below, Inc.* | | 14,486 | | 2,120,606 | |
| | | | | |
SYSTEMS SOFTWARE—2.1% | | | | | |
Proofpoint, Inc.* | | 32,939 | | 4,131,209 | |
TOTAL COMMON STOCKS (Cost $105,679,502) | | | | 191,417,506 | |
| | | | | | |
PREFERRED STOCKS—0.3% | | SHARES | | VALUE | |
BIOTECHNOLOGY—0.1% | | | | | |
Prosetta Biosciences, Inc., Series D*,@,(a),(b) | | 133,263 | | 267,859 | |
PHARMACEUTICALS—0.2% | | | | | |
Intarcia Therapeutics, Inc., Series DD*,@,(b) | | 41,238 | | 383,101 | |
TOTAL PREFERRED STOCKS (Cost $1,935,383) | | | | 650,960 | |
RIGHTS—0.8% | | SHARES | | VALUE | |
BIOTECHNOLOGY—0.8% | | | | | |
Tolero CDR*,@,(b),(c) | | 528,559 | | 1,501,108 | |
(Cost $285,725) | | | | 1,501,108 | |
SPECIAL PURPOSE VEHICLE—0.0% | | SHARES | | VALUE | |
CONSUMER FINANCE—0.0% | | | | | |
JS Kred SPV I, LLC*,@,(b) | | 775,134 | | — | |
(Cost $775,134) | | | | — | |
35
THE ALGER INSTITUTIONAL FUNDS | ALGER SMALL CAP GROWTH INSTITUTIONAL FUND
Schedule of Investments April 30, 2019 (Unaudited) (Continued)
| | | | VALUE | |
Total Investments (Cost $108,675,744) | | 97.9 | % | $ | 193,569,574 | |
Affiliated Securities (Cost $599,684) | | | | 267,859 | |
Unaffiliated Securities (Cost $108,076,060) | | | | 193,301,715 | |
Other Assets in Excess of Liabilities | | 2.1 | % | 4,159,408 | |
NET ASSETS | | 100.0 | % | $ | 197,728,982 | |
# American Depositary Receipts.
(a) Deemed an affiliate of the Fund in accordance with Section 2(a)(3) of the Investment Company Act of 1940. See Note 11 - Affiliated Securities.
(b) Security is valued in good faith at fair value determined using significant unobservable inputs pursuant to procedures established by the Board.
(c) Contingent Deferred Rights.
* Non-income producing security.
@ Restricted security - Investment in security not registered under the Securities Act of 1933. The investment may be sold only to qualified buyers.
| | | | | | % of net assets | | | | % of net assets | |
| | Acquisition | | Acquisition | | (Acquisition | | Market | | as of | |
Security | | Date(s) | | Cost | | Date) | | Value | | 4/30/2019 | |
Intarcia Therapeutics, Inc., Series DD | | 03/27/14 | | $ | 1,335,699 | | 0.15 | % | $ | 383,101 | | 0.19 | % |
JS Kred SPV I, LLC | | 06/26/15 | | 775,134 | | 0.15 | % | 0 | | 0.00 | % |
Prosetta Biosciences, Inc., Series D | | 02/06/15 | | 599,684 | | 0.10 | % | 267,859 | | 0.14 | % |
Toler o CDR | | 02/06/17 | | 285,725 | | 0.16 | % | 1,501,108 | | 0.76 | % |
Total | | | | | | | | $ | 2,152,068 | | 1.09 | % |
| | | | | | | | | | | | | |
See Notes to Financial Statements.
36
THE ALGER INSTITUTIONAL FUNDS
Statements of Assets and Liabilities April 30, 2019 (Unaudited)
| | Alger Capital | | | |
| | Appreciation | | Alger Focus Equity | |
| | Institutional Fund | | Fund | |
ASSETS: | | | | | |
Investments in unaffiliated securities, at value (Identified cost below)* see accompanying schedules of investments | | $ | 3,570,048,031 | | $ | 501,427,845 | |
Investments in affiliated securities, at value (Identified cost below)** see accompanying schedules of investments | | — | | 154,418 | |
Cash and cash equivalents | | 20,699,713 | | 1,108,648 | |
Receivable for investment securities sold | | 30,151,889 | | 12,387,414 | |
Receivable for shares of beneficial interest sold | | 4,204,964 | | 2,336,883 | |
Dividends and interest receivable | | 1,076,067 | | 131,380 | |
Receivable from Investment Manager | | 15,684 | | 2,573 | |
Prepaid expenses | | 210,391 | | 81,957 | |
Total Assets | | 3,626,406,739 | | 517,631,118 | |
| | | | | |
LIABILITIES: | | | | | |
Payable for investment securities purchased | | 42,760,272 | | 8,483,692 | |
Payable for shares of beneficial interest redeemed | | 10,541,139 | | 138,743 | |
Accrued investment advisory fees | | 2,252,741 | | 222,098 | |
Accrued transfer agent fees | | 1,179,186 | | 45,644 | |
Accrued distribution fees | | 253,546 | | 40,534 | |
Accrued administrative fees | | 84,365 | | 11,746 | |
Accrued shareholder servicing fees | | 608,287 | | 9,772 | |
Accrued shareholder administrative fees | | 30,678 | | 4,732 | |
Accrued trustee fees | | 10,214 | | 1,349 | |
Accrued other expenses | | 273,721 | | 66,511 | |
Total Liabilities | | 57,994,149 | | 9,024,821 | |
NET ASSETS | | $ | 3,568,412,590 | | $ | 508,606,297 | |
NET ASSETS CONSIST OF: | | | | | |
Paid in capital (par value of $.001 per share) | | 2,234,548,232 | | 433,931,071 | |
Distributable earnings | | 1,333,864,358 | | 74,675,226 | |
NET ASSETS | | $ | 3,568,412,590 | | $ | 508,606,297 | |
* Identified cost | | $ | 2,349,499,032 | (a) | $ | 420,351,788 | (b) |
** Identified cost | | $ | — | | $ | 345,713 | (b) |
See Notes to Financial Statements.
37
THE ALGER INSTITUTIONAL FUNDS
Statements of Assets and Liabilities April 30, 2019 (Unaudited) (Continued)
| | Alger Capital Appreciation Institutional Fund | | Alger Focus Equity Fund | |
NET ASSETS BY CLASS: | | | | | |
Class A | | $ | — | | $ | 48,368,436 | |
Class C | | $ | — | | $ | 35,812,361 | |
Class I | | $ | 2,238,624,727 | | $ | 46,306,212 | |
Class R | | $ | 588,064,675 | | $ | — | |
Class Y | | $ | 247,057,701 | | $ | 66,776,748 | |
Class Z | | $ | — | | $ | 311,342,540 | |
Class Z-2 | | $ | 494,665,487 | | $ | — | |
| | | | | |
SHARES OF BENEFICIAL INTEREST OUTSTANDING — NOTE 6: | | | | | |
Class A | | — | | 1,321,233 | |
Class C | | — | | 1,030,401 | |
Class I | | 64,419,482 | | 1,257,568 | |
Class R | | 19,261,836 | | — | |
Class Y | | 7,038,991 | | 1,781,415 | |
Class Z | | — | | 8,322,212 | |
Class Z-2 | | 14,101,548 | | — | |
| | | | | |
NET ASSET VALUE PER SHARE: | | | | | |
Class A — Net Asset Value Per Share Class A | | $ | — | | $ | 36.61 | |
Class A — Offering Price Per Share (includes a 5.25% sales charge) | | $ | — | | $ | 38.64 | |
Class C — Net Asset Value Per Share Class C | | $ | — | | $ | 34.76 | |
Class I — Net Asset Value Per Share Class I | | $ | 34.75 | | $ | 36.82 | |
Class R — Net Asset Value Per Share Class R | | $ | 30.53 | | $ | — | |
Class Y — Net Asset Value Per Share Class Y | | $ | 35.10 | | $ | 37.49 | |
Class Z — Net Asset Value Per Share Class Z | | $ | — | | $ | 37.41 | |
Class Z-2 — Net Asset Value Per Share Class Z-2 | | $ | 35.08 | | $ | — | |
See Notes to Financial Statements.
(a) At April 30, 2019, the net unrealized appreciation on investments, based on cost for federal income tax purposes of $2,368,299,874, amounted to $1,201,748,157 which consisted of aggregate gross unrealized appreciation of $1,227,345,507 and aggregate gross unrealized depreciation of $25,597,350.
(b) At April 30, 2019, the net unrealized appreciation on investments, based on cost for federal income tax purposes of $423,212,135, amounted to $78,370,128 which consisted of aggregate gross unrealized appreciation of $81,275,471 and aggregate gross unrealized depreciation of $2,905,343.
38
THE ALGER INSTITUTIONAL FUNDS
Statements of Assets and Liabilities April 30, 2019 (Unaudited) (Continued)
| | Alger Mid Cap Growth Institutional Fund | | Alger Small Cap Growth Institutional Fund | |
ASSETS: | | | | | |
Investments in unaffiliated securities, at value (Identified cost below)* see accompanying schedules of investments | | $ | 108,200,435 | | $ | 193,301,715 | |
Investments in affiliated securities, at value (Identified cost below)** see accompanying schedules of investments | | 333,678 | | 267,859 | |
Cash and cash equivalents | | 868,177 | | 3,389,990 | |
Receivable for investment securities sold | | 1,856,429 | | 1,298,922 | |
Receivable for shares of beneficial interest sold | | 168,416 | | 132,558 | |
Dividends and interest receivable | | 40,034 | | 187,622 | |
Receivable from Investment Manager | | — | | 1,023 | |
Prepaid expenses | | 55,461 | | 37,317 | |
Total Assets | | 111,522,630 | | 198,617,006 | |
| | | | | |
LIABILITIES: | | | | | |
Payable for investment securities purchased | | 2,456,544 | | — | |
Payable for shares of beneficial interest redeemed | | 456,222 | | 553,455 | |
Accrued investment advisory fees | | 72,066 | | 137,094 | |
Due to investment advisor | | 212 | | — | |
Accrued transfer agent fees | | 45,416 | | 75,027 | |
Accrued distribution fees | | 4,575 | | 4,182 | |
Accrued administrative fees | | 2,608 | | 4,654 | |
Accrued shareholder servicing fees | | 20,185 | | 31,490 | |
Accrued shareholder administrative fees | | 948 | | 1,693 | |
Accrued trustee fees | | 329 | | 570 | |
Accrued other expenses | | 66,674 | | 79,859 | |
Total Liabilities | | 3,125,779 | | 888,024 | |
NET ASSETS | | $ | 108,396,851 | | $ | 197,728,982 | |
| | | | | |
NET ASSETS CONSIST OF: | | | | | |
Paid in capital (par value of $.001 per share) | | 91,524,002 | | 108,882,334 | |
Distributable earnings | | 16,872,849 | | 88,846,648 | |
NET ASSETS | | $ | 108,396,851 | | $ | 197,728,982 | |
* Identified cost | | $ | 92,166,634 | (a) | $ | 108,076,060 | (b) |
** Identified cost | | $ | 747,040 | (a) | $ | 599,684 | (b) |
See Notes to Financial Statements.
39
THE ALGER INSTITUTIONAL FUNDS
Statements of Assets and Liabilities April 30, 2019 (Unaudited) (Continued)
| | Alger Mid Cap | | Alger Small Cap | |
| | Growth Institutional | | Growth Institutional | |
| | Fund | | Fund | |
NET ASSETS BY CLASS: | | | | | |
Class I | | $ | 82,595,360 | | $ | 137,845,965 | |
Class R | | $ | 10,375,819 | | $ | 9,734,809 | |
Class Z-2 | | $ | 15,425,672 | | $ | 50,148,208 | |
| | | | | |
SHARES OF BENEFICIAL INTEREST OUTSTANDING — NOTE 6: Class I | | 2,648,330 | | 6,326,388 | |
Class R | | 367,030 | | 548,004 | |
Class Z-2 | | 491,010 | | 2,277,358 | |
| | | | | |
NET ASSET VALUE PER SHARE: | | | | | |
Class I — Net Asset Value Per Share Class I | | $ | 31.19 | | $ | 21.79 | |
Class R — Net Asset Value Per Share Class R | | $ | 28.27 | | $ | 17.76 | |
Class Z-2 — Net Asset Value Per Share Class Z-2 | | $ | 31.42 | | $ | 22.02 | |
See Notes to Financial Statements.
(a) At April 30, 2019, the net unrealized appreciation on investments, based on cost for federal income tax purposes of $93,052,459, amounted to $15,481,654 which consisted of aggregate gross unrealized appreciation of $17,273,823 and aggregate gross unrealized depreciation of $1,792,169.
(b) At April 30, 2019, the net unrealized appreciation on investments, based on cost for federal income tax purposes of $111,050,904, amounted to $82,518,670 which consisted of aggregate gross unrealized appreciation of $90,597,458 and aggregate gross unrealized depreciation of $8,078,788.
40
THE ALGER INSTITUTIONAL FUNDS
Statements of Operations for the six months ended April 30, 2019 (Unaudited)
| | Alger Capital Appreciation Institutional Fund | | Alger Focus Equity Fund | |
INCOME: | | | | | |
Dividends (net of foreign withholding taxes*) | | $ | 16,683,639 | | $ | 2,222,347 | |
Interest | | 715,975 | | 120,026 | |
Total Income | | 17,399,614 | | 2,342,373 | |
| | | | | |
EXPENSES: | | | | | |
Advisory fees — Note 3(a) | | 12,358,594 | | 1,048,588 | |
Distribution fees — Note 3(c) | | | | | |
Class A | | — | | 51,711 | |
Class C | | — | | 149,621 | |
Class R | | 1,400,694 | | — | |
Shareholder servicing fees — Note 3(k) | | 3,364,216 | | 49,228 | |
Shareholder administrative fees — Note 3(f) | | 167,138 | | 22,482 | |
Administration fees — Note 3(b) | | 459,629 | | 55,454 | |
Custodian fees | | 78,977 | | 41,326 | |
Transfer agent fees and expenses — Note 3(f) | | 1,184,467 | | 74,814 | |
Printing fees | | 118,630 | | 25,525 | |
Professional fees | | 77,285 | | 21,858 | |
Registration fees | | 53,723 | | 50,894 | |
Trustee fees — Note 3(g) | | 60,938 | | 7,968 | |
Fund accounting fees | | 229,007 | | 35,148 | |
Miscellaneous | | 139,300 | | 18,216 | |
Total Expenses | | 19,692,598 | | 1,652,833 | |
Less, expense reimbursements/waivers — Note 3(a) | | (91,068 | ) | (14,254 | ) |
Net Expenses | | 19,601,530 | | 1,638,579 | |
NET INVESTMENT INCOME (LOSS) | | (2,201,916 | ) | 703,794 | |
| | | | | |
REALIZED AND UNREALIZED GAIN (LOSS) ON INVESTMENTS AND FOREIGN CURRENCY: | | | | | |
Net realized gain (loss) on unaffiliated investments | | 141,577,580 | | (4,065,416 | ) |
Net realized gain (loss) on foreign currency transactions | | 2,136 | | (8,463 | ) |
Net change in unrealized appreciation on unaffiliated investments | | 271,832,635 | | 65,817,513 | |
Net change in unrealized (depreciation) on affiliated investments | | — | | (86,812 | ) |
Net realized and unrealized gain on investments and foreign currency | | 413,412,351 | | 61,656,822 | |
NET INCREASE IN NET ASSETS RESULTING FROM OPERATIONS | | $ | 411,210,435 | | $ | 62,360,616 | |
* Foreign withholding taxes | | $ | 962 | | $ | — | |
See Notes to Financial Statements.
41
THE ALGER INSTITUTIONAL FUNDS
Statements of Operations for the six months ended April 30, 2019 (Unaudited) (Continued)
| | Alger Mid Cap Growth Institutional Fund | | Alger Small Cap Growth Institutional Fund | |
INCOME: | | | | | |
Dividends | | $ | 354,290 | | $ | 200,219 | |
Interest | | 10,062 | | 20,735 | |
Total Income | | 364,352 | | 220,954 | |
| | | | | |
EXPENSES: | | | | | |
Advisory fees — Note 3(a) | | 381,237 | | 742,682 | |
Distribution fees — Note 3(c) Class R | | 24,978 | | 22,295 | |
Shareholder servicing fees — Note 3(k) | | 107,949 | | 170,201 | |
Shareholder administrative fees — Note 3(f) | | 5,016 | | 9,169 | |
Administration fees — Note 3(b) | | 13,795 | | 25,214 | |
Custodian fees | | 29,662 | | 30,405 | |
Interest expenses | | 978 | | 1,523 | |
Transfer agent fees and expenses — Note 3(f) | | 43,127 | | 83,870 | |
Printing fees | | 5,430 | | 17,575 | |
Professional fees | | 31,270 | | 31,675 | |
Registration fees | | 22,601 | | 23,857 | |
Trustee fees — Note 3(g) | | 1,864 | | 3,245 | |
Fund accounting fees | | 12,284 | | 18,093 | |
Miscellaneous | | 11,229 | | 14,148 | |
Total Expenses | | 691,420 | | 1,193,952 | |
Less, expense reimbursements/waivers — Note 3(a) | | (2,599 | ) | (9,184 | ) |
Net Expenses | | 688,821 | | 1,184,768 | |
NET INVESTMENT LOSS | | (324,469 | ) | (963,814 | ) |
| | | | | |
REALIZED AND UNREALIZED GAIN (LOSS) ON INVESTMENTS, OPTIONS AND FOREIGN CURRENCY: | | | | | |
Net realized gain on unaffiliated investments | | 1,718,235 | | 7,583,301 | |
Net change in unrealized appreciation on unaffiliated investments and purchased options | | 10,079,915 | | 13,914,230 | |
Net change in unrealized (depreciation) on affiliated investments | | (187,590 | ) | (150,587 | ) |
Net realized and unrealized gain on investments, options and foreign currency | | 11,610,560 | | 21,346,944 | |
NET INCREASE IN NET ASSETS RESULTING FROM OPERATIONS | | $ | 11,286,091 | | $ | 20,383,130 | |
See Notes to Financial Statements.
42
THE ALGER INSTITUTIONAL FUNDS
Statements of Changes in Net Assets (Unaudited)
| | Alger Capital Appreciation Institutional Fund | |
| | For the Six Months Ended April 30, 2019 | | For the Year Ended October 31, 2018 | |
Net investment loss | | $ | (2,201,916 | ) | $ | (6,666,406 | ) |
Net realized gain on investments and foreign currency | | 141,579,716 | | 404,392,712 | |
Net change in unrealized appreciation (depreciation) on investments and foreign currency | | 271,832,635 | | (92,086,299 | ) |
Net increase in net assets resulting from operations | | 411,210,435 | | 305,640,007 | |
| | | | | |
Dividends and distributions to shareholders: | | | | | |
Class I | | (228,361,283 | ) | (155,695,093 | ) |
Class R | | (65,649,382 | ) | (45,926,496 | ) |
Class Y | | (17,935,797 | ) | (6,401,127 | ) |
Class Z-2 | | (46,762,552 | ) | (28,017,833 | ) |
Total dividends and distributions to shareholders | | (358,709,014 | ) | (236,040,549 | ) |
| | | | | |
Increase (decrease) from shares of beneficial interest transactions: | | | | | |
Class I | | (48,375,398 | ) | (244,851,310 | ) |
Class R | | (9,054,869 | ) | (67,006,545 | ) |
Class Y | | 67,901,120 | | 68,027,078 | |
Class Z-2 | | 21,606,584 | | 17,242,397 | |
Net increase (decrease) from shares of beneficial interest transactions — Note 6 | | 32,077,437 | | (226,588,380 | ) |
Total increase (decrease) | | 84,578,858 | | (156,988,922 | ) |
| | | | | |
Net Assets: | | | | | |
Beginning of period | | 3,483,833,732 | | 3,640,822,654 | |
END OF PERIOD | | $ | 3,568,412,590 | | $ | 3,483,833,732 | |
See Notes to Financial Statements.
43
THE ALGER INSTITUTIONAL FUNDS
Statements of Changes in Net Assets (Unaudited) (Continued)
| | Alger Focus Equity Fund | |
| | For the | | For the | |
| | Six Months Ended | | Year Ended | |
| | April 30, 2019 | | October 31, 2018 | |
Net investment income (loss) | | $ | 703,794 | | $ | (141,806 | ) |
Net realized gain (loss) on investments and foreign currency | | (4,073,879 | ) | 16,804,967 | |
Net change in unrealized appreciation (depreciation) on investments | | 65,730,701 | | (11,374,281 | ) |
Net increase in net assets resulting from operations | | 62,360,616 | | 5,288,880 | |
| | | | | |
Dividends and distributions to shareholders: | | | | | |
Class A | | (1,751,631 | ) | (928,906 | ) |
Class C | | (1,389,363 | ) | (741,526 | ) |
Class I | | (1,705,045 | ) | (903,457 | ) |
Class Y | | (2,863,709 | ) | (166,506 | ) |
Class Z | | (9,580,668 | ) | (2,493,828 | ) |
Total dividends and distributions to shareholders | | (17,290,416 | ) | (5,234,223 | ) |
| | | | | |
Increase from shares of beneficial interest transactions: | | | | | |
Class A | | 1,336,252 | | 18,547,617 | |
Class C | | 6,554,167 | | 6,715,162 | |
Class I | | 5,738,382 | | 11,784,060 | |
Class Y | | 3,772,734 | | 56,440,501 | |
Class Z | | 108,297,974 | | 111,949,959 | |
Net increase from shares of beneficial interest transactions — Note 6 | | 125,699,509 | | 205,437,299 | |
Total increase | | 170,769,709 | | 205,491,956 | |
| | | | | |
Net Assets: | | | | | |
Beginning of period | | 337,836,588 | | 132,344,632 | |
END OF PERIOD | | $ | 508,606,297 | | $ | 337,836,588 | |
See Notes to Financial Statements.
44
THE ALGER INSTITUTIONAL FUNDS
Statements of Changes in Net Assets (Unaudited) (Continued)
| | Alger Mid Cap Growth Institutional Fund | |
| | For the Six Months Ended April 30, 2019 | | For the Year Ended October 31, 2018 | |
Net investment loss | | $ | (324,469 | ) | $ | (925,192 | ) |
Net realized gain on investments, escrow receivable and foreign currency | | 1,718,235 | | 8,003,745 | |
Net change in unrealized appreciation (depreciation) on investments, options and escrow receivable | | 9,892,325 | | (904,918 | ) |
Net increase in net assets resulting from operations | | 11,286,091 | | 6,173,635 | |
| | | | | |
Dividends and distributions to shareholders: | | | | | |
Class I | | (5,058,264 | ) | — | |
Class R | | (731,578 | ) | — | |
Class Z-2 | | (847,416 | ) | — | |
Total dividends and distributions to shareholders | | (6,637,258 | ) | — | |
| | | | | |
Increase (decrease) from shares of beneficial interest transactions: | | | | | |
Class I | | (629,646 | ) | (10,944,024 | ) |
Class R | | (628,978 | ) | (2,923,958 | ) |
Class Z-2 | | 3,064,914 | | 1,992,841 | |
Net increase (decrease) from shares of beneficial interest transactions — Note 6 | | 1,806,290 | | (11,875,141 | ) |
Total increase (decrease) | | 6,455,123 | | (5,701,506 | ) |
| | | | | |
Net Assets: | | | | | |
Beginning of period | | 101,941,728 | | 107,643,234 | |
END OF PERIOD | | $ | 108,396,851 | | $ | 101,941,728 | |
See Notes to Financial Statements.
45
THE ALGER INSTITUTIONAL FUNDS
Statements of Changes in Net Assets (Unaudited) (Continued)
| | Alger Small Cap Growth Institutional Fund | |
| | For the Six Months Ended April 30, 2019 | | For the Year Ended October 31, 2018 | |
Net investment loss | | $ | (963,814 | ) | $ | (1,941,932 | ) |
Net realized gain on investments, escrow receivable and foreign currency | | 7,583,301 | | 24,786,872 | |
Net change in unrealized appreciation on investments and escrow receivable | | 13,763,643 | | 3,411,196 | |
Net increase in net assets resulting from operations | | 20,383,130 | | 26,256,136 | |
| | | | | |
Dividends and distributions to shareholders: | | | | | |
Class I | | (15,958,474 | ) | (3,663,266 | ) |
Class R | | (1,321,082 | ) | (360,715 | ) |
Class Z-2 | | (5,897,370 | ) | (1,861,053 | ) |
Total dividends and distributions to shareholders | | (23,176,926 | ) | (5,885,034 | ) |
| | | | | |
Increase (decrease) from shares of beneficial interest transactions: | | | | | |
Class I | | 7,194,082 | | (10,825,882 | ) |
Class R | | 849,522 | | (2,949,728 | ) |
Class Z-2 | | 1,162,468 | | (24,326,697 | ) |
Net increase (decrease) from shares of beneficial interest transactions — Note 6 | | 9,206,072 | | (38,102,307 | ) |
Total increase (decrease) | | 6,412,276 | | (17,731,205 | ) |
| | | | | |
Net Assets: | | | | | |
Beginning of period | | 191,316,706 | | 209,047,911 | |
END OF PERIOD | | $ | 197,728,982 | | $ | 191,316,706 | |
See Notes to Financial Statements.
46
THE ALGER INSTITUTIONAL FUNDS
Financial Highlights for a share outstanding throughout the period (Unaudited)
Alger Capital Appreciation Institutional Fund
| | Class I | |
| | Six months ended | | Year ended | | Year ended | | Year ended | | Year ended | | Year ended | |
| | 4/30/2019(i) | | 10/31/2018 | | 10/31/2017 | | 10/31/2016 | | 10/31/2015 | | 10/31/2014 | |
Net asset value, beginning of period | | $ | 34.51 | | $ | 33.96 | | $ | 26.44 | | $ | 28.48 | | $ | 29.34 | | $ | 28.21 | |
INCOME FROM INVESTMENT OPERATIONS: | | | | | | | | | | | | | |
Net investment income (loss)(ii) | | (0.02 | ) | (0.05 | ) | — | | 0.02 | | (0.02 | ) | (0.02 | ) |
Net realized and unrealized gain (loss) on investments | | 3.81 | | 2.79 | | 7.71 | | (0.02 | ) | 2.46 | | 4.57 | |
Total from investment operations | | 3.79 | | 2.74 | | 7.71 | | — | | 2.44 | | 4.55 | |
Dividends from net investment income | | — | | — | | — | | — | | — | | (0.01 | ) |
Distributions from net realized gains | | (3.55 | ) | (2.19 | ) | (0.19 | ) | (2.04 | ) | (3.30 | ) | (3.41 | ) |
Net asset value, end of period | | $ | 34.75 | | $ | 34.51 | | $ | 33.96 | | $ | 26.44 | | $ | 28.48 | | $ | 29.34 | |
Total return | | 12.99 | % | 8.46 | % | 29.38 | % | (0.08 | )% | 8.96 | % | 17.63 | % |
RATIOS/SUPPLEMENTAL DATA: | | | | | | | | | | | | | |
Net assets, end of period (000’s omitted) | | $ | 2,238,625 | | $ | 2,259,000 | | $ | 2,451,822 | | $ | 2,965,503 | | $ | 3,194,261 | | $ | 2,555,737 | |
Ratio of gross expenses to average net assets | | 1.17 | % | 1.15 | % | 1.14 | % | 1.12 | % | 1.12 | % | 1.16 | % |
Ratio of expense reimbursements to average net assets | | — | | — | (iii) | — | | — | | — | | — | |
Ratio of net expenses to average net assets | | 1.17 | % | 1.15 | % | 1.14 | % | 1.12 | % | 1.12 | % | 1.16 | % |
Ratio of net investment income (loss) to average net assets | | (0.13 | )% | (0.16 | )% | 0.01 | % | 0.07 | % | (0.07 | )% | (0.07 | )% |
Portfolio turnover rate | | 39.73 | % | 64.77 | % | 66.72 | % | 94.56 | % | 136.03 | %(iv) | 136.20 | %(v) |
See Notes to Financial Statements.
(i) Ratios have been annualized; total return and portfolio turnover rate have not been annualized.
(ii) Amount was computed based on average shares outstanding during the period.
(iii) Amount was less than 0.005% per share.
(iv) Amount excludes redemption in kind transaction of $294,638,130.
(v) Amount excludes redemption in kind transaction of $71,436,408.
47
THE ALGER INSTITUTIONAL FUNDS
Financial Highlights for a share outstanding throughout the period (Unaudited)
Alger Capital Appreciation Institutional Fund
| | Class R | |
| | Six months ended | | Year ended | | Year ended | | Year ended | | Year ended | | Year ended | |
| | 4/30/2019(i) | | 10/31/2018 | | 10/31/2017 | | 10/31/2016 | | 10/31/2015 | | 10/31/2014 | |
Net asset value, beginning of period | | $ | 30.83 | | $ | 30.70 | | $ | 24.03 | | $ | 26.19 | | $ | 27.35 | | $ | 26.63 | |
INCOME FROM INVESTMENT OPERATIONS: | | | | | | | | | | | | | |
Net investment loss(ii) | | (0.08 | ) | (0.19 | ) | (0.13 | ) | (0.10 | ) | (0.15 | ) | (0.14 | ) |
Net realized and unrealized gain (loss) on investments | | 3.33 | | 2.51 | | 6.99 | | (0.02 | ) | 2.29 | | 4.27 | |
Total from investment operations | | 3.25 | | 2.32 | | 6.86 | | (0.12 | ) | 2.14 | | 4.13 | |
Distributions from net realized gains | | (3.55 | ) | (2.19 | ) | (0.19 | ) | (2.04 | ) | (3.30 | ) | (3.41 | ) |
Net asset value, end of period | | $ | 30.53 | | $ | 30.83 | | $ | 30.70 | | $ | 24.03 | | $ | 26.19 | | $ | 27.35 | |
Total return | | 12.77 | % | 7.96 | % | 28.78 | % | (0.57 | )% | 8.46 | % | 17.04 | % |
RATIOS/SUPPLEMENTAL DATA: | | | | | | | | | | | | | |
Net assets, end of period (000’s omitted) | | $ | 588,065 | | $ | 595,010 | | $ | 654,966 | | $ | 578,297 | | $ | 656,469 | | $ | 529,757 | |
Ratio of gross expenses to average net assets | | 1.60 | % | 1.59 | % | 1.62 | % | 1.61 | % | 1.61 | % | 1.64 | % |
Ratio of expense reimbursements to average net assets | | — | | — | (iii) | — | | — | | — | | — | |
Ratio of net expenses to average net assets | | 1.60 | % | 1.59 | % | 1.62 | % | 1.61 | % | 1.61 | % | 1.64 | % |
Ratio of net investment loss to average net assets | | (0.56 | )% | (0.60 | )% | (0.48 | )% | (0.41 | )% | (0.57 | )% | (0.55 | )% |
Portfolio turnover rate | | 39.73 | % | 64.77 | % | 66.72 | % | 94.56 | % | 136.03 | %(iv) | 136.20 | %(v) |
See Notes to Financial Statements.
(i) Ratios have been annualized; total return and portfolio turnover rate have not been annualized.
(ii) Amount was computed based on average shares outstanding during the period.
(iii) Amount was less than 0.005% per share.
(iv) Amount excludes redemption in kind transaction of $294,638,130.
(v) Amount excludes redemption in kind transaction of $71,436,408.
48
THE ALGER INSTITUTIONAL FUNDS
Financial Highlights for a share outstanding throughout the period (Unaudited)
Alger Capital Appreciation Institutional Fund
| | Class Y | |
| | Six months ended 4/30/2019(i) | | Year ended 10/31/2018 | | From 2/28/2017 (commencement of operations) to 10/31/2017(ii) | |
Net asset value, beginning of period | | $ | 34.75 | | $ | 34.05 | | $ | 28.85 | |
INCOME FROM INVESTMENT OPERATIONS: | | | | | | | |
Net investment income(iii) | | 0.04 | | 0.08 | | 0.02 | |
Net realized and unrealized gain on investments | | 3.86 | | 2.81 | | 5.18 | |
Total from investment operations | | 3.90 | | 2.89 | | 5.20 | |
Distributions from net realized gains | | (3.55 | ) | (2.19 | ) | — | |
Net asset value, end of period | | $ | 35.10 | | $ | 34.75 | | $ | 34.05 | |
Total return | | 13.23 | % | 8.90 | % | 18.02 | % |
RATIOS/SUPPLEMENTAL DATA: | | | | | | | |
Net assets, end of period (000’s omitted) | | $ | 247,058 | | $ | 166,778 | | $ | 97,889 | |
Ratio of gross expenses to average net assets | | 0.84 | % | 0.83 | % | 0.85 | % |
Ratio of expense reimbursements to average net assets | | (0.09 | )% | (0.10 | )% | (0.10 | )% |
Ratio of net expenses to average net assets | | 0.75 | % | 0.73 | % | 0.75 | % |
Ratio of net investment income to average net assets | | 0.26 | % | 0.22 | % | 0.10 | % |
Portfolio turnover rate | | 39.73 | % | 64.77 | % | 66.72 | % |
See Notes to Financial Statements.
(i) Ratios have been annualized; total return and portfolio turnover rate have not been annualized.
(ii) Ratios have been annualized; total return has not been annualized; portfolio turnover is for the twelve months then ended.
(iii) Amount was computed based on average shares outstanding during the period.
49
THE ALGER INSTITUTIONAL FUNDS
Financial Highlights for a share outstanding throughout the period (Unaudited)
Alger Capital Appreciation Institutional Fund
| | Class Z-2 | |
| | Six months ended 4/30/2019(i) | | Year ended 10/31/2018 | | Year ended 10/31/2017 | | From 10/14/2016 (commencement of operations) to 10/31/2016(ii) | |
Net asset value, beginning of period | | $ | 34.74 | | $ | 34.08 | | $ | 26.44 | | $ | 26.67 | |
INCOME FROM INVESTMENT OPERATIONS: | | | | | | | | | |
Net investment income(iii) | | 0.03 | | 0.06 | | 0.07 | | 0.01 | |
Net realized and unrealized gain (loss) on investments | | 3.86 | | 2.79 | | 7.76 | | (0.24 | ) |
Total from investment operations | | 3.89 | | 2.85 | | 7.83 | | (0.23 | ) |
Distributions from net realized gains | | (3.55 | ) | (2.19 | ) | (0.19 | ) | — | |
Net asset value, end of period | | $ | 35.08 | | $ | 34.74 | | $ | 34.08 | | $ | 26.44 | |
Total return | | 13.17 | % | 8.80 | % | 29.83 | % | (0.86 | )% |
RATIOS/SUPPLEMENTAL DATA: | | | | | | | | | |
Net assets, end of period (000’s omitted) | | $ | 494,665 | | $ | 463,046 | | $ | 436,145 | | $ | 2,212 | |
Ratio of gross expenses to average net assets | | 0.84 | % | 0.82 | % | 0.84 | % | 3.11 | % |
Ratio of expense reimbursements to average net assets | | — | | — | (iv) | — | | (2.16 | )% |
Ratio of net expenses to average net assets | | 0.84 | % | 0.82 | % | 0.84 | % | 0.95 | % |
Ratio of net investment income to average net assets | | 0.20 | % | 0.16 | % | 0.22 | % | 1.29 | % |
Portfolio turnover rate | | 39.73 | % | 64.77 | % | 66.72 | % | 94.56 | % |
See Notes to Financial Statements.
(i) Ratios have been annualized; total return and portfolio turnover rate have not been annualized.
(ii) Ratios have been annualized; total return has not been annualized; portfolio turnover is for the twelve months then ended.
(iii) Amount was computed based on average shares outstanding during the period.
(iv) Amount was less than 0.005% per share.
50
THE ALGER INSTITUTIONAL FUNDS
Financial Highlights for a share outstanding throughout the period (Unaudited)
Alger Focus Equity Fund
| | Class A | |
| | Six months ended 4/30/2019(i) | | Year ended 10/31/2018 | | Year ended 10/31/2017 | | Year ended 10/31/2016 | | Year ended 10/31/2015 | | Year ended 10/31/2014 | |
Net asset value, beginning of period | | $ | 34.00 | | $ | 31.74 | | $ | 23.95 | | $ | 24.13 | | $ | 22.01 | | $ | 18.69 | |
INCOME FROM INVESTMENT OPERATIONS: | | | | | | | | | | | | | |
Net investment income (loss)(ii) | | 0.03 | | (0.06 | ) | 0.01 | | (0.03 | ) | (0.02 | ) | (0.04 | ) |
Net realized and unrealized gain on investments | | 4.20 | | 3.55 | | 7.78 | | 0.12 | | 2.14 | | 3.36 | |
Total from investment operations | | 4.23 | | 3.49 | | 7.79 | | 0.09 | | 2.12 | | 3.32 | |
Distributions from net realized gains | | (1.62 | ) | (1.23 | ) | — | | (0.27 | ) | — | | — | |
Net asset value, end of period | | $ | 36.61 | | $ | 34.00 | | $ | 31.74 | | $ | 23.95 | | $ | 24.13 | | $ | 22.01 | |
Total return(iii) | | 13.33 | % | 11.33 | % | 32.53 | % | 0.36 | % | 9.63 | % | 17.76 | % |
RATIOS/SUPPLEMENTAL DATA: | | | | | | | | | | | | | |
Net assets, end of period (000’s omitted) | | $ | 48,368 | | $ | 43,621 | | $ | 23,693 | | $ | 25,524 | | $ | 23,961 | | $ | 5,158 | |
Ratio of gross expenses to average net assets | | 1.03 | % | 1.03 | % | 1.11 | % | 1.26 | % | 1.48 | % | 2.38 | % |
Ratio of expense reimbursements to average net assets | | — | | — | | — | | (0.07 | )% | (0.18 | )% | (1.08 | )% |
Ratio of net expenses to average net assets | | 1.03 | % | 1.03 | % | 1.11 | % | 1.19 | % | 1.30 | % | 1.30 | % |
Ratio of net investment income (loss) to average net assets | | 0.17 | % | (0.17 | )% | 0.03 | % | (0.13 | )% | (0.08 | )% | (0.19 | )% |
Portfolio turnover rate | | 73.17 | % | 135.54 | % | 98.57 | % | 127.40 | % | 182.58 | % | 153.69 | % |
See Notes to Financial Statements.
(i) Ratios have been annualized; total return and portfolio turnover rate have not been annualized.
(ii) Amount was computed based on average shares outstanding during the period.
(iii) Does not reflect the effect of sales charges, if applicable.
51
THE ALGER INSTITUTIONAL FUNDS
Financial Highlights for a share outstanding throughout the period (Unaudited)
Alger Focus Equity Fund
| | Class C | |
| | Six months ended 4/30/2019(i) | | Year ended 10/31/2018 | | Year ended 10/31/2017 | | Year ended 10/31/2016 | | Year ended 10/31/2015 | | Year ended 10/31/2014 | |
Net asset value, beginning of period | | $ | 32.47 | | $ | 30.59 | | $ | 23.27 | | $ | 23.62 | | $ | 21.71 | | $ | 18.58 | |
INCOME FROM INVESTMENT OPERATIONS: | | | | | | | | | | | | | |
Net investment loss(ii) | | (0.09 | ) | (0.31 | ) | (0.21 | ) | (0.20 | ) | (0.20 | ) | (0.19 | ) |
Net realized and unrealized gain on investments | | 4.00 | | 3.42 | | 7.53 | | 0.12 | | 2.11 | | 3.32 | |
Total from investment operations | | 3.91 | | 3.11 | | 7.32 | | (0.08 | ) | 1.91 | | 3.13 | |
Distributions from net realized gains | | (1.62 | ) | (1.23 | ) | — | | (0.27 | ) | — | | — | |
Net asset value, end of period | | $ | 34.76 | | $ | 32.47 | | $ | 30.59 | | $ | 23.27 | | $ | 23.62 | | $ | 21.71 | |
Total return(iii) | | 12.93 | % | 10.51 | % | 31.46 | % | (0.36 | )% | 8.80 | % | 16.85 | % |
RATIOS/SUPPLEMENTAL DATA: | | | | | | | | | | | | | |
Net assets, end of period (000’s omitted) | | $ | 35,812 | | $ | 26,366 | | $ | 18,660 | | $ | 12,021 | | $ | 6,542 | | $ | 2,635 | |
Ratio of gross expenses to average net assets | | 1.75 | % | 1.80 | % | 1.90 | % | 2.03 | % | 2.25 | % | 3.14 | % |
Ratio of expense reimbursements to average net assets | | — | | — | | — | | (0.10 | )% | (0.20 | )% | (1.09 | )% |
Ratio of net expenses to average net assets | | 1.75 | % | 1.80 | % | 1.90 | % | 1.93 | % | 2.05 | % | 2.05 | % |
Ratio of net investment loss to average net assets | | (0.58 | )% | (0.93 | )% | (0.79 | )% | (0.87 | )% | (0.85 | )% | (0.94 | )% |
Portfolio turnover rate | | 73.17 | % | 135.54 | % | 98.57 | % | 127.40 | % | 182.58 | % | 153.69 | % |
See Notes to Financial Statements.
(i) Ratios have been annualized; total return and portfolio turnover rate have not been annualized.
(ii) Amount was computed based on average shares outstanding during the period.
(iii) Does not reflect the effect of sales charges, if applicable.
52
THE ALGER INSTITUTIONAL FUNDS
Financial Highlights for a share outstanding throughout the period (Unaudited)
Alger Focus Equity Fund
| | Class I | |
| | Six months ended 4/30/2019(i) | | Year ended 10/31/2018 | | Year ended 10/31/2017 | | Year ended 10/31/2016 | | Year ended 10/31/2015 | | Year ended 10/31/2014 | |
Net asset value, beginning of period | | $ | 34.17 | | $ | 31.88 | | $ | 24.06 | | $ | 24.23 | | $ | 22.07 | | $ | 18.72 | |
INCOME FROM INVESTMENT OPERATIONS: | | | | | | | | | | | | | |
Net investment income (loss)(ii) | | 0.04 | | (0.05 | ) | 0.01 | | (0.02 | ) | 0.01 | | (0.01 | ) |
Net realized and unrealized gain on investments | | 4.23 | | 3.57 | | 7.81 | | 0.12 | | 2.15 | | 3.36 | |
Total from investment operations | | 4.27 | | 3.52 | | 7.82 | | 0.10 | | 2.16 | | 3.35 | |
Distributions from net realized gains | | (1.62 | ) | (1.23 | ) | — | | (0.27 | ) | — | | — | |
Net asset value, end of period | | $ | 36.82 | | $ | 34.17 | | $ | 31.88 | | $ | 24.06 | | $ | 24.23 | | $ | 22.07 | |
Total return(iii) | | 13.35 | % | 11.40 | % | 32.50 | % | 0.40 | % | 9.79 | % | 17.90 | % |
RATIOS/SUPPLEMENTAL DATA: | | | | | | | | | | | | | |
Net assets, end of period (000’s omitted) | | $ | 46,306 | | $ | 37,070 | | $ | 23,952 | | $ | 22,527 | | $ | 24,487 | | $ | 12,897 | |
Ratio of gross expenses to average net assets | | 0.99 | % | 1.02 | % | 1.12 | % | 1.30 | % | 1.49 | % | 2.36 | % |
Ratio of expense reimbursements to average net assets | | (0.04 | )% | (0.02 | )% | — | | (0.15 | )% | (0.34 | )% | (1.21 | )% |
Ratio of net expenses to average net assets | | 0.95 | % | 1.00 | % | 1.12 | % | 1.15 | % | 1.15 | % | 1.15 | % |
Ratio of net investment income (loss) to average net assets | | 0.22 | % | (0.13 | )% | 0.02 | % | (0.09 | )% | 0.03 | % | (0.04 | )% |
Portfolio turnover rate | | 73.17 | % | 135.54 | % | 98.57 | % | 127.40 | % | 182.58 | % | 153.69 | % |
See Notes to Financial Statements.
(i) Ratios have been annualized; total return and portfolio turnover rate have not been annualized.
(ii) Amount was computed based on average shares outstanding during the period.
(iii) Does not reflect the effect of sales charges, if applicable.
53
THE ALGER INSTITUTIONAL FUNDS
Financial Highlights for a share outstanding throughout the period (Unaudited)
Alger Focus Equity Fund
| | Class Y | |
| | | | | | From 2/28/2017 | |
| | Six months | | | | (commencement of | |
| | ended | | Year ended | | operations) to | |
| | 4/30/2019(i) | | 10/31/2018 | | 10/31/2017(ii) | |
Net asset value, beginning of period | | $ | 34.79 | | $ | 32.33 | | $ | 26.86 | |
INCOME FROM INVESTMENT OPERATIONS: | | | | | | | |
Net investment income (loss)(iii) | | 0.09 | | 0.04 | | (0.01 | ) |
Net realized and unrealized gain on investments | | 4.31 | | 3.65 | | 5.48 | |
Total from investment operations | | 4.40 | | 3.69 | | 5.47 | |
Dividends from net investment income | | (0.08 | ) | — | | — | |
Distributions from net realized gains | | (1.62 | ) | (1.23 | ) | — | |
Net asset value, end of period | | $ | 37.49 | | $ | 34.79 | | $ | 32.33 | |
Total return(iv) | | 13.54 | % | 11.78 | % | 20.36 | % |
RATIOS/SUPPLEMENTAL DATA: | | | | | | | |
Net assets, end of period (000’s omitted) | | $ | 66,777 | | $ | 57,880 | | $ | 4,319 | |
Ratio of gross expenses to average net assets | | 0.67 | % | 0.70 | % | 1.51 | % |
Ratio of expense reimbursements to average net assets | | (0.02 | )% | (0.05 | )% | (0.86 | )% |
Ratio of net expenses to average net assets | | 0.65 | % | 0.65 | % | 0.65 | % |
Ratio of net investment income (loss) to average net assets | | 0.53 | % | 0.11 | % | (0.05 | )% |
Portfolio turnover rate | | 73.17 | % | 135.54 | % | 98.57 | % |
See Notes to Financial Statements.
(i) Ratios have been annualized; total return and portfolio turnover rate have not been annualized.
(ii) Ratios have been annualized; total return has not been annualized; portfolio turnover is for the twelve months then ended.
(iii) Amount was computed based on average shares outstanding during the period.
(iv) Does not reflect the effect of sales charges, if applicable.
54
THE ALGER INSTITUTIONAL FUNDS
Financial Highlights for a share outstanding throughout the period (Unaudited)
Alger Focus Equity Fund
| | Class Z | |
| | Six months ended | | Year ended | | Year ended | | Year ended | | Year ended | | Year ended | |
| | 4/30/2019(i) | | 10/31/2018 | | 10/31/2017 | | 10/31/2016 | | 10/31/2015 | | 10/31/2014 | |
Net asset value, beginning of period | | $ | 34.73 | | $ | 32.28 | | $ | 24.30 | | $ | 24.41 | | $ | 22.17 | | $ | 18.75 | |
INCOME FROM INVESTMENT OPERATIONS: | | | | | | | | | | | | | |
Net investment income(ii) | | 0.08 | | 0.05 | | 0.07 | | 0.03 | | 0.07 | | 0.05 | |
Net realized and unrealized gain on investments | | 4.30 | | 3.63 | | 7.91 | | 0.13 | | 2.17 | | 3.37 | |
Total from investment operations | | 4.38 | | 3.68 | | 7.98 | | 0.16 | | 2.24 | | 3.42 | |
Dividends from net investment income | | (0.08 | ) | — | | — | | — | | — | | — | |
Distributions from net realized gains | | (1.62 | ) | (1.23 | ) | — | | (0.27 | ) | — | | — | |
Net asset value, end of period | | $ | 37.41 | | $ | 34.73 | | $ | 32.28 | | $ | 24.30 | | $ | 24.41 | | $ | 22.17 | |
Total return(iii) | | 13.50 | % | 11.74 | % | 32.84 | % | 0.64 | % | 10.10 | % | 18.24 | % |
RATIOS/SUPPLEMENTAL DATA: | | | | | | | | | | | | | | | | | | | |
Net assets, end of period (000’s omitted) | | $ | 311,343 | | $ | 172,900 | | $ | 61,721 | | $ | 15,693 | | $ | 3,683 | | $ | 1,262 | |
Ratio of gross expenses to average net assets | | 0.67 | % | 0.71 | % | 0.84 | % | 1.05 | % | 1.50 | % | 4.78 | % |
Ratio of expense reimbursements to average net assets | | — | | (0.02 | )% | — | | (0.12 | )% | (0.61 | )% | (3.89 | )% |
Ratio of net expenses to average net assets | | 0.67 | % | 0.69 | % | 0.84 | % | 0.93 | % | 0.89 | % | 0.89 | % |
Ratio of net investment income to average net assets | | 0.48 | % | 0.15 | % | 0.25 | % | 0.12 | % | 0.30 | % | 0.23 | % |
Portfolio turnover rate | | 73.17 | % | 135.54 | % | 98.57 | % | 127.40 | % | 182.58 | % | 153.69 | % |
See Notes to Financial Statements.
(i) Ratios have been annualized; total return and portfolio turnover rate have not been annualized.
(ii) Amount was computed based on average shares outstanding during the period.
(iii) Does not reflect the effect of sales charges, if applicable.
55
THE ALGER INSTITUTIONAL FUNDS
Financial Highlights for a share outstanding throughout the period (Unaudited)
Alger Mid Cap Growth Institutional Fund
| | Class I | |
| | Six months ended | | Year ended | | Year ended | | Year ended | | Year ended | | Year ended | |
| | 4/30/2019(i) | | 10/31/2018 | | 10/31/2017 | | 10/31/2016 | | 10/31/2015 | | 10/31/2014 | |
Net asset value, beginning of period | | $ | 30.20 | | $ | 28.65 | | $ | 21.59 | | $ | 22.54 | | $ | 22.18 | | $ | 19.43 | |
INCOME FROM INVESTMENT OPERATIONS: | | | | | | | | | | | | | |
Net investment loss(ii) | | (0.09 | ) | (0.25 | ) | (0.13 | ) | (0.05 | ) | (0.13 | ) | (0.07 | ) |
Net realized and unrealized gain (loss) on investments | | 3.06 | | 1.80 | | 7.19 | | (0.90 | ) | 0.49 | | 2.82 | |
Total from investment operations | | 2.97 | | 1.55 | | 7.06 | | (0.95 | ) | 0.36 | | 2.75 | |
Distributions from net realized gains | | (1.98 | ) | — | | — | | — | | — | | — | |
Net asset value, end of period | | $ | 31.19 | | $ | 30.20 | | $ | 28.65 | | $ | 21.59 | | $ | 22.54 | | $ | 22.18 | |
Total return | | 11.29 | % | 5.44 | % | 32.70 | % | (4.21 | )% | 1.62 | % | 14.15 | % |
RATIOS/SUPPLEMENTAL DATA: | | | | | | | | | | | | | |
Net assets, end of period (000’s omitted) | | $ | 82,595 | | $ | 79,954 | | $ | 85,890 | | $ | 81,782 | | $ | 114,984 | | $ | 132,426 | |
Ratio of gross expenses to average net assets | | 1.37 | % | 1.34 | % | 1.28 | % | 1.25 | % | 1.20 | % | 1.30 | % |
Ratio of net expenses to average net assets | | 1.37 | % | 1.34 | % | 1.28 | % | 1.25 | % | 1.20 | % | 1.30 | % |
Ratio of net investment loss to average net assets | | (0.64 | )% | (0.80 | )% | (0.50 | )% | (0.24 | )% | (0.55 | )% | (0.32 | )% |
Portfolio turnover rate | | 80.10 | % | 127.57 | % | 157.49 | % | 95.75 | % | 120.97 | % | 192.15 | % |
See Notes to Financial Statements.
(i) Ratios have been annualized; total return and portfolio turnover rate have not been annualized.
(ii) Amount was computed based on average shares outstanding during the period.
56
THE ALGER INSTITUTIONAL FUNDS
Financial Highlights for a share outstanding throughout the period (Unaudited)
Alger Mid Cap Growth Institutional Fund
| | Class R | |
| | Six months ended | | Year ended | | Year ended | | Year ended | | Year ended | | Year ended | |
| | 4/30/2019(i) | | 10/31/2018 | | 10/31/2017 | | 10/31/2016 | | 10/31/2015 | | 10/31/2014 | |
Net asset value, beginning of period | | $ | 27.64 | | $ | 26.35 | | $ | 19.96 | | $ | 20.96 | | $ | 20.74 | | $ | 18.26 | |
INCOME FROM INVESTMENT OPERATIONS: | | | | | | | | | | | | | |
Net investment loss(ii) | | (0.14 | ) | (0.36 | ) | (0.24 | ) | (0.16 | ) | (0.23 | ) | (0.16 | ) |
Net realized and unrealized gain (loss) on investments | | 2.75 | | 1.65 | | 6.63 | | (0.84 | ) | 0.45 | | 2.64 | |
Total from investment operations | | 2.61 | | 1.29 | | 6.39 | | (1.00 | ) | 0.22 | | 2.48 | |
Distributions from net realized gains | | (1.98 | ) | — | | — | | — | | — | | — | |
Net asset value, end of period | | $ | 28.27 | | $ | 27.64 | | $ | 26.35 | | $ | 19.96 | | $ | 20.96 | | $ | 20.74 | |
Total return | | 11.06 | % | 4.90 | % | 32.01 | % | (4.82 | )% | 1.11 | % | 13.58 | % |
RATIOS/SUPPLEMENTAL DATA: | | | | | | | | | | | | | |
Net assets, end of period (000’s omitted) | | $ | 10,376 | | $ | 10,672 | | $ | 12,943 | | $ | 13,093 | | $ | 17,795 | | $ | 21,953 | |
Ratio of gross expenses to average net assets | | 1.83 | % | 1.82 | % | 1.81 | % | 1.82 | % | 1.74 | % | 1.80 | % |
Ratio of net expenses to average net assets | | 1.83 | % | 1.82 | % | 1.81 | % | 1.82 | % | 1.74 | % | 1.80 | % |
Ratio of net investment loss to average net assets | | (1.10 | )% | (1.28 | )% | (1.04 | )% | (0.81 | )% | (1.08 | )% | (0.82 | )% |
Portfolio turnover rate | | 80.10 | % | 127.57 | % | 157.49 | % | 95.75 | % | 120.97 | % | 192.15 | % |
See Notes to Financial Statements.
(i) �� Ratios have been annualized; total return and portfolio turnover rate have not been annualized.
(ii) Amount was computed based on average shares outstanding during the period.
57
THE ALGER INSTITUTIONAL FUNDS
Financial Highlights for a share outstanding throughout the period (Unaudited)
Alger Mid Cap Growth Institutional Fund
| | Class Z-2 | |
| | | | | | | | From 10/14/2016 | |
| | Six months | | | | | | (commencement of | |
| | ended | | Year ended | | Year ended | | operations) to | |
| | 4/30/2019(i) | | 10/31/2018 | | 10/31/2017 | | 10/31/2016(ii) | |
Net asset value, beginning of period | | $ | 30.36 | | $ | 28.72 | | $ | 21.59 | | $ | 21.95 | |
INCOME FROM INVESTMENT OPERATIONS: | | | | | | | | | |
Net investment income (loss)(iii) | | (0.05 | ) | (0.17 | ) | (0.08 | ) | 0.04 | |
Net realized and unrealized gain (loss) on investments | | 3.09 | | 1.81 | | 7.21 | | (0.40 | ) |
Total from investment operations | | 3.04 | | 1.64 | | 7.13 | | (0.36 | ) |
Distributions from net realized gains | | (1.98 | ) | — | | — | | — | |
Net asset value, end of period | | $ | 31.42 | | $ | 30.36 | | $ | 28.72 | | $ | 21.59 | |
Total return | | 11.47 | % | 5.74 | % | 33.02 | % | (1.64 | )% |
RATIOS/SUPPLEMENTAL DATA: | | | | | | | | | |
Net assets, end of period (000’s omitted) | | $ | 15,426 | | $ | 11,316 | | $ | 8,810 | | $ | 113 | |
Ratio of gross expenses to average net assets | | 1.09 | % | 1.08 | % | 1.14 | % | 32.21 | % |
Ratio of expense reimbursements to average net assets | | (0.04 | )% | (0.03 | )% | (0.09 | )% | (31.16 | )% |
Ratio of net expenses to average net assets | | 1.05 | % | 1.05 | % | 1.05 | % | 1.05 | % |
Ratio of net investment income (loss) to average net assets | | (0.33 | )% | (0.53 | )% | (0.31 | )% | 4.35 | % |
Portfolio turnover rate | | 80.10 | % | 127.57 | % | 157.49 | % | 95.75 | % |
See Notes to Financial Statements.
(i) Ratios have been annualized; total return and portfolio turnover rate have not been annualized.
(ii) Ratios have been annualized; total return has not been annualized; portfolio turnover is for the twelve months then ended.
(iii) Amount was computed based on average shares outstanding during the period.
58
THE ALGER INSTITUTIONAL FUNDS
Financial Highlights for a share outstanding throughout the period (Unaudited)
Alger Small Cap Growth Institutional Fund
| | Class I | |
| | Six months ended | | Year ended | | Year ended | | Year ended | | Year ended | | Year ended | |
| | 4/30/2019(i) | | 10/31/2018 | | 10/31/2017 | | 10/31/2016 | | 10/31/2015 | | 10/31/2014 | |
Net asset value, beginning of period | | $ | 22.53 | | $ | 20.52 | | $ | 14.83 | | $ | 23.10 | | $ | 28.14 | | $ | 33.48 | |
INCOME FROM INVESTMENT OPERATIONS: | | | | | | | | | | | | | |
Net investment loss(ii) | | (0.11 | ) | (0.22 | ) | (0.14 | ) | (0.10 | ) | (0.20 | ) | (0.20 | ) |
Net realized and unrealized gain (loss) on investments | | 2.11 | | 2.81 | | 5.83 | | (0.54 | ) | 0.42 | | 0.60 | |
Total from investment operations | | 2.00 | | 2.59 | | 5.69 | | (0.64 | ) | 0.22 | | 0.40 | |
Distributions from net realized gains | | (2.74 | ) | (0.58 | ) | — | | (7.63 | ) | (5.26 | ) | (5.74 | ) |
Net asset value, end of period | | $ | 21.79 | | $ | 22.53 | | $ | 20.52 | | $ | 14.83 | | $ | 23.10 | | $ | 28.14 | |
Total return | | 11.74 | % | 12.96 | % | 38.37 | % | (3.76 | )% | 0.53 | % | 1.21 | % |
RATIOS/SUPPLEMENTAL DATA: | | | | | | | | | | | | | |
Net assets, end of period (000’s omitted) | | $ | 137,846 | | $ | 132,526 | | $ | 130,527 | | $ | 129,188 | | $ | 357,189 | | $ | 659,692 | |
Ratio of gross expenses to average net assets | | 1.37 | % | 1.32 | % | 1.32 | % | 1.28 | % | 1.25 | % | 1.24 | % |
Ratio of net expenses to average net assets | | 1.37 | % | 1.32 | % | 1.32 | % | 1.28 | % | 1.25 | % | 1.24 | % |
Ratio of net investment loss to average net assets | | (1.13 | )% | (1.00 | )% | (0.77 | )% | (0.67 | )% | (0.80 | )% | (0.70 | )% |
Portfolio turnover rate | | 6.39 | % | 28.20 | % | 29.70 | % | 55.08 | % | 125.72 | % | 84.10 | % |
See Notes to Financial Statements.
(i) Ratios have been annualized; total return and portfolio turnover rate have not been annualized.
(ii) Amount was computed based on average shares outstanding during the period.
59
THE ALGER INSTITUTIONAL FUNDS
Financial Highlights for a share outstanding throughout the period (Unaudited)
Alger Small Cap Growth Institutional Fund
| | Class R | |
| | Six months ended | | Year ended | | Year ended | | Year ended | | Year ended | | Year ended | |
| | 4/30/2019(i) | | 10/31/2018 | | 10/31/2017 | | 10/31/2016 | | 10/31/2015 | | 10/31/2014 | |
Net asset value, beginning of period | | $ | 18.97 | | $ | 17.44 | | $ | 12.67 | | $ | 20.92 | | $ | 26.08 | | $ | 31.58 | |
INCOME FROM INVESTMENT OPERATIONS: | | | | | | | | | | | | | |
Net investment loss(ii) | | (0.13 | ) | (0.27 | ) | (0.19 | ) | (0.16 | ) | (0.29 | ) | (0.32 | ) |
Net realized and unrealized gain (loss) on investments | | 1.66 | | 2.38 | | 4.96 | | (0.46 | ) | 0.39 | | 0.56 | |
Total from investment operations | | 1.53 | | 2.11 | | 4.77 | | (0.62 | ) | 0.10 | | 0.24 | |
Distributions from net realized gains | | (2.74 | ) | (0.58 | ) | — | | (7.63 | ) | (5.26 | ) | (5.74 | ) |
Net asset value, end of period | | $ | 17.76 | | $ | 18.97 | | $ | 17.44 | | $ | 12.67 | | $ | 20.92 | | $ | 26.08 | |
Total return | | 11.43 | % | 12.48 | % | 37.65 | % | (4.22 | )% | 0.02 | % | 0.74 | % |
RATIOS/SUPPLEMENTAL DATA: | | | | | | | | | | | | | |
Net assets, end of period (000’s omitted) | | $ | 9,735 | | $ | 9,238 | | $ | 11,253 | | $ | 12,675 | | $ | 18,577 | | $ | 31,062 | |
Ratio of gross expenses to average net assets | | 1.80 | % | 1.77 | % | 1.82 | % | 1.80 | % | 1.74 | % | 1.72 | % |
Ratio of net expenses to average net assets | | 1.80 | % | 1.77 | % | 1.82 | % | 1.80 | % | 1.74 | % | 1.72 | % |
Ratio of net investment loss to average net assets | | (1.56 | )% | (1.44 | )% | (1.27 | )% | (1.20 | )% | (1.30 | )% | (1.18 | )% |
Portfolio turnover rate | | 6.39 | % | 28.20 | % | 29.70 | % | 55.08 | % | 125.72 | % | 84.10 | % |
See Notes to Financial Statements.
(i) Ratios have been annualized; total return and portfolio turnover rate have not been annualized.
(ii) Amount was computed based on average shares outstanding during the period.
60
THE ALGER INSTITUTIONAL FUNDS
Financial Highlights for a share outstanding throughout the period (Unaudited)
Alger Small Cap Growth Institutional Fund
| | Class Z-2 | |
| | Six months ended 4/30/2019(i) | | Year ended 10/31/2018 | | Year ended 10/31/2017 | | From 8/1/2016 (commencement of operations) to 10/31/2016(ii) | |
Net asset value, beginning of period | | $ | 22.70 | | $ | 20.60 | | $ | 14.84 | | $ | 15.35 | |
INCOME FROM INVESTMENT OPERATIONS: | | | | | | | | | |
Net investment loss(iii) | | (0.08 | ) | (0.15 | ) | (0.09 | ) | (0.03 | ) |
Net realized and unrealized gain (loss) on investments | | 2.14 | | 2.83 | | 5.85 | | (0.48 | ) |
Total from investment operations | | 2.06 | | 2.68 | | 5.76 | | (0.51 | ) |
Distributions from net realized gains | | (2.74 | ) | (0.58 | ) | — | | — | |
Net asset value, end of period | | $ | 22.02 | | $ | 22.70 | | $ | 20.60 | | $ | 14.84 | |
Total return | | 11.94 | % | 13.35 | % | 38.81 | % | (3.32 | )% |
RATIOS/SUPPLEMENTAL DATA: | | | | | | | | | |
Net assets, end of period (000’s omitted) | | $ | 50,148 | | $ | 49,552 | | $ | 67,268 | | $ | 41,787 | |
Ratio of gross expenses to average net assets | | 1.03 | % | 1.00 | % | 1.03 | % | 1.07 | % |
Ratio of expense reimbursements to average net assets | | (0.04 | )% | (0.01 | )% | (0.04 | )% | (0.08 | )% |
Ratio of net expenses to average net assets | | 0.99 | % | 0.99 | % | 0.99 | % | 0.99 | % |
Ratio of net investment loss to average net assets | | (0.75 | )% | (0.66 | )% | (0.51 | )% | (0.76 | )% |
Portfolio turnover rate | | 6.39 | % | 28.20 | % | 29.70 | % | 55.08 | % |
See Notes to Financial Statements.
(i) Ratios have been annualized; total return and portfolio turnover rate have not been annualized.
(ii) Ratios have been annualized; total return has not been annualized; portfolio turnover is for the twelve months then ended.
(iii) Amount was computed based on average shares outstanding during the period.
61
THE ALGER INSTITUTIONAL FUNDS
NOTES TO FINANCIAL STATEMENTS (Unaudited)
NOTE 1 — General:
The Alger Institutional Funds (the “Trust”) is an open-end registered investment company organized as a business trust under the laws of the Commonwealth of Massachusetts. The Trust qualifies as an investment company as defined in Financial Accounting Standards Board Accounting Standards Codification 946-Financial Services — Investment Companies. The Trust operates as a series company and currently offers an unlimited number of shares of beneficial interest in four funds — Alger Capital Appreciation Institutional Fund, Alger Focus Equity Fund, Alger Mid Cap Growth Institutional Fund and Alger Small Cap Growth Institutional Fund (collectively, the “Funds” or individually, each a “Fund”). The Funds normally invest primarily in equity securities and each has an investment objective of longterm capital appreciation.
Each Fund offers one or more of the following share classes: Class A, C, I, R, Y, Z and Z-2. Class A shares are generally subject to an initial sales charge while Class C shares are generally subject to a deferred sales charge. Class I, R, Y, Z and Z-2 shares are sold to institutional investors without an initial or deferred sales charge. Class C shares will automatically convert to Class A shares on the fifth business day of the month following the tenth anniversary of the purchase date of a shareholder’s Class C shares, without the imposition of any sales load, fee or other charge. Class C shares held at certain dealers may convert to Class A shares earlier. At conversion, a proportionate amount of shares representing reinvested dividends and distributions will also be converted into Class A shares. Each class has identical rights to assets and earnings except that each share class bears the pro rata allocation of the Fund’s expenses other than a class expense (not including advisory or custodial fees or other expenses related to the management of the Fund’s assets).
NOTE 2 — Significant Accounting Policies:
(a) Investment Valuation: The Funds value their financial instruments at fair value using independent dealers or pricing services under policies approved by the Trust’s Board of Trustees (“Board”). Investments held by the Funds are valued on each day the New York Stock Exchange (the “NYSE”) is open, as of the close of the NYSE (normally 4:00 p.m. Eastern Standard Time).
Equity securities, including traded rights, warrants and option contracts for which valuation information is readily available are valued at the last quoted sales price or official closing price on the primary market or exchange on which they are traded as reported by an independent pricing service. In the absence of quoted sales, such securities are valued at the bid price or, in the absence of a recent bid price, the equivalent as obtained from one or more of the major market makers for the securities to be valued.
Debt securities generally trade in the over-the-counter market. Debt securities with remaining maturities of more than sixty days at the time of acquisition are valued on the basis of last available bid prices or current market quotations provided by dealers or pricing services. In determining the value of a particular investment, pricing services may use certain information with respect to transactions in such investments, quotations from dealers, pricing matrixes, market transactions in comparable investments, various
62
THE ALGER INSTITUTIONAL FUNDS
NOTES TO FINANCIAL STATEMENTS (Unaudited) (Continued)
relationships observed in the market between investments and calculated yield measures based on valuation technology commonly employed in the market for such investments. Asset-backed and mortgage-backed securities are valued by independent pricing services using models that consider estimated cash flows of each tranche of the security, establish a benchmark yield and develop an estimated tranche-specific spread to the benchmark yield based on the unique attributes of the tranche. Debt securities with a remaining maturity of sixty days or less are valued at amortized cost which approximates market value.
Securities for which market quotations are not readily available are valued at fair value, as determined in good faith pursuant to procedures established by the Board.
Securities in which the Funds invest may be traded in foreign markets that close before the close of the NYSE. Developments that occur between the close of the foreign markets and the close of the NYSE may result in adjustments to the closing foreign prices to reflect what the investment adviser, pursuant to policies established by the Board, believes to be the fair value of these securities as of the close of the NYSE. The Funds may also fair value securities in other situations, for example, when a particular foreign market is closed but the Funds are open.
Financial Accounting Standards Board Accounting Standards Codification 820 — Fair Value Measurements and Disclosures (“ASC 820”) defines fair value as the price that the Funds would receive upon selling an investment in a timely transaction to an independent buyer in the principal or most advantageous market of the investment. ASC 820 established a three-tier hierarchy to maximize the use of observable market data and minimize the use of unobservable inputs and to establish classification of fair value measurements for disclosure purposes. Inputs refer broadly to the assumptions that market participants would use in pricing the asset or liability and may be observable or unobservable. Observable inputs are based on market data obtained from sources independent of the Funds. Unobservable inputs are inputs that reflect the Funds’ own assumptions based on the best information available in the circumstances. The three-tier hierarchy of inputs is summarized in the three broad Levels listed below.
· Level 1 — quoted prices in active markets for identical investments
· Level 2 — significant other observable inputs (including quoted prices for similar investments, interest rates, prepayment speeds, credit risk, etc.)
· Level 3 — significant unobservable inputs (including the Funds’ own assumptions in determining the fair value of investments)
The Funds’ valuation techniques are generally consistent with either the market or the income approach to fair value. The market approach considers prices and other relevant information generated by market transactions involving identical or comparable assets to measure fair value. The income approach converts future amounts to a current, or discounted, single amount. These fair value measurements are determined on the basis of the value indicated by current market expectations about such future events. Inputs for Level 1 include exchange-listed prices and broker quotes in an active market. Inputs for Level 2 include the last trade price in the case of a halted security, an exchange-listed price which
63
THE ALGER INSTITUTIONAL FUNDS
NOTES TO FINANCIAL STATEMENTS (Unaudited) (Continued)
has been adjusted for fair value factors, and prices of closely related securities. Additional Level 2 inputs include an evaluated price which is based upon a compilation of observable market information such as spreads for fixed income and preferred securities. Inputs for Level 3 include, but are not limited to, revenue multiples, earnings before interest, taxes, depreciation and amortization (“EBITDA”) multiples, discount rates, and the probabilities of success of certain outcomes. Such unobservable market information may be obtained from a company’s financial statements and from industry studies, market data, and market indicators such as benchmarks and indexes. Because of the inherent uncertainty and often limited markets for restricted securities, the values may significantly differ from the values if there was an active market.
Valuation processes are determined by a Valuation Committee (“Committee”) established by the Board and comprised of representatives of the Trust’s investment adviser and officers of the Trust. The Committee reports its fair valuation determinations and related valuation information to the Board. The Board is responsible for approving valuation policy and procedures.
While the Committee meets on an as-needed basis, the Committee generally meets quarterly to review and evaluate the effectiveness of the procedures for making fair value determinations. The Committee considers, among other things, the results of quarterly back testing of the fair value model for foreign securities, pricing comparisons between primary and secondary price sources, the outcome of price challenges put to the Funds’ pricing vendor, and variances between transactional prices and the previous day’s price.
The Funds will record a change to a security’s fair value level if new inputs are available or it becomes evident that inputs previously considered for leveling have changed or are no longer relevant. Transfers between Levels 1, 2 and 3 are recognized at the end of the reporting period.
(b) Cash and Cash Equivalents: Cash and Cash Equivalents include U.S. dollars and overnight time deposits.
(c) Securities Transactions and Investment Income: Securities transactions are recorded on a trade date basis. Realized gains and losses from securities transactions are recorded on the identified cost basis. Dividend income is recognized on the ex-dividend date and interest income is recognized on the accrual basis.
Premiums and discounts on debt securities purchased are amortized or accreted over the lives of the respective securities.
(d) Foreign Currency Translations: The books and records of the Funds are maintained in U.S. dollars. Foreign currencies, investments and other assets and liabilities are translated into U.S. dollars at the prevailing rates of exchange on the valuation date. Purchases and sales of investment securities and income and expenses are translated into U.S. dollars at the prevailing exchange rates on the respective dates of such transactions.
Net realized gains and losses on foreign currency transactions represent net gains and losses from the disposition of foreign currencies, currency gains and losses realized between the
64
THE ALGER INSTITUTIONAL FUNDS
NOTES TO FINANCIAL STATEMENTS (Unaudited) (Continued)
trade dates and settlement dates of security transactions, and the difference between the amount of net investment income accrued and the U.S. dollar amount actually received. The effects of changes in foreign currency exchange rates on investments in securities are included in realized and unrealized gain or loss on investments in the accompanying Statements of Operations.
(e) Lending of Fund Securities: The Funds may lend their securities to financial institutions, provided that the market value of the securities loaned will not at any time exceed one third of a Fund’s total assets including borrowings, as defined in its prospectuses. The Funds earn fees on the securities loaned, which are included in interest income in the accompanying Statements of Operations. In order to protect against the risk of failure by the borrower to return the securities loaned or any delay in the delivery of such securities, the loan is collateralized by cash or securities that are maintained with Brown Brothers Harriman & Company, the Funds’ Custodian (“BBH” or the “Custodian”), in an amount equal to at least 102 percent of the current market value of U.S. loaned securities or 105 percent for non-U.S. loaned securities. The market value of the loaned securities is determined at the close of business of the Fund. Any required additional collateral is delivered to the Custodian and any excess collateral is returned to the borrower on the next business day. In the event the borrower fails to return the loaned securities when due, the Funds may take the collateral to replace the securities. If the value of the collateral is less than the purchase cost of replacement securities, the Custodian shall be responsible for any shortfall, but only to the extent that the shortfall is not due to any diminution in collateral value, as defined in the securities lending agreement. The Funds are required to maintain the collateral in a segregated account and determine its value each day until the loaned securities are returned. Cash collateral may be invested as determined by the Funds. Collateral is returned to the borrower upon settlement of the loan. There were no securities loaned as of April 30, 2019.
(f) Dividends to Shareholders: Dividends and distributions payable to shareholders are recorded by the Funds on the ex-dividend date. Dividends from net investment income, if available, and distributions from net realized gains, offset by any loss carryforward, are declared and paid annually after the end of the fiscal year in which earned.
Each class is treated separately in determining the amounts of dividends from net investment income payable to holders of its shares.
The characterization of distributions to shareholders for financial reporting purposes is determined in accordance with federal income tax rules. Therefore, the source of a Fund’s distributions may be shown in the accompanying financial statements as either from, or in excess of, net investment income, net realized gain on investment transactions or return of capital, depending on the type of book/tax differences that may exist. Capital accounts within the financial statements are adjusted for permanent book/tax differences. Reclassifications result primarily from the difference in tax treatment of net operating losses, passive foreign investment companies, and foreign currency transactions. The reclassifications are done annually at fiscal year-end and have no impact on the net asset values of the Funds and are designed to present each Fund’s capital accounts on a tax basis.
65
THE ALGER INSTITUTIONAL FUNDS
NOTES TO FINANCIAL STATEMENTS (Unaudited) (Continued)
(g) Federal Income Taxes: It is each Fund’s policy to comply with the requirements of the Internal Revenue Code Subchapter M applicable to regulated investment companies and to distribute all of its taxable income to its shareholders. Provided that the Funds maintain such compliance, no federal income tax provision is required. Each Fund is treated as a separate entity for the purpose of determining such compliance.
Financial Accounting Standards Board Accounting Standards Codification 740 — Income Taxes (“ASC 740”) requires the Funds to measure and recognize in their financial statements the benefit of a tax position taken (or expected to be taken) on an income tax return if such position will more likely than not be sustained upon examination based on the technical merits of the position. No tax years are currently under investigation. The Funds file income tax returns in the U.S., as well as New York State and New York City. The statute of limitations on the Funds’ tax returns remains open for the tax years 2015-2018. Management does not believe there are any uncertain tax positions that require recognition of a tax liability.
(h) Allocation Methods: The Trust accounts separately for the assets, liabilities and operations of each Fund. Expenses directly attributable to each Fund are charged to that Fund’s operations; expenses which are applicable to all Funds are allocated among them based on net assets. Income, realized and unrealized gains and losses, and expenses of each Fund are allocated among the Fund’s classes based on relative net assets, with the exception of distribution fees, transfer agency fees, and shareholder servicing and related fees.
(i) Estimates: These financial statements have been prepared in accordance with accounting principles generally accepted in the United States of America, which require using estimates and assumptions that affect the reported amounts therein. These unaudited interim financial statements reflect all adjustments which are, in the opinion of management, necessary to present a fair statement of results for the interim period. Actual results may differ from those estimates. All such estimates are of normal recurring nature.
(j) Recent Accounting Pronouncement: In August 2018, the Financial Accounting Standards Board issued Accounting Standards Update 2018-13 “Disclosure Framework - Changes to the Disclosure Requirements for Fair Value Measurement” (“ASU 2018-13”) which modifies disclosure requirements for fair value measurements principally for Level 3 securities and transfers between levels of the fair value hierarchy. ASU 2018-13 is effective for fiscal years beginning after December 15, 2019 and for interim periods within those fiscal years.
Management is currently evaluating the application of ASU 2018-13 and its impact, if any, on the Funds’ financial statements.
NOTE 3 — Investment Advisory Fees and Other Transactions with Affiliates:
(a) Investment Advisory Fees: Fees incurred by each Fund, pursuant to the provisions of the Trust’s Investment Advisory Agreement with Fred Alger Management, Inc. (“Alger Management” or the “Investment Manager”), are payable monthly and computed based on the following rates. The actual rate paid as a percentage of average daily net assets, for the six months ended April 30, 2019, is set forth below under the heading “Actual Rate”:
66
THE ALGER INSTITUTIONAL FUNDS
NOTES TO FINANCIAL STATEMENTS (Unaudited) (Continued)
| | Tier 1 | | Tier 2 | | Tier 3 | | Tier 4 | | Tier 5 | | Actual Rate | |
Alger Capital Appreciation Institutional Fund(a) | | 0.81 | % | 0.65 | % | 0.60 | % | 0.55 | % | 0.45 | % | 0.74 | % |
Alger Focus Equity Fund(c) | | 0.52 | % | — | | — | | — | | — | | 0.52 | % |
Alger Mid Cap Growth Institutional Fund(b) | | 0.76 | % | 0.70 | % | — | | — | | — | | 0.76 | % |
Alger Small Cap Growth Institutional Fund(b) | | 0.81 | % | 0.75 | % | — | | — | | — | | 0.81 | % |
(a) Tier 1 rate is paid on assets up to $2 billion, Tier 2 rate is paid on assets between $2 billion and $3 billion, Tier 3 rate is paid on assets between $3 billion and $4 billion, Tier 4 rate is paid on assets between $4 billion and $5 billion, and Tier 5 rate is paid on assets in excess of $5 billion.
(b) Tier 1 rate is paid on assets up to $1 billion and Tier 2 rate is paid on assets in excess of $1 billion.
(c) Tier 1 rate is paid on all assets.
Alger Management has agreed to expense caps for several share classes, effective through February 28, 2021 whereby it reimburses the share classes if annualized operating expenses (excluding acquired fund fees and expenses, interest, taxes, dividend expenses on short sales, borrowing costs, brokerage and extraordinary expenses) exceed the rates, based on average daily net assets, listed below.
| | | | | | | | | | | | | | FEES WAIVED / REIMBURSED FOR THE SIX MONTHS | |
| | CLASS | | ENDED | |
| | A | | C | | I | | Y | | Z | | Z-2 | | APRIL 30, 2019 | |
| | | | | | | | | | | | | | | |
Alger Capital Appreciation Institutional Fund | | — | | — | | — | | 0.75 | % | — | | — | * | $ | 91,068 | |
| | | | | | | | | | | | | | | |
Alger Focus Equity Fund | | — | ** | — | ** | 0.89 | %** | 0.65 | % | 0.68 | % | — | | 14,254 | |
| | | | | | | | | | | | | | | |
Alger Mid Cap Growth Institutional Fund | | — | | — | | — | | — | | — | | 1.05 | % | 2,599 | |
| | | | | | | | | | | | | | | |
Alger Small Cap Growth Institutional Fund | | — | | — | | — | | — | | — | | 0.99 | % | 9,184 | |
| | | | | | | | | | | | | | | | |
* Prior to March 1, 2019, the expense cap for the Alger Capital Appreciation Institutional Fund Class Z-2 was 0.95%.
** Prior to March 1, 2019, the expense cap for the Alger Focus Equity Fund Class A was 1.15%, Class C was 1.95% and Class I was 0.99%.
Alger Management may, during the first year of the expense reimbursement contract, recoup any expenses waived or reimbursed pursuant to the expense reimbursement contract to the extent that such recoupment would not cause the expense ratio to exceed the lesser of the stated limitation in effect at the time of (i) the waiver or reimbursement and (ii) the recoupment. For the six months ended April 30, 2019, the recoupments made by the Alger Mid Cap Growth Institutional Fund to the Investment Manager were $212. As of April 30, 2019, the total repayments that may potentially be made by the Funds to the Investment Manager for the Alger Capital Appreciation Institutional Fund, Alger Focus Equity Fund, Alger Mid Cap Growth Institutional Fund and Alger Small Cap Growth Institutional Fund are $155,677, $48,417, $4,024 and $9,716, respectively, which will expire February 28, 2020.
67
THE ALGER INSTITUTIONAL FUNDS
NOTES TO FINANCIAL STATEMENTS (Unaudited) (Continued)
(b) Administration Fees: Fees incurred by each Fund, pursuant to the provisions of the Trust’s Administration Agreement with Alger Management, are payable monthly and computed based on the average daily net assets of each Fund at the annual rate of 0.0275%.
(c) Distribution Fees:
Class A Shares: The Trust has adopted a Distribution Plan pursuant to which Class A shares of Alger Focus Equity Fund pays Fred Alger & Company, Incorporated, the Fund’s distributor (the “Distributor” or “Alger Inc.”) and an affiliate of Alger Management, a fee at the annual rate of 0.25% of the respective average daily net assets of the Class A shares of the Fund to compensate Alger Inc. for its activities and expenses incurred in distributing and/or servicing the Class A shares. The fees paid may be more or less than the expenses incurred by Alger Inc.
Class C Shares: The Trust has adopted a Distribution Plan pursuant to which Class C shares of Alger Focus Equity Fund pays Alger Inc. a fee at the annual rate of 1% of the average daily net assets of the Class C shares of the Fund to compensate Alger Inc. for its activities and expenses incurred in distributing and/or servicing the Class C shares. The fees paid may be more or less than the expenses incurred by Alger Inc.
Class R Shares: The Trust has adopted a Distribution Plan pursuant to which Class R shares of each Fund issuing such shares pays Alger Inc. a fee at the annual rate of 0.50% of the respective average daily net assets of the Class R shares of the designated Fund to compensate Alger Inc. for its activities and expenses incurred in distributing and/or servicing the Class R shares. The fees paid may be more or less than the expenses incurred by the Distributor.
(d) Sales Charges: Purchases and sales of shares of the Alger Focus Equity Fund may be subject to initial sales charges or contingent deferred sales charges. The contingent deferred sales charges are used by Alger Inc. to offset distribution expenses previously incurred. Sales charges do not represent expenses of the Trust. For the six months ended April 30, 2019, the initial sales charges and contingent deferred sales charges imposed, all of which were retained by Alger Inc., were as follows:
| | | | CONTINGENT | |
| | INITIAL SALES | | DEFERRED SALES | |
| | CHARGES | | CHARGES | |
Alger Focus Equity Fund | | $ | 807 | | $ | 2,607 | |
| | | | | | | |
(e) Brokerage Commissions: During the six months ended April 30, 2019, Alger Capital Appreciation Institutional Fund, Alger Focus Equity Fund, Alger Mid Cap Growth Institutional Fund and Alger Small Cap Growth Institutional Fund paid Alger Inc. commissions of $190,042, $57,085, $14,265 and $1,974, respectively, in connection with securities transactions.
(f) Shareholder Administrative Fees: The Trust has entered into a shareholder administrative services agreement with Alger Management to compensate Alger Management for its liaison and administrative oversight of DST Asset Manager Solutions, Inc., the transfer agent, and for other related services. The Funds compensate Alger Management at the annual rate of
68
THE ALGER INSTITUTIONAL FUNDS
NOTES TO FINANCIAL STATEMENTS (Unaudited) (Continued)
0.0165% of their respective average daily net assets for the Class A and Class C shares and 0.01% of their respective average daily net assets of the Class I, Class R, Class Y, Class Z and Class Z-2 shares for these services.
Alger Management makes payments to intermediaries that provide sub-accounting services to omnibus accounts invested in the Funds. A portion of the fees paid by Alger Management to intermediaries that provide sub-accounting services are charged back to the appropriate Fund, subject to certain limitations, as approved by the Trust’s Board of Trustees. For the six months ended April 30, 2019, Alger Management charged back to Alger Capital Appreciation Institutional Fund, Alger Focus Equity Fund, Alger Mid Cap Growth Institutional Fund, and Alger Small Cap Growth Institutional Fund, $877,376, $25,453, $30,415 and $51,896, respectively, for these services, which are included in the transfer agent fees and expenses in the accompanying Statements of Operations.
(g) Trustee Fees: Prior to January 1, 2019, each Independent Trustee receives a fee of $112,000 per annum, paid pro rata based on net assets by each fund in the Alger Fund Complex, plus travel expenses incurred for attending board meetings. The term “Alger Fund Complex” refers to the Trust, The Alger Funds, The Alger Funds II, The Alger Portfolios and Alger Global Focus Fund, each of which is a registered investment company managed by Alger Management. The Independent Trustee appointed as Chairman of the Board of Trustees receives additional compensation of $30,000 per annum paid pro rata based on net assets by each fund in the Alger Fund Complex. Additionally, each member of the Audit Committee receives a fee of $11,000 per annum, paid pro rata based on net assets by each fund in the Alger Fund Complex.
Effective January 1, 2019, each Independent Trustee receives a fee of $122,000 per annum, paid pro rata based on net assets by each fund in the Alger Fund Complex, plus travel expenses incurred for attending board meetings. The Independent Trustee appointed as Chairman of the Board of Trustees receives additional compensations of $30,000 per annum paid pro rata based on net assets by each fund in the Alger Fund Complex. Additionally, each member of the Audit Committee receives a fee of $11,000 per annum, paid pro rata based on net assets by each fund in the Alger Fund Complex.
(h) Interfund Trades: The Funds engage in purchase and sale transactions with other funds advised by Alger Management. For the six months ended April 30, 2019, these purchases and sales were as follows:
| | Purchases | | Sales | | Realized loss | |
| | | | | | | |
Alger Capital Appreciation Institutional Fund | | $ | 8,223,418 | | $ | — | | $ | — | |
| | | | | | | | | | |
(i) Interfund Loans: The Funds, along with other funds advised by Alger Management, may borrow money from and lend money to each other temporary or emergency purposes. To the extent permitted under its investment restrictions, each fund may lend uninvested cash in an amount up to %15 of its net assets to other funds. If a fund has borrowed from other funds and has aggregate borrowings from all sources that exceed 10% of the fund’s total assets, such fund will secure all of its loans from other funds. The interest rate charged on
69
THE ALGER INSTITUTIONAL FUNDS
NOTES TO FINANCIAL STATEMENTS (Unaudited) (Continued)
interfund loans is equal to the average of the overnight time deposit rate and bank loan rate available to the funds. There were no interfund loans outstanding as of April 30, 2019.
During the six months ended April 30, 2019, Alger Mid Cap Growth Institutional Fund and Alger Small Cap Growth Institutional Fund incurred interest expense of $811 and $617, respectively, in connection with interfund loans.
(j) Other Transactions With Affiliates: Certain officers of the Trust are directors or officers of Alger Management and the Distributor. At April 30, 2019, Alger Management and its affiliated entities owned the following shares:
| | SHARE CLASS | |
| | A | | C | | Y | | Z | | Z-2 | |
| | | | | | | | | | | |
Alger Capital Appreciation Institutional Fund | | — | | — | | 415 | | — | | 4,518 | |
Alger Focus Equity Fund | | 7,530 | | 7,563 | | 408 | | 38,745 | | — | |
Alger Mid Cap Growth Institutional Fund | | — | | — | | — | | — | | 4,909 | |
Alger Small Cap Growth Institutional Fund | | — | | — | | — | | — | | 7,733 | |
(k) Shareholder Servicing Fees: The Trust has entered into a shareholder servicing agreement with Alger Inc. whereby Alger Inc. provides Class I shares and Class R shares of the Trust with ongoing servicing of shareholder accounts. As compensation for such services, the Class I shares and Class R shares of each Fund pay Alger Inc. a monthly fee at an annual rate of 0.25% of the value of the average daily net assets of those classes. The fees paid may be more or less than the expenses incurred by the Distributor.
NOTE 4 — Securities Transactions:
The following summarizes the securities transactions by the Funds other than U.S. Government securities, short-term securities and purchased options for the six months ended April 30, 2019:
| | PURCHASES | | SALES | |
Alger Capital Appreciation Institutional Fund | | $ | 1,321,573,890 | | $ | 1,431,987,739 | |
Alger Focus Equity Fund | | 416,423,817 | | 292,253,857 | |
Alger Mid Cap Growth Institutional Fund | | 81,229,892 | | 86,684,824 | |
Alger Small Cap Growth Institutional Fund | | 11,829,407 | | 27,971,451 | |
| | | | | | | |
Transactions in foreign securities may involve certain considerations and risks not typically associated with those of U.S. companies because of, among other factors, the level of governmental supervision and regulation of foreign security markets, and the possibility of political or economic instability. Additional risks associated with investing in emerging markets include increased volatility, limited liquidity, and less stringent regulatory and legal systems.
NOTE 5 — Borrowing:
The Funds may borrow from the Custodian on an uncommitted basis. Each Fund pays the Custodian a market rate of interest, generally based upon the London Interbank Offered Rate. The Funds may also borrow from other funds advised by Alger Management, as
70
THE ALGER INSTITUTIONAL FUNDS
NOTES TO FINANCIAL STATEMENTS (Unaudited) (Continued)
discussed in Note 3(i). For the six months ended April 30, 2019, the Funds had the following borrowings:
| | AVERAGE DAILY | | WEIGHTED AVERAGE | |
| | BORROWING | | INTEREST RATE | |
Alger Mid Cap Growth Institutional Fund | | $ | 61,661 | | 3.18 | % |
Alger Small Cap Growth Institutional Fund | | 80,014 | | 3.84 | |
| | | | | | |
The highest amount borrowed from the Custodian and other funds during the six months ended April 30, 2019, for each Fund was as follows:
| | HIGHEST BORROWING | |
Alger Mid Cap Growth Institutional Fund | | $ | 4,183,633 | |
Alger Small Cap Growth Institutional Fund | | 2,059,906 | |
| | | | |
NOTE 6 — Share Capital:
The Trust has an unlimited number of authorized shares of beneficial interest of $.001 par value which are presently divided into four series. Each series is divided into separate classes. The transactions of shares of beneficial interest were as follows:
| | FOR THE SIX MONTHS ENDED | | FOR THE YEAR ENDED | |
| | APRIL 30, 2019 | | OCTOBER 31, 2018 | |
| | SHARES | | AMOUNT | | SHARES | | AMOUNT | |
Alger Capital Appreciation Institutional Fund | | | | | | | | | |
Class I: | | | | | | | | | |
Shares sold | | 5,231,850 | | $ | 170,182,148 | | 10,006,791 | | $ | 350,703,708 | |
Dividends reinvested | | 7,740,393 | | 224,935,972 | | 4,697,031 | | 152,798,034 | |
Shares redeemed | | (14,016,401 | ) | (443,493,518 | ) | (21,430,691 | ) | (748,353,052 | ) |
Net decrease | | (1,044,158 | ) | $ | (48,375,398 | ) | (6,726,869 | ) | $ | (244,851,310 | ) |
Class R: | | | | | | | | | |
Shares sold | | 1,116,413 | | $ | 31,748,408 | | 2,203,506 | | $ | 69,275,136 | |
Dividends reinvested | | 2,457,724 | | 62,843,991 | | 1,485,308 | | 43,341,280 | |
Shares redeemed | | (3,610,455 | ) | (103,647,268 | ) | (5,724,494 | ) | (179,622,961 | ) |
Net decrease | | (36,318 | ) | $ | (9,054,869 | ) | (2,035,680 | ) | $ | (67,006,545 | ) |
Class Y: | | | | | | | | | |
Shares sold | | 2,561,736 | | $ | 80,402,164 | | 2,298,619 | | $ | 81,779,555 | |
Dividends reinvested | | 559,332 | | 16,394,033 | | 182,194 | | 5,946,816 | |
Shares redeemed | | (881,993 | ) | (28,895,077 | ) | (555,770 | ) | (19,699,293 | ) |
Net increase | | 2,239,075 | | $ | 67,901,120 | | 1,925,043 | | $ | 68,027,078 | |
Class Z-2: | | | | | | | | | |
Shares sold | | 1,703,643 | | $ | 54,623,624 | | 4,370,312 | | $ | 155,188,302 | |
Dividends reinvested | | 1,588,574 | | 46,545,228 | | 855,586 | | 27,943,443 | |
Shares redeemed | | (2,517,820 | ) | (79,562,268 | ) | (4,697,581 | ) | (165,889,348 | ) |
Net increase | | 774,397 | | $ | 21,606,584 | | 528,317 | | $ | 17,242,397 | |
71
THE ALGER INSTITUTIONAL FUNDS
NOTES TO FINANCIAL STATEMENTS (Unaudited) (Continued)
| | FOR THE SIX MONTHS ENDED | | FOR THE YEAR ENDED | |
| | APRIL 30, 2019 | | OCTOBER 31, 2018 | |
| | SHARES | | AMOUNT | | SHARES | | AMOUNT | |
Alger Focus Equity Fund | | | | | | | | | |
Class A: | | | | | | | | | |
Shares sold | | 476,041 | | $ | 15,884,183 | | 789,769 | | $ | 27,646,665 | |
Shares converted from Class C | | 67 | | 2,294 | | 754 | | 27,548 | |
Dividends reinvested | | 56,429 | | 1,713,609 | | 28,879 | | 899,639 | |
Shares redeemed | | (494,339 | ) | (16,263,834 | ) | (282,909 | ) | (10,026,235 | ) |
Net increase | | 38,198 | | $ | 1,336,252 | | 536,493 | | $ | 18,547,617 | |
Class C: | | | | | | | | | |
Shares sold | | 253,610 | | $ | 7,783,116 | | 279,833 | | $ | 9,336,518 | |
Shares converted to Class A | | (70 | ) | (2,294 | ) | (788 | ) | (27,548 | ) |
Dividends reinvested | | 46,342 | | 1,339,278 | | 23,852 | | 717,111 | |
Shares redeemed | | (81,371 | ) | (2,565,933 | ) | (100,961 | ) | (3,310,919 | ) |
Net increase | | 218,511 | | $ | 6,554,167 | | 201,936 | | $ | 6,715,162 | |
Class I: | | | | | | | | | |
Shares sold | | 584,668 | | $ | 19,682,838 | | 566,064 | | $ | 19,821,622 | |
Dividends reinvested | | 53,123 | | 1,621,831 | | 26,742 | | 838,900 | |
Shares redeemed | | (465,033 | ) | (15,566,287 | ) | (259,288 | ) | (8,876,462 | ) |
Net increase | | 172,758 | | $ | 5,738,382 | | 333,518 | | $ | 11,784,060 | |
Class Y: | | | | | | | | | |
Shares sold | | 83,084 | | $ | 2,806,739 | | 1,588,900 | | $ | 58,532,409 | |
Dividends reinvested | | 82,863 | | 2,572,911 | | 130 | | 4,151 | |
Shares redeemed | | (48,037 | ) | (1,606,916 | ) | (59,099 | ) | (2,096,059 | ) |
Net increase | | 117,910 | | $ | 3,772,734 | | 1,529,931 | | $ | 56,440,501 | |
Class Z: | | | | | | | | | |
Shares sold | | 4,136,819 | | $ | 135,866,471 | | 3,842,417 | | $ | 139,643,911 | |
Dividends reinvested | | 309,154 | | 9,580,668 | | 78,423 | | 2,493,828 | |
Shares redeemed | | (1,102,292 | ) | (37,149,165 | ) | (854,082 | ) | (30,187,780 | ) |
Net increase | | 3,343,681 | | $ | 108,297,974 | | 3,066,758 | | $ | 111,949,959 | |
72
THE ALGER INSTITUTIONAL FUNDS
NOTES TO FINANCIAL STATEMENTS (Unaudited) (Continued)
| | FOR THE SIX MONTHS ENDED | | FOR THE YEAR ENDED | |
| | APRIL 30, 2019 | | OCTOBER 31, 2018 | |
| | SHARES | | AMOUNT | | SHARES | | AMOUNT | |
Alger Mid Cap Growth Institutional Fund | | | | | | | | | |
Class I: | | | | | | | | | |
Shares sold | | 371,840 | | $ | 10,832,661 | | 396,452 | | $ | 12,232,743 | |
Dividends reinvested | | 192,548 | | 4,898,432 | | — | | — | |
Shares redeemed | | (563,661 | ) | (16,360,739 | ) | (746,839 | ) | (23,176,767 | ) |
Net increase (decrease) | | 727 | | $ | (629,646 | ) | (350,387 | ) | $ | (10,944,024 | ) |
Class R: | | | | | | | | | |
Shares sold | | 32,006 | | $ | 821,784 | | 58,079 | | $ | 1,662,159 | |
Dividends reinvested | | 26,127 | | 603,527 | | — | | — | |
Shares redeemed | | (77,269 | ) | (2,054,289 | ) | (163,200 | ) | (4,586,117 | ) |
Net decrease | | (19,136 | ) | $ | (628,978 | ) | (105,121 | ) | $ | (2,923,958 | ) |
Class Z-2: | | | | | | | | | |
Shares sold | | 218,786 | | $ | 6,252,182 | | 301,202 | | $ | 9,269,628 | |
Dividends reinvested | | 33,064 | | 846,450 | | — | | — | |
Shares redeemed | | (133,574 | ) | (4,033,718 | ) | (235,237 | ) | (7,276,787 | ) |
Net increase | | 118,276 | | $ | 3,064,914 | | 65,965 | | $ | 1,992,841 | |
Alger Small Cap Growth Institutional Fund | | | | | | | | | |
Class I: | | | | | | | | | |
Shares sold | | 706,617 | | $ | 14,472,953 | | 1,354,745 | | $ | 30,871,230 | |
Dividends reinvested | | 862,759 | | 15,236,332 | | 172,670 | | 3,468,935 | |
Shares redeemed | | (1,124,668 | ) | (22,515,203 | ) | (2,007,574 | ) | (45,166,047 | ) |
Net increase (decrease) | | 444,708 | | $ | 7,194,082 | | (480,159 | ) | $ | (10,825,882 | ) |
Class R: | | | | | | | | | |
Shares sold | | 50,553 | | $ | 837,063 | | 101,659 | | $ | 1,928,735 | |
Dividends reinvested | | 88,237 | | 1,272,379 | | 20,472 | | 347,611 | |
Shares redeemed | | (77,879 | ) | (1,259,920 | ) | (280,406 | ) | (5,226,074 | ) |
Net increase (decrease) | | 60,911 | | $ | 849,522 | | (158,275 | ) | $ | (2,949,728 | ) |
Class Z-2: | | | | | | | | | |
Shares sold | | 267,812 | | $ | 5,358,613 | | 350,581 | | $ | 8,089,851 | |
Dividends reinvested | | 330,775 | | 5,894,407 | | 92,064 | | 1,858,797 | |
Shares redeemed | | (504,034 | ) | (10,090,552 | ) | (1,525,069 | ) | (34,275,345 | ) |
Net increase (decrease) | | 94,553 | | $ | 1,162,468 | | (1,082,424 | ) | $ | (24,326,697 | ) |
NOTE 7 — Income Tax Information:
At October 31, 2018 the Funds, for federal income tax purposes, had no capital loss carryforwards.
Under the Regulated Investment Company Modernization Act of 2010, capital losses incurred by the Funds will not be subject to expiration.
The difference between book-basis and tax-basis unrealized appreciation (depreciation) is determined annually and is attributable primarily to the tax deferral of losses on wash sales, U.S. Internal Revenue Code Section 988 currency transactions, nondeductible expenses
73
THE ALGER INSTITUTIONAL FUNDS
NOTES TO FINANCIAL STATEMENTS (Unaudited) (Continued)
on dividends sold short, the tax treatment of partnership investments, the realization of unrealized appreciation of passive foreign investment companies, and return of capital from real estate investment trust investments.
NOTE 8 — Fair Value Measurements
The following is a summary of the inputs used as of April 30, 2019 in valuing the Funds’ investments carried at fair value on a recurring basis. Based upon the nature, characteristics, and risks associated with their investments, the Funds have determined that presenting them by security type and sector is appropriate.
| | TOTAL | | LEVEL 1 | | LEVEL 2 | | LEVEL 3 | |
Alger Capital Appreciation Institutional Fund | | | | | | | | | |
COMMON STOCKS | | | | | | | | | |
Communication Services | | $ | 455,913,238 | | $ | 434,887,058 | | $ | 21,026,180 | | — | |
Consumer Discretionary | | 686,973,587 | | 686,973,587 | | — | | — | |
Energy | | 10,081,151 | | 10,081,151 | | — | | — | |
Financials | | 196,672,374 | | 196,672,374 | | — | | — | |
Health Care | | 527,635,318 | | 527,635,318 | | — | | — | |
Industrials | | 272,787,241 | | 272,787,241 | | — | | — | |
Information Technology | | 1,289,871,797 | | 1,288,497,374 | | — | | $ | 1,374,423 | |
Materials | | 106,592,410 | | 106,592,410 | | — | | — | |
TOTAL COMMON STOCKS | | $ | 3,546,527,116 | | $ | 3,524,126,513 | | $ | 21,026,180 | | $ | 1,374,423 | |
PREFERRED STOCKS | | | | | | | | | |
Health Care | | 1,037,275 | | — | | — | | 1,037,275 | |
Information Technology | | 6,335,626 | | — | | — | | 6,335,626 | |
TOTAL PREFERRED STOCKS | | $ | 7,372,901 | | — | | — | | $ | 7,372,901 | |
REAL ESTATE INVESTMENT TRUST | | | | | | | | | |
Real Estate | | 16,148,014 | | 16,148,014 | | — | | — | |
TOTAL INVESTMENTS IN SECURITIES | | $ | 3,570,048,031 | | $ | 3,540,274,527 | | $ | 21,026,180 | | $ | 8,747,324 | |
| | TOTAL | | LEVEL 1 | | LEVEL 2 | | LEVEL 3 | |
Alger Focus Equity Fund | | | | | | | | | |
COMMON STOCKS | | | | | | | | | |
Communication Services | | $ | 53,958,682 | | $ | 53,958,682 | | — | | — | |
Consumer Discretionary | | 103,169,990 | | 103,169,990 | | — | | — | |
Financials | | 33,939,561 | | 33,939,561 | | — | | — | |
Health Care | | 62,649,431 | | 62,649,431 | | — | | — | |
Industrials | | 40,940,655 | | 40,940,655 | | — | | — | |
Information Technology | | 192,441,467 | | 192,441,467 | | — | | — | |
Materials | | 14,328,059 | | 14,328,059 | | — | | — | |
TOTAL COMMON STOCKS | | $ | 501,427,845 | | $ | 501,427,845 | | — | | — | |
PREFERRED STOCKS | | | | | | | | | |
Health Care | | 154,418 | | — | | — | | $ | 154,418 | |
TOTAL INVESTMENTS IN SECURITIES | | $ | 501,582,263 | | $ | 501,427,845 | | — | | $ | 154,418 | |
74
THE ALGER INSTITUTIONAL FUNDS
NOTES TO FINANCIAL STATEMENTS (Unaudited) (Continued)
| | TOTAL | | LEVEL 1 | | LEVEL 2 | | LEVEL 3 | |
Alger Mid Cap Growth Institutional Fund | | | | | | | | | |
COMMON STOCKS | | | | | | | | | |
Communication Services | | $ | 6,820,069 | | $ | 6,820,069 | | — | | — | |
Consumer Discretionary | | 20,275,543 | | 20,275,543 | | — | | — | |
Consumer Staples | | 2,104,554 | | 2,104,554 | | — | | — | |
Energy | | 361,832 | | 361,832 | | — | | — | |
Financials | | 4,983,758 | | 4,983,758 | | — | | — | |
Health Care | | 17,515,531 | | 17,515,531 | | — | | — | |
Industrials | | 18,832,251 | | 18,832,251 | | — | | — | |
Information Technology | | 27,940,922 | | 27,869,472 | | — | | $ | 71,450 | |
Materials | | 1,398,690 | | 1,398,690 | | — | | — | |
Real Estate | | 496,837 | | 496,837 | | — | | — | |
TOTAL COMMON STOCKS | | $ | 100,729,987 | | $ | 100,658,537 | | — | | $ | 71,450 | |
MASTER LIMITED PARTNERSHIP | | | | | | | | | |
Financials | | 536,509 | | 536,509 | | — | | — | |
PREFERRED STOCKS | | | | | | | | | |
Health Care | | 404,171 | | — | | — | | 404,171 | |
Information Technology | | 291,381 | | — | | — | | 291,381 | |
TOTAL PREFERRED STOCKS | | $ | 695,552 | | — | | — | | $ | 695,552 | |
PURCHASED OPTIONS | | | | | | | | | |
Consumer Discretionary | | 50,240 | | 50,240 | | — | | — | |
REAL ESTATE INVESTMENT TRUST | | | | | | | | | |
Real Estate | | 5,320,710 | | 5,320,710 | | — | | — | |
RIGHTS | | | | | | | | | |
Health Care | | 1,201,115 | | — | | — | | 1,201,115 | |
SPECIAL PURPOSE VEHICLE | | | | | | | | | |
Financials | | — | * | — | | — | | — | * |
TOTAL INVESTMENTS IN SECURITIES | | $ | 108,534,113 | | $ | 106,565,996 | | — | | $ | 1,968,117 | |
| | TOTAL | | LEVEL 1 | | LEVEL 2 | | LEVEL 3 | |
Alger Small Cap Growth Institutional Fund | | | | | | | | | |
COMMON STOCKS | | | | | | | | | |
Communication Services | | $ | 6,839,895 | | $ | 6,839,895 | | — | | — | |
Consumer Discretionary | | 23,310,556 | | 23,310,556 | | — | | — | |
Consumer Staples | | 2,771,391 | | 2,771,391 | | — | | — | |
Energy | | 3,555,781 | | 3,555,781 | | — | | — | |
Financials | | 2,988,881 | | 2,988,881 | | — | | — | |
Health Care | | 80,293,933 | | 80,293,933 | | — | | — | |
Industrials | | 5,486,925 | | 5,486,925 | | — | | — | |
Information Technology | | 62,819,603 | | 62,819,603 | | — | | — | |
Materials | | 3,350,541 | | 3,350,541 | | — | | — | |
TOTAL COMMON STOCKS | | $ | 191,417,506 | | $ | 191,417,506 | | — | | — | |
75
THE ALGER INSTITUTIONAL FUNDS
NOTES TO FINANCIAL STATEMENTS (Unaudited) (Continued)
| | TOTAL | | LEVEL 1 | | LEVEL 2 | | LEVEL 3 | |
Alger Small Cap Growth Institutional Fund | | | | | | | | | |
PREFERRED STOCKS | | | | | | | | | |
Health Care | | $ | 650,960 | | — | | — | | $ | 650,960 | |
RIGHTS | | | | | | | | | |
Health Care | | 1,501,108 | | — | | — | | 1,501,108 | |
SPECIAL PURPOSE VEHICLE | | | | | | | | | |
Financials | | — | * | — | | — | | — | * |
TOTAL INVESTMENTS IN SECURITIES | | $ | 193,569,574 | | $ | 191,417,506 | | — | | $ | 2,152,068 | |
| | | | | | | | | | | | |
*Alger Small Cap Growth Institutional Fund’s holdings of JS Kred SPV I, LLC shares are classified as a Level 3 investment and fair valued at zero as of April 30, 2019.
| | FAIR VALUE MEASUREMENTS USING SIGNIFICANT UNOBSERVABLE INPUTS (LEVEL 3) | |
| | Common Stocks | |
Alger Capital Appreciation Institutional Fund | | | |
Opening balance at November 1, 2018 | | $ | 1,374,423 | |
Transfers into Level 3 | | — | |
Transfers out of Level 3 | | — | |
Total gains or losses | | | |
Included in net realized gain (loss) on investments | | — | |
Included in net change in unrealized appreciation (depreciation) on investments | | — | |
Purchases and sales | | | |
Purchases | | — | |
Sales | | — | |
Closing balance at April 30, 2019 | | 1,374,423 | |
Net change in unrealized appreciation (depreciation) attributable to investments still held at April 30, 2019 | | $ | — | |
| | Preferred Stocks | |
Alger Capital Appreciation Institutional Fund | | | |
Opening balance at November 1, 2018 | | $ | 7,554,899 | |
Transfers into Level 3 | | — | |
Transfers out of Level 3 | | — | |
Total gains or losses | | | |
Included in net realized gain (loss) on investments | | — | |
Included in net change in unrealized appreciation (depreciation) on investments | | (181,998 | ) |
Purchases and sales | | | |
Purchases | | — | |
Sales | | — | |
Closing balance at April 30, 2019 | | 7,372,901 | |
Net change in unrealized appreciation (depreciation) attributable to investments still held at April 30, 2019 | | $ | (181,998 | ) |
76
THE ALGER INSTITUTIONAL FUNDS
NOTES TO FINANCIAL STATEMENTS (Unaudited) (Continued)
| | FAIR VALUE MEASUREMENTS USING SIGNIFICANT UNOBSERVABLE INPUTS (LEVEL 3) | |
Alger Focus Equity Fund | | Preferred Stocks | |
Opening balance at November 1, 2018 | | $ | 241,230 | |
Transfers into Level 3 | | — | |
Transfers out of Level 3 | | — | |
Total gains or losses | | | |
Included in net realized gain (loss) on investments | | — | |
Included in net change in unrealized appreciation (depreciation) on investments | | (86,812 | ) |
Purchases and sales | | | |
Purchases | | — | |
Sales | | — | |
Closing balance at April 30, 2019 | | 154,418 | |
Net change in unrealized appreciation (depreciation) attributable to investments still held at April 30, 2019 | | $ | (86,812 | ) |
| | FAIR VALUE MEASUREMENTS USING SIGNIFICANT UNOBSERVABLE INPUTS (LEVEL 3) | |
Alger Mid Cap Growth Institutional Fund | | Common Stocks | |
Opening balance at November 1, 2018 | | $ | 71,450 | |
Transfers into Level 3 | | — | |
Transfers out of Level 3 | | — | |
Total gains or losses | | | |
Included in net realized gain (loss) on investments | | — | |
Included in net change in unrealized appreciation (depreciation) on investments | | — | |
Purchases and sales | | | |
Purchases | | — | |
Sales | | — | |
Closing balance at April 30, 2019 | | 71,450 | |
Net change in unrealized appreciation (depreciation) attributable to investments still held at April 30, 2019 | | $ | — | |
77
THE ALGER INSTITUTIONAL FUNDS
NOTES TO FINANCIAL STATEMENTS (Unaudited) (Continued)
| | FAIR VALUE MEASUREMENTS USING SIGNIFICANT UNOBSERVABLE INPUTS (LEVEL 3) | |
Alger Mid Cap Growth Institutional Fund | | Preferred Stocks | |
Opening balance at November 1, 2018 | | $ | 895,510 | |
Transfers into Level 3 | | — | |
Transfers out of Level 3 | | — | |
Total gains or losses | | | |
Included in net realized gain (loss) on investments | | — | |
Included in net change in unrealized appreciation (depreciation) on investments | | (199,958 | ) |
Purchases and sales | | | |
Purchases | | — | |
Sales | | — | |
Closing balance at April 30, 2019 | | 695,552 | |
Net change in unrealized appreciation (depreciation) attributable to investments still held at April 30, 2019 | | $ | (199,958 | ) |
Alger Mid Cap Growth Institutional Fund | | Rights | |
Opening balance at November 1, 2018 | | $ | 1,190,838 | |
Transfers into Level 3 | | — | |
Transfers out of Level 3 | | — | |
Total gains or losses | | | |
Included in net realized gain (loss) on investments | | — | |
Included in net change in unrealized appreciation (depreciation) on investments | | 10,277 | |
Purchases and sales | | | |
Purchases | | — | |
Sales | | — | |
Closing balance at April 30, 2019 | | 1,201,115 | |
Net change in unrealized appreciation (depreciation) attributable to investments still held at April 30, 2019 | | $ | 10,277 | |
| | Special Purpose | |
Alger Mid Cap Growth Institutional Fund | | Vehicle | |
Opening balance at November 1, 2018 | | $ | 0 | * |
Transfers into Level 3 | | — | |
Transfers out of Level 3 | | — | |
Total gains or losses | | | |
Included in net realized gain (loss) on investments | | — | |
Included in net change in unrealized appreciation (depreciation) on investments | | — | |
Purchases and sales | | | |
Purchases | | — | |
Sales | | — | |
Closing balance at April 30, 2019 | | 0 | * |
Net change in unrealized appreciation (depreciation) attributable to investments still held at April 30, 2019 | | $ | — | |
78
THE ALGER INSTITUTIONAL FUNDS
NOTES TO FINANCIAL STATEMENTS (Unaudited) (Continued)
| | FAIR VALUE MEASUREMENTS USING SIGNIFICANT UNOBSERVABLE INPUTS (LEVEL 3) | |
Alger Small Cap Growth Institutional Fund | | Preferred Stocks | |
Opening balance at November 1, 2018 | | $ | 868,765 | |
Transfers into Level 3 | | — | |
Transfers out of Level 3 | | — | |
Total gains or losses | | | |
Included in net realized gain (loss) on investments | | — | |
Included in net change in unrealized appreciation (depreciation) on investments | | (217,805 | ) |
Purchases and sales | | | |
Purchases | | — | |
Sales | | — | |
Closing balance at April 30, 2019 | | 650,960 | |
Net change in unrealized appreciation (depreciation) attributable to investments still held at April 30, 2019 | | $ | (217,805 | ) |
Alger Small Cap Growth Institutional Fund | | Rights | |
Opening balance at November 1, 2018 | | $ | 1,488,264 | |
Transfers into Level 3 | | — | |
Transfers out of Level 3 | | — | |
Total gains or losses | | | |
Included in net realized gain (loss) on investments | | — | |
Included in net change in unrealized appreciation (depreciation) on investments | | 12,844 | |
Purchases and sales | | | |
Purchases | | — | |
Sales | | — | |
Closing balance at April 30, 2019 | | 1,501,108 | |
Net change in unrealized appreciation (depreciation) attributable to investments still held at April 30, 2019 | | $ | 12,844 | |
| | Special Purpose | |
Alger Small Cap Growth Institutional Fund | | Vehicle | |
Opening balance at November 1, 2018 | | $ | 0 | * |
Transfers into Level 3 | | — | |
Transfers out of Level 3 | | — | |
Total gains or losses | | | |
Included in net realized gain (loss) on investments | | — | |
Included in net change in unrealized appreciation (depreciation) on investments | | — | |
Purchases and sales | | | |
Purchases | | — | |
Sales | | — | |
Closing balance at April 30, 2019 | | 0 | * |
Net change in unrealized appreciation (depreciation) attributable to investments still held at April 30, 2019 | | $ | — | |
* Includes securities that are fair valued at zero.
79
THE ALGER INSTITUTIONAL FUNDS
NOTES TO FINANCIAL STATEMENTS (Unaudited) (Continued)
The following table provides quantitative information about our Level 3 fair value measurements of our investments as of April 30, 2019. In addition to the techniques and inputs noted in the table below, according to our valuation policy we may also use other valuation techniques and methodologies when determining our fair value measurements. The table below is not intended to be all-inclusive, but rather provides information on the Level 3 inputs as they relate to our fair value measurements.
| | Fair Value April 30, 2019 | | Valuation Methodology | | Unobservable Input | | Input/Range | | Weighted Average Inputs | |
Alger Capital Appreciation Institutional Fund | | | | | | | | | | | |
Common Stocks | | $ | 1,374,423 | | Market Approach | | Market Quotation | | N/A* | | N/A | |
Preferred Stocks | | 7,372,901 | | Market Approach | | Time to Exit | | 2.5 years | | N/A | |
| | | | | | Volatility | | 70.50% | | N/A | |
| | | | | | Market Quotation | | N/A* | | N/A | |
| | | | | | | | | | | |
Alger Focus Equity Fund | | | | | | | | | | | |
Preferred Stocks | | $ | 154,418 | | Income Approach | | Discount Rate | | 48.00%-53.00% | | N/A | |
| | | | | | | | | | | |
Alger Mid Cap Growth Institutional Fund | | | | | | | | | | | |
Common Stocks | | $ | 71,450 | | Market Approach | | Market Quotation | | N/A* | | N/A | |
Preferred Stocks | | 333,678 | | Income Approach | | Discount Rate | | 48.00%-53.00% | | N/A | |
Preferred Stocks | | 361,874 | | Market Approach | | Time to Exit | | 2.5 years | | N/A | |
| | | | | | Volatility | | 70.50% | | N/A | |
| | | | | | Market Quotation | | N/A* | | N/A | |
Rights | | 1,201,115 | | Income Approach | | Discount Rate | | 7.77%-8.05% | | N/A | |
| | | | | | | | | | | |
Special Purpose Vehicle | | 0 | | Market Approach | | Revenue Multiple | | 4.55x-5.05x | | N/A | |
| | | | | | | | | | | |
Alger Small Cap Growth Institutional Fund | | | | | | | | | | | |
Preferred Stocks | | $ | 267,859 | | Income Approach | | Discount Rate | | 48.00%-53.00% | | N/A | |
| | | | | | | | | | | |
Preferred Stocks | | 383,101 | | Market Approach | | Time to Exit | | 2.5 years | | N/A | |
| | | | | | Volatility | | 70.50% | | N/A | |
Rights | | 1,501,108 | | Income Approach | | Discount Rate | | 7.77%-8.05% | | N/A | |
| | | | | | | | | | | |
Special Purpose Vehicle | | 0 | | Market Approach | | Revenue Multiple | | 4.55x-5.05x | | N/A | |
* The Fund utilized a market approach to fair value this security. The significant unobservable input used in the valuation model was a private sale available to the Fund at April 30, 2019.
80
THE ALGER INSTITUTIONAL FUNDS
NOTES TO FINANCIAL STATEMENTS (Unaudited) (Continued)
The significant unobservable inputs used in the fair value measurement of the Fund’s securities are revenue and EBITDA multiples, discount rates, and the probabilities of success of certain outcomes. Significant increases and decreases in these inputs in isolation and interrelationships between those inputs could result in significantly higher or lower fair value measurements than those noted in the table above.
As of April 30, 2019, there were no transfers of securities between Level 1 and Level 2.
Certain of the Funds’ assets and liabilities are held at carrying amount or face value, which approximates fair value for financial statement purposes. As of April 30, 2019, such assets were categorized within the disclosure hierarchy as follows:
| | TOTAL | | LEVEL 1 | | LEVEL 2 | | LEVEL 3 | |
Cash and Cash Equivalents: | | | | | | | | | |
Alger Capital Appreciation Institutional Fund | | $ | 20,699,713 | | — | | $ | 20,699,713 | | — | |
Alger Focus Equity Fund | | 1,108,648 | | — | | 1,108,648 | | — | |
Alger Mid Cap Growth Institutional Fund | | 868,177 | | — | | 868,177 | | — | |
Alger Small Cap Growth Institutional Fund | | 3,389,990 | | — | | 3,389,990 | | — | |
| | | | | | | | | | | |
NOTE 9 — Derivatives:
Financial Accounting Standards Board Accounting Standards Codification 815 — Derivatives and Hedging (“ASC 815”) requires qualitative disclosures about objectives and strategies for using derivatives, quantitative disclosures about fair value amounts of and gains and losses on derivative instruments, and disclosures about credit-risk-related contingent features in derivative agreements.
Options— The Funds seek to capture the majority of the returns associated with equity market investments. To meet this investment goal, the Funds invest in a broadly diversified portfolio of common stocks, while also buying and selling call and put options on equities and equity indexes. The Funds purchase call options to increase their exposure to the stock market and also provide diversification of risk. The Funds purchase put options in order to protect from significant market declines that may occur over a short period of time. The Funds will write covered call and cash secured put options to generate cash flows while reducing the volatility of the Funds’ portfolios. The cash flows may be an important source of the Funds’ returns, although written call options may reduce the Funds’ ability to profit from increases in the value of the underlying security or equity portfolio. The value of a call option generally increases as the price of the underlying stock increases and decreases as the stock decreases in price. Conversely, the value of a put option generally increases as the price of the underlying stock decreases and decreases as the stock increases in price. The combination of the diversified stock portfolio and the purchase and sale of options is intended to provide the Funds with the majority of the returns associated with equity market investments but with reduced volatility and returns that are augmented with the cash flows from the sale of options. During the six months ended April 30, 2019, options were used in accordance with these objectives.
81
THE ALGER INSTITUTIONAL FUNDS
NOTES TO FINANCIAL STATEMENTS (Unaudited) (Continued)
The Funds’ option contracts were not subject to any rights of offset with any counterparty. All of the Funds’ options were exchange traded which utilize a clearing house that acts as an intermediary between buyer and seller, receiving initial and maintenance margin from both, and guaranteeing performance of the option contract. The purchased options included on the Statements of Assets and Liabilities are exchange traded and not subject to offsetting.
Alger Mid Cap Growth Institutional Fund
| | ASSET DERIVATIVES 2019 | | LIABILITY DERIVATIVES 2019 | |
Derivatives not accounted | | Balance Sheet | | | | Balance Sheet | | | |
for as hedging instruments | | Location | | Fair Value | | Location | | Fair Value | |
Purchased Put Options | | Investments in unaffiliated securities, at value | | $ | 50,240 | | — | | $ | — | |
Total | | | | $ | 50,240 | | | | $ | — | |
For the six months ended April 30, 2019, Alger Mid Cap Growth Institutional Fund had option purchases of $86,766. The average volume of contracts for purchased options for the six months ended April 30, 2019, is $50,240 market value. The effect of derivative instruments on the accompanying Statement of Operations for the six months ended April 30, 2019, is as follows:
NET CHANGE IN UNREALIZED DEPRECIATION ON OPTIONS
Alger Mid Cap Growth Institutional Fund
Derivatives not accounted for as hedging instruments | | Options | |
Purchased Options | | $ | (36,526 | ) |
Total | | $ | (36,526 | ) |
NOTE 10 — Principal Risks:
Alger Capital Appreciation Institutional Fund — Investing in the stock market involves risks, and may not be suitable for all investors. Growth stocks tend to be more volatile than other stocks as their prices tend to be higher in relation to their companies’ earnings and may be more sensitive to market, political, and economic developments. A significant portion of assets may be invested in technology and healthcare companies, which may be significantly affected by competition, innovation, regulation, and product obsolescence, and may be more volatile than the securities of other companies.
Alger Focus Equity Fund — Investing in the stock market involves certain risks, and may not be suitable for all investors. Growth stocks tend to be more volatile than other stocks as their prices tend to be higher in relation to their companies’ earnings and may be more sensitive to market, political, and economic developments. A significant portion of assets may be invested in technology companies, which may be significantly affected by competition, innovation, regulation, and product obsolescence, and may be more volatile than the securities of other companies. Assets may be focused in a small number of holdings, making them susceptible to risks associated with a single economic, political or regulatory event than a more diversified portfolio. Active trading may increase transaction costs, brokerage commissions, and taxes, which can lower the return on investment.
82
THE ALGER INSTITUTIONAL FUNDS
NOTES TO FINANCIAL STATEMENTS (Unaudited) (Continued)
Alger Mid Cap Growth Institutional Fund — Investing in the stock market involves certain risks, and may not be suitable for all investors. Growth stocks tend to be more volatile than other stocks as their prices tend to be higher in relation to their companies’ earnings and may be more sensitive to market, political, and economic developments. A significant portion of assets may be invested in technology and healthcare companies, which may be significantly affected by competition, innovation, regulation, and product obsolescence, and may be more volatile than the securities of other companies. Investing in companies of medium capitalizations involves the risk that such issuers may have limited product lines or financial resources, lack management depth, or have limited liquidity.
Alger Small Cap Growth Institutional Fund — Investing in the stock market involves certain risks, and may not be suitable for all investors. Growth stocks tend to be more volatile than other stocks as their prices tend to be higher in relation to their companies’ earnings and may be more sensitive to market, political, and economic developments. A significant portion of assets may be invested in technology companies, which may be significantly affected by competition, innovation, regulation, and product obsolescence, and may be more volatile than the securities of other companies. Investing in companies of small capitalizations involves the risk that such issuers may have limited product lines or financial resources, lack management depth, or have limited liquidity.
NOTE 11 — Affiliated Securities:
The issuers of the securities listed below are deemed to be affiliates of the Funds because the Funds or their affiliates owned 5% or more of the issuer’s voting securities during all or part of the six months ended April 30, 2019. Purchase and sale transactions, interest income and dividend income earned during the period were as follows:
Security | | Shares/ Par at October 31, 2018 | | Purchases/ Conversion | | Sales/ Conversion | | Shares/ Par at April 30, 2019 | | Dividend/ Interest Income | | Realized Gain (Loss) | | Net Increase (Decrease) in Unrealized App(Dep) | | Value at April 30, 2019 | |
Alger Focus Equity Fund | | | | | | | | | | | | | | | | | |
Preferred Stocks | | | | | | | | | | | | | | | | | |
Prosetta Biosciences, Inc., Series D | | 76,825 | | — | | — | | 76,825 | | — | | — | | $ | (86,812 | ) | $ | 154,418 | |
Total | | | | | | | | | | — | | — | | $ | (86,812 | ) | $ | 154,418 | |
Security | | Shares/ Par at October 31, 2018 | | Purchases/ Conversion | | Sales/ Conversion | | Shares/ Par at April 30, 2019 | | Dividend/ Interest Income | | Realized Gain (Loss) | | Net Increase (Decrease) in Unrealized App(Dep) | | Value at April 30, 2019 | |
Alger Mid Cap Growth Institutional Fund | | | | | | | | | | | | | | | | | |
Preferred Stocks | | | | | | | | | | | | | | | | | |
Prosetta Biosciences, Inc., Series D | | 166,009 | | — | | — | | 166,009 | | — | | — | | $ | (187,590 | ) | $ | 333,678 | |
Total | | | | | | | | | | — | | — | | $ | (187,590 | ) | $ | 333,678 | |
83
THE ALGER INSTITUTIONAL FUNDS
NOTES TO FINANCIAL STATEMENTS (Unaudited) (Continued)
Security | | Shares/ Par at October 31, 2018 | | Purchases/ Conversion | | Sales/ Conversion | | Shares/ Par at April 30, 2019 | | Dividend/ Interest Income | | Realized Gain (Loss) | | Net Increase (Decrease) in Unrealized App(Dep) | | Value at April 30, 2019 | |
Alger Small Cap Growth Institutional Fund | | | | | | | | | | | | | | | | | |
Preferred Stocks | | | | | | | | | | | | | | | | | |
Prosetta Biosciences, Inc., Series D | | 133,263 | | — | | — | | 133,263 | | — | | — | | $ | (150,587 | ) | $ | 267,859 | |
Total | | | | | | | | | | — | | — | | $ | (150,587 | ) | $ | 267,859 | |
NOTE 12 — Subsequent Events:
Management of each Fund has evaluated events that have occurred subsequent to April 30, 2019, through the issuance date of the Financial Statements. No such events have been identified which require recognition and/or disclosure other than the Funds entering into a new transfer agency agreement with UMB Fund Services, Inc. effective October 5, 2019.
84
THE ALGER INSTITUTIONAL FUNDS
ADDITIONAL INFORMATION (Unaudited)
Shareholder Expense Example
As a shareholder of the Fund, you incur two types of costs: transaction costs, if applicable, including sales charges (loads) and redemption fees; and ongoing costs, including management fees, distribution (12b-1) fees, if applicable, and other fund expenses. This example is intended to help you understand your ongoing costs (in dollars) of investing in the Fund and to compare these costs with the ongoing costs of investing in other mutual funds.
The example below is based on an investment of $1,000 invested at the beginning of the six-month period starting November 1, 2018 and ending April 30, 2019.
Actual Expenses
The first line for each class of shares in the table below provides information about actual account values and actual expenses. You may use the information in this line, together with the amount you invested, to estimate the expenses that you would have paid over the period. Simply divide your account value by $1,000 (for example, an $8,600 account value divided by $1,000 = 8.6), then multiply the result by the number in the first line under the heading entitled “Expenses Paid During the Six Months Ended April 30, 2019” to estimate the expenses you paid on your account during this period.
Hypothetical Example for Comparison Purposes
The second line for each class of shares in the table below provides information about hypothetical account values and hypothetical expenses based on the Fund’s actual expense ratios for each class of shares and an assumed rate of return of 5% per year before expenses, which is not the Fund’s actual return. The hypothetical account values and expenses may not be used to estimate the actual ending account balance or expenses you paid for the period. You may use this information to compare the ongoing costs of investing in the Fund and other funds. To do so, compare this 5% hypothetical example with the 5% hypothetical examples that appear in the shareholder reports of other funds.
Please note that the expenses shown in the table are meant to highlight your ongoing costs only and do not reflect any transaction costs, such as sales charges (loads) and redemption fees. Therefore, the second line under each class of shares in the table is useful in comparing ongoing costs only, and will not help you determine the relative total costs of owning different funds. In addition, if these transactional costs were included, your costs would have been higher.
85
THE ALGER INSTITUTIONAL FUNDS
ADDITIONAL INFORMATION (Unaudited) (Continued)
| | | | Beginning Account Value November 1, 2018 | | Ending Account Value April 30, 2019 | | Expenses Paid During the Six Months Ended April 30, 2019(a) | | Annualized Expense Ratio For the Six Months Ended April 30, 2019(b) | |
Alger Capital Appreciation Institutional Fund | | | | | | | |
Class I | | Actual | | $ | 1,000.00 | | $ | 1,129.90 | | $ | 6.18 | | 1.17 | % |
| | Hypothetical(c) | | 1,000.00 | | 1,018.99 | | 5.86 | | 1.17 | |
Class R | | Actual | | 1,000.00 | | 1,127.70 | | 8.44 | | 1.60 | |
| | Hypothetical(c) | | 1,000.00 | | 1,016.86 | | 8.00 | | 1.60 | |
Class Y | | Actual | | 1,000.00 | | 1,132.30 | | 3.97 | | 0.75 | |
| | Hypothetical(c) | | 1,000.00 | | 1,021.08 | | 3.76 | | 0.75 | |
Class Z-2 | | Actual | | 1,000.00 | | 1,131.70 | | 4.44 | | 0.84 | |
| | Hypothetical(c) | | 1,000.00 | | 1,020.63 | | 4.21 | | 0.84 | |
| | | | | | | | | | | |
Alger Focus Equity Fund | | | | | | | |
Class A | | Actual | | $ | 1,000.00 | | $ | 1,073.70 | | $ | 5.30 | | 1.03 | % |
| | Hypothetical(c) | | 1,000.00 | | 1,019.69 | | 5.16 | | 1.03 | |
Class C | | Actual | | 1,000.00 | | 1,119.30 | | 9.20 | | 1.75 | |
| | Hypothetical(c) | | 1,000.00 | | 1,016.12 | | 8.75 | | 1.75 | |
Class I | | Actual | | 1,000.00 | | 1,133.50 | | 5.03 | | 0.95 | |
| | Hypothetical(c) | | 1,000.00 | | 1,020.08 | | 4.76 | | 0.95 | |
Class Y | | Actual | | 1,000.00 | | 1,135.40 | | 3.44 | | 0.65 | |
| | Hypothetical(c) | | 1,000.00 | | 1,021.57 | | 3.26 | | 0.65 | |
Class Z | | Actual | | 1,000.00 | | 1,135.00 | | 3.55 | | 0.67 | |
| | Hypothetical(c) | | 1,000.00 | | 1,021.47 | | 3.36 | | 0.67 | |
| | | | | | | | | | | |
Alger Mid Cap Growth Institutional Fund | | | | | | | |
Class I | | Actual | | $ | 1,000.00 | | $ | 1,112.90 | | $ | 7.18 | | 1.37 | % |
| | Hypothetical(c) | | 1,000.00 | | 1,018.00 | | 6.85 | | 1.37 | |
Class R | | Actual | | 1,000.00 | | 1,110.60 | | 9.58 | | 1.83 | |
| | Hypothetical(c) | | 1,000.00 | | 1,015.72 | | 9.15 | | 1.83 | |
Class Z-2 | | Actual | | 1,000.00 | | 1,114.70 | | 5.51 | | 1.05 | |
| | Hypothetical(c) | | 1,000.00 | | 1,019.59 | | 5.26 | | 1.05 | |
| | | | | | | | | | | |
Alger Small Cap Growth Institutional Fund | | | | | | | |
Class I | | Actual | | $ | 1,000.00 | | $ | 1,117.40 | | $ | 7.19 | | 1.37 | % |
| | Hypothetical(c) | | 1,000.00 | | 1,018.00 | | 6.85 | | 1.37 | |
Class R | | Actual | | 1,000.00 | | 1,114.30 | | 9.44 | | 1.80 | |
| | Hypothetical(c) | | 1,000.00 | | 1,015.87 | | 9.00 | | 1.80 | |
Class Z-2 | | Actual | | 1,000.00 | | 1,119.40 | | 5.20 | | 0.99 | |
| | Hypothetical(c) | | 1,000.00 | | 1,019.89 | | 4.96 | | 0.99 | |
(a) Expenses are equal to the annualized expense ratio of the respective share class, multiplied by the average account value over the period, multiplied by 181/365 (to reflect the one-half year period).
(b) Annualized.
(c) 5% annual return before expenses.
86
THE ALGER INSTITUTIONAL FUNDS
ADDITIONAL INFORMATION (Unaudited) (Continued)
Privacy Policy
U.S. Consumer Privacy Notice | Rev. 12/20/16 |
FACTS | | WHAT DOES ALGER DO WITH YOUR PERSONAL INFORMATION? |
Why? | | Financial companies choose how they share your personal information. Federal law gives consumers the right to limit some but not all sharing. Federal law also requires us to tell you how we collect, share, and protect your personal information. Please read this notice carefully to understand what we do. |
What? | | The types of personal information we collect and share depend on the product or service you have with us. This information can include: · Social Security number and · Account balances and · Transaction history and · Purchase history and · Assets When you are no longer our customer, we continue to share your information as described in this notice. |
How? | | All financial companies need to share personal information to run their everyday business. In the section below, we list the reasons financial companies can share personal information; the reasons Alger chooses to share; and whether you can limit this sharing. |
Reasons we can share your personal information | | Does Alger share? | | Can you limit this sharing? |
For our everyday business purposes — such as to process your transactions, maintain your account(s), respond to court orders and legal investigations, or report to credit bureaus | | Yes | | No |
For our marketing purposes — to offer our products and services to you | | Yes | | No |
For joint marketing with other financial companies | | No | | We don’t share |
For our affiliates’ everyday business purposes — information about your transactions and experiences | | Yes | | No |
For our affiliates’ everyday business purposes — information about your creditworthiness | | No | | We don’t share |
For nonaffiliates to market to you | | No | | We don’t share |
Questions? Call 1-800-342-2186 | | | | |
87
THE ALGER INSTITUTIONAL FUNDS
ADDITIONAL INFORMATION (Unaudited) (Continued)
Who we are | | |
| | |
Who is providing this notice? | | · Alger includes Fred Alger Management, Inc. and Fred Alger & Company, Incorporated as well as the following funds: The Alger Funds, The Alger Funds II, The Alger Institutional Funds, The Alger Portfolios, and Alger Global Focus Fund. |
| | |
What we do | | |
| | |
How does Alger protect my personal information? | | To protect your personal information from unauthorized access and use, we use security measures that comply with federal law. These measures include computer safeguards and secured files and buildings. |
| | |
How does Alger collect my personal information? | | We collect your personal information, for example, when you: · Open an account or · Make deposits or withdrawals from your account or · Give us your contact information or · Provide account information or · Pay us by check. |
| | |
Why can’t I limit all sharing? | | Federal law gives you the right to limit some but not all sharing related to: · sharing for affiliates’ everyday business purposes — information about your credit worthiness · affiliates from using your information to market to you · sharing for nonaffiliates to market to you State laws and individual companies may give you additional rights to limit sharing. |
| | |
Definitions | | |
| | |
Affiliates | | Companies related by common ownership or control. They can be financial and nonfinancial companies. · Our affiliates include Fred Alger Management, Inc., Weatherbie Capital, LLC and Fred Alger & Company, Incorporated as well as the following funds: The Alger Funds, The Alger Funds II, The Alger Institutional Funds, The Alger Portfolios, and Alger Global Focus Fund. |
| | |
Nonaffiliates | | Companies not related by common ownership or control. They can be financial and nonfinancial companies. |
| | |
Joint marketing | | A formal agreement between nonaffiliated financial companies that together market financial products or services to you. |
88
THE ALGER INSTITUTIONAL FUNDS
ADDITIONAL INFORMATION (Unaudited) (Continued)
Proxy Voting Policies
A description of the policies and procedures the Trust uses to determine how to vote proxies relating to portfolio securities and information regarding how the Fund voted proxies relating to portfolio securities during the most recent 12-month period ended June 30 are available, without charge, by calling (800) 992-3863 or online on the Funds’ website at www.alger.com or on the SEC’s website at www.sec.gov.
Fund Holdings
The Board of Trustees has adopted policies and procedures relating to disclosure of the Funds’ portfolio securities. These policies and procedures recognize that there may be legitimate business reasons for holdings to be disclosed and seek to balance those interests to protect the proprietary nature of the trading strategies and implementation thereof by the Funds.
Generally, the policies prohibit the release of information concerning portfolio holdings which have not previously been made public to individual investors, institutional investors, intermediaries that distribute the Funds’ shares and other parties which are not employed by the Investment Manager or its affiliates except when the legitimate business purposes for selective disclosure and other conditions (designed to protect the Funds) are acceptable.
The Funds make their complete schedules of portfolio holdings available semi-annually in shareholder reports filed on Form N-CSR and after the first and third fiscal quarters as an exhibit to their reports on Form N-PORT. Previously, the Funds made their complete schedules of portfolio holdings available after the first and third fiscal quarters in regulatory filings on Form N-Q. The Funds’ Forms N-CSR, N-PORT and N-Q are available online on the SEC’s website at www.sec.gov.
In addition, the Funds make publicly available their respective month-end top 10 holdings with a 10 day lag and their month-end full portfolios with a 60 day lag on their website www. alger.com and through other marketing communications (including printed advertising/ sales literature and/or shareholder telephone customer service centers). No compensation or other consideration is received for the non-public disclosure of portfolio holdings information.
In accordance with the foregoing, the Funds provide portfolio holdings information to service providers who provide necessary or beneficial services when such service providers need access to this information in the performance of their services and are subject to duties of confidentiality (1) imposed by law, including a duty not to trade on non-public information, and/or (2) pursuant to an agreement that confidential information is not to be disclosed or used (including trading on such information) other than as required by law. From time to time, the Funds will communicate with these service providers to confirm that they understand the Funds’ policies and procedures regarding such disclosure. This agreement must be approved by the Funds’ Chief Compliance Officer, President, Secretary or Assistant Secretary.
89
THE ALGER INSTITUTIONAL FUNDS
ADDITIONAL INFORMATION (Unaudited) (Continued)
The Board of Trustees periodically reviews a report disclosing the third parties to whom each Fund’s holdings information has been disclosed and the purpose for such disclosure, and it considers whether or not the release of information to such third parties is in the best interest of the Fund and its shareholders.
In addition to material the Funds routinely provide to shareholders, the Investment Manager may make additional statistical information available regarding the Funds. Such information may include, but not be limited to, characteristics of a Fund versus an index (such as P/E ratio, alpha, beta, capture ratio, maximum drawdown, standard deviation, EPS forecasts, Sharpe ratio, information ratio, R-squared and market cap analysis), security specific impact on overall portfolio performance, month-end top ten contributors to and detractors from performance, portfolio turnover, and other similar information. Shareholders should visit www.alger.com or may also contact the Funds at (800) 992-3863 to obtain such information.
90
THE ALGER INSTITUTIONAL FUNDS
360 Park Avenue South
New York, NY 10010
(800) 992-3863
www.alger.com
Investment Manager
Fred Alger Management, Inc.
360 Park Avenue South
New York, NY 10010
Distributor
Fred Alger & Company, Incorporated
360 Park Avenue South
New York, NY 10010
Transfer Agent and Dividend Disbursing Agent
DST Asset Manager Solutions, Inc.
Attn: Alger Funds
430 W 7th Street
STE 219432
Kansas City, MO 64105-1407
Custodian
Brown Brothers Harriman & Company
50 Post Office Square
Boston, MA 02110
Independent Registered Public Accounting Firm
Deloitte & Touche LLP
30 Rockefeller Plaza
New York, NY 10112
This report is submitted for the general information of the shareholders of The Alger Institutional Funds. It is not authorized for distribution to prospective investors unless accompanied by an effective Prospectus for the Trust, which contains information concerning the Trust’s investment policies, fees and expenses as well as other pertinent information.
91
(This page has been intentionally left blank.)
(This page has been intentionally left blank.)
![](https://capedge.com/proxy/N-CSRS/0001104659-19-038912/g72444bm09i001.jpg)
ITEM 2. CODE OF ETHICS.
Not applicable.
ITEM 3. AUDIT COMMITTEE FINANCIAL EXPERT.
Not applicable.
ITEM 4. PRINCIPAL ACCOUNTANT FEES AND SERVICES.
Not applicable.
ITEM 5. AUDIT COMMITTEE OF LISTED REGISTRANTS.
Not applicable.
ITEM 6. INVESTMENTS.
Not applicable.
ITEM 7. DISCLOSURE OF PROXY VOTING POLICIES AND PROCEDURES FOR CLOSED-END MANAGEMENT INVESTMENT COMPANIES.
Not applicable.
ITEM 8. PORTFOLIO MANAGERS OF CLOSED-END MANAGEMENT INVESTMENT COMPANIES.
Not applicable.
ITEM 9. PURCHASES OF EQUITY SECURITIES BY CLOSED-END MANAGEMENT INVESTMENT COMPANY AND AFFILIATED PURCHASERS.
Not applicable.
ITEM 10. SUBMISSION OF MATTERS TO A VOTE OF SECURITY HOLDERS.
Not applicable.
ITEM 11. CONTROLS AND PROCEDURES.
(a) The Registrant’s principal executive officer and principal financial officer have concluded that the Registrant’s disclosure controls and procedures (as defined in Rule 30a-3(c) under the Investment Company Act of 1940, as amended) are effective based on their evaluation of the disclosure controls and procedures as of a date within 90 days of the filing date of this document.
(b) No changes in the Registrant’s internal control over financial reporting occurred during the Registrant’s second fiscal quarter of the period covered by this report that materially affected, or are reasonably likely to materially affect, the Registrant’s internal control over financial reporting.
ITEM 12. Disclosure of Securities Lending Activities for Closed-End Management Investment Companies.
Not applicable.
ITEM 13. EXHIBITS.
(a) (1) Not applicable
(a) (2) Certifications of principal executive officer and principal financial officer as required by rule 30a-2(a) under the Investment Company Act of 1940 are attached as Exhibit 99.CERT
(a) (3) Not applicable
(a) (4) Not applicable
(b) Certifications of principal executive officer and principal financial officer as required by rule 30a-2(b) under the Investment Company Act of 1940 are attached as Exhibit 99.906CERT
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934 and the Investment Company Act of 1940, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.
The Alger Institutional Funds | |
| | |
By: | /s/Hal Liebes | |
| | |
| Hal Liebes | |
| | |
| President | |
| | |
Date: | June 25, 2019 | |
Pursuant to the requirements of the Securities Exchange Act of 1934 and the Investment Company Act of 1940, this report has been signed below by the following persons on behalf of the registrant and in the capacities and on the dates indicated.
By: | /s/Hal Liebes | |
| | |
| Hal Liebes | |
| | |
| President | |
| | |
Date: | June 25, 2019 | |
| | |
By: | /s/Michael D. Martins | |
| | |
| Michael D. Martins | |
| | |
| Treasurer | |
| | |
Date: | June 25, 2019 | |